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Abstract
During embryonic tissue morphogenesis, cell division increases both the number
of cells and cellular diversity. This is often regulated by the positioning of daughter cells
post-mitosis. The goal of this dissertation research is to determine the mechanisms that
place daughter cells, and how this contributes to tissue development. First, the
zebrafish left-right organizer, Kupffer’s vesicle (KV) is used as a model to investigate the
role of cytokinesis and abscission during de novo lumen formation. The cytokinetic
bridge places at the center of the developing KV rosette, where it acts as a landmark for
Rab11-mediated vesicle trafficking to bring polarity components such as CFTR to the
site of future lumen formation. Next, the early zebrafish embryo is used as a model to
determine how the spindle is oriented to create a monolayer grid formation prior to
three-dimensional embryo expansion. Here, the mitotic spindles are oriented parallel to
each other and perpendicular to the previous cell division plane. A stark asymmetry in
spindle pole size creates a directionality in this spindle positioning, where the larger
spindle pole points towards the center of the embryo in a PLK1- and PLK4-dependent
manner. Lastly, a local drug delivery system was developed in zebrafish embryos to
target a PLK1 inhibitor to the centrosome. Through this system, it was revealed that
centrosomal PLK1 is responsible for spindle organization and mitotic progression in
zebrafish embryos. Taken together, this work describes how the contribution of cell
division to tissue morphogenesis is tissue-specific, raising the argument that further cell
division studies should be conducted in vertebrate systems to understand mitosis in a
three-dimensional tissue context.
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Chapter One:
Introduction: The regulation of post-mitotic daughter cell size, placement,
and fate drives tissue morphogenesis

1

1.1. Abstract. During early development, rapid cell divisions give rise to a large mass of
embryonic cells that will eventually differentiate and build complex tissue structures.
Beyond increasing the number of cells in a tissue, cell division also regulates the
positioning and contents of daughter cells post-division. The work highlighted in this
dissertation focuses on the mechanism of tissue morphogenesis through cell division in
the vertebrate zebrafish model. In this introductory chapter, we define mechanisms that
place the mitotic spindle to give rise to daughter cells of differing position, size, and
content. Additionally, we highlight what is currently known about these mechanisms in
vertebrate and invertebrate settings, as well as discuss the advantages and limitations
of cell division studies in various model systems. Overall, the work detailed in
subsequent chapters aims to contribute to this understanding, detailing novel
mechanisms by which cell division contributes to tissue morphogenesis and introducing
new tool sets to continue this research in the future.

1.2. Introduction. During development, rapid cell divisions give rise to a cell mass that
must organize into functional tissues in order for the organism to survive. Multicellular
structures can have a variety of shapes and functions, spanning from early monolayer
grids in vertebrate development to networks of tubes in an organ system. For example,
a monolayer grid is crucial for the early development of a vertebrate zebrafish embryo,
as it provides a foundation upon which the cell mass will expand on top of a yolk. The
specific placement of cells within this monolayer will impact the integrity of the cell mass
as it grows (Figure 1.1a). Additionally, rosettes are a common multicellular intermediate
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a

Grid

Monolayer

Multiple Cell Layers

rotate
90°

b

Rosette

Lumen

Tubule

Figure 1.1. Examples of multicellular structures in vivo. (a)
Model of early monolayer grid formed in zebrafish embryo
development at 1.5 hours post-fertilization (hpf). Top view of
embryo shown on left with yolk behind gray cells. Side view of
same embryo shown in center panel, rotated such that gray
cells are on top and white yolk on bottom. Later embryonic
stage shown in right panel with multiple gray cell layers on top
of white yolk. (b) Model depicting transition from multicellular
rosette intermediate (left) to lumen (center) and subsequent
tubule formation (right). Lumen space shown in black in center
and right panels.
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structure that precedes the formation of lumens and tubules in tissues within the gut,
renal system, and cardiovasculature1 (Figure 1.1b). These shapes can be formed
through the positioning of cells during and after cell division. The final placement of a
daughter cell post-mitosis is often coordinated through a multi-step process. First, by
the orientation of the mitotic spindle, a macromolecular machine that orchestrates cell
division (Chapter 3)2. Second, by determining the cytokinetic cleavage plane placement
and the directionality of cleavage plane constriction3. Third, through the decision to
sever the cytokinetic bridge connecting two daughter cells within a tissue (Chapter 2). It
is therefore important to understand how the mitotic spindle is positioned, how the
cleavage plane is placed, and when the final severing of the cytokinetic bridge occurs
within a developing tissue to understand the crucial role of cell division in tissue
morphogenesis.

1.3. The role of mitotic machinery in spindle placement during tissue
morphogenesis. In order to create two genetically identical cells from one, the mitotic
spindle is required to physically separate duplicated genetic material into two daughter
cells. This macro-molecular machine is organized by two bipolar microtubule organizing
centers, termed centrosomes (centrosomes are cyan in Figure 1.2). To make two
centrosomes, the single interphase centrosome is duplicated at the same time as the
genetic material during S phase, prior to the construction of the mitotic spindle (Figure
1.3). Centrosomes, microtubules, and microtubule motor proteins (e.g. dynein and
kinesin) are used to build the bipolar mitotic spindle drawn in Figure 1.2. There are
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metaphase
kinetochores
plate
chromosome

Centrosome:
CEP215
pericentrin
ninein (oldest)
cenexin (oldest)

Cell cortex:
NuMA
LGN

astral
microtubules
microtubule

kinetochore
fibers

Figure 1.2. Components of a mitotic spindle.
Model of metaphase mitotic spindle including
kinetochore fibers and astral microtubules (purple),
kinetochores (gold), chromosomes (blue), centrosomes (cyan), and cell cortex (black). Example
proteins found in centrosomes and at the cell
cortex are listed in model.
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multiple microtubule populations within the spindle, including kinetochore fibers and
astral microtubules (Figure 1.2), required to successfully segregate and pull
chromosomes into two daughter cells and to position the mitotic spindle within the cell.
Kinetochore fibers connect the centrosomes to the chromosomes at the
kinetochores. Kinetochores are multi-protein structures that function to connect
microtubules to the chromosomes at the centromere region4. The microtubules that
make up kinetochore fibers can both push and pull on the kinetochores during
chromosomes segregation5 (Figure 1.2). Checkpoints ensure that kinetochore fibers are
attached completely and equally to each duplicated chromosome to ensure segregation
fidelity6. Defects at the interface between kinetochore fibers and chromosomes can
result in defects such as abnormal chromosome number termed aneuploidy. One
consequence of this are genetic conditions such as Down’s syndrome where trisomy
occurs resulting in an extra copy of chromosome 217. A second population of
microtubules called astral microtubules connect the centrosomes to the cell cortex to
anchor the spindle within the cell. These microtubules attach in regions where proteins
such as NuMA and LGN reside at the cell cortex, guiding the placement of the mitotic
spindle within the cell volume (Figure 1.2). This placement can determine how the
spindle orients in context with its surrounding tissue and subsequently determine where
each daughter cell is positioned as a tissue is developing (refer to models Figure 1.41.5).
While chromosome segregation defects are typically the focus when discussing
mitotic errors, spindle orientation defects can also arise when the connection between
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centrosomes and the cell cortex is lost. These occur with loss-of-function mutations in
cell cortex (LGN8,9) and/or centrosome genes (e.g. Cep215/CDK5RAP210 or
pericentrin11), which manifest in disease phenotypes such as microcephaly, heart
malformation, small stature, and/or hearing loss (Figure 1.2).
Mitotic spindle orientation is orchestrated by centrosomes, astral microtubules,
and anchoring proteins at the cortex. A major driver of spindle orientation is signaling at
the oldest centrosome12. During centrosome duplication, one centriole within the
centrosome (the oldest) acts as a template for the other (youngest)13. Once the
centrioles duplicate and centrosomes separate from one another, one of the
centrosomes within the bipolar spindle is innately older than the other as a result (Figure
1.3). This age-dependent asymmetry between the two centrosomes is thought to
modulate spindle placement through astral microtubule regulation by the oldest
centrosome14. For example, the protein cenexin is asymmetrically distributed between
the two centrosomes, localizing to the appendage structures unique to the oldest
centriole in the oldest centrosome14. Cenexin is a scaffold protein for the essential
mitotic kinase PLK1, which is required for the recruitment of pericentriolar matrix
proteins such as pericentrin and CEP21515. The asymmetry in cenexin and other related
asymmetries between centrosomes can therefore result in downstream biochemical
asymmetries that contribute to mitotic spindle orientation.

1.4. Mitotic spindle drives daughter cell position, size, and composition. Based on
mitotic spindle placement, daughter cells can vary in their post-mitotic positions, size
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older
centriole
younger
centriole
Daughter
cell 1

centrosome
containing
younger
centriole

centrosome
containing
older
centriole

Daughter
cell 2

G1 Phase

S Phase

Prophase

Cytokinesis/
Abscission

Kinetochore fibers (MTs)
Chromosomes
Kinetochores
Centrosomes
Centrioles
Midbody

G2 Phase

Prometaphase

Metaphase

Telophase
Anaphase

Figure 1.3. Model of centrosome duplication and cell division. Model depicting the cell cycle
with corresponding centrosome duplication stages. Kinetochore fiber microtubules (purple),
chromosomes (blue), kinetochores (gold), centrosomes (cyan), centrioles (magenta), and
midbody (green) shown. Older and younger centrioles denoted.
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and composition. In cases where cells divide in relation to an extracellular matrix, mitotic
spindles orient such that either both daughter cells interface with the substrate (planar
division), or one daughter cell remains at the substrate and one is located away from
the substrate (oriented division, Figure 1.4)2. By changing the orientation of the spindle,
daughter cells can be placed specifically to contribute to the directional growth of a
tissue. Additionally, cell division can be regulated to result in unequal daughter cells in
regards to their size or composition16. First, the mitotic spindle can be positioned either
at the center of the cell or off-center, resulting in daughter cells of equal size or unequal
size, respectively (Figure 1.5). This occurs in contexts like mammalian germline cell
divisions where cell divisions result in one large daughter cell and one smaller daughter
cell17. The larger of the two daughter cells becomes the ovum, which will go on to be
fertilized and produce a zygote. The smaller daughter cell is extruded as a polar body,
which degenerates through apoptosis in most species and is not capable of fertilization
and organism development18. Secondly, proteins can be asymmetrically segregated
during division to produce daughter cells with different protein composition. This
frequently results in a difference in cell fate for the daughter cells. For example, polarity
proteins such as Par proteins are asymmetrically segregated during early C. elegans
cell divisions to give rise to different cell types in later development19 (Figure 1.6). After
this initial polarity establishment, cells derived from the original anterior cell are primarily
fated to become hypodermis, neural, or pharynx cells, compared to cells derived from
the original posterior cell that are also fated to function as muscle, germline, or intestine
cells20.
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Microtubules Centrosomes
Chromosomes Cell Cortex
Kinetochores Extracellular
Substrate

Planar cell division:

Oriented cell
division:

Figure 1.4. Planar and oriented cell divisions are driven by spindle
orientation in relation to extracellular substrate. Model depicting
examples of planar (left) and oriented (right) cell divisions in relation to
an extracellular substrate (gray, bottom). Microtubules (purple),
chromosomes (blue), kinetochores (gold), centrosomes (cyan), and cell
cortex (black) shown.
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a

b

Daughter cells of same size:

Daughter cells of different size:
Microtubules
Chromosomes
Kinetochores
Centrosomes
Cell Cortex

Figure 1.5. Cell divisions can result in daughter cells
of symmetric or asymmetric size. Model depicting
examples of cell divisions producing daughter cells of
equal (a) or unequal size (b). Microtubules (purple),
chromosomes (blue), kinetochores (gold), centrosomes
(cyan), and cell cortex (black) shown.
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a

Daughter cells with same protein composition:

b Daughter cells with different protein composition:
Microtubules
Chromosomes
Kinetochores
Centrosomes
Cell Cortex
Protein A
Protein B

Figure 1.6. Daughter cells can differ in protein composition
post-division. Model depicting examples of cell divisions
producing daughter cells of symmetric (a) or asymmetric
composition (b). Microtubules (purple), chromosomes (blue),
kinetochores (gold), centrosomes (cyan), and cell cortex
(black) shown. Example of proteins segregated symmetrically
or asymmetrically shown in grayscale.
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Mitotic spindles can be placed to create divisions that fit into more than one of
these categories as well. For example, in the context of brain development, planar cell
divisions are symmetric in nature and produce two progenitor daughter cells residing at
the extracellular matrix, expanding the progenitor pool (Figure 1.4). Alternatively,
oriented and asymmetric divisions result in one progenitor daughter cell at the
extracellular matrix and one daughter cell placed away from the niche that will go on to
differentiate and create cellular diversity in the developing tissue21 (Figure 1.4). Here,
both daughter cell positioning and fate are regulated by spindle orientation.
Alternatively, Drosophila neuroblasts undergo cell divisions that result in daughter cells
of different size, composition, and subsequent fate22. Careful coordination of daughter
cell placement and composition is crucial for the proper development of a functional
tissue. The wide range of daughter cell phenotypes created by the positioning and
orientation of the mitotic spindle ensures that cell division during tissue morphogenesis
not only increases cell number, but cellular diversity as well.
Once the spindle has formed and chromosomes segregated, the process of
cytokinesis constricts the cell cortex into a cleavage furrow to begin daughter cell
separation. This cleavage furrow is typically positioned over the center of the spindle,
further defining the plane by which the daughter cells will be positioned post-mitosis3
(Figure 1.3). This process resolves the cleavage furrow into a cytokinetic bridge
connecting the two daughter cells that is eventually severed through the process of
abscission. During abscission, endocytic and secretory vesicles are trafficked to the
cytokinetic bridge to coordinate the final severing of the bridge by the ESCRT
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(endosomal sorting complex required for transport) complex, completing the final
separation of the two daughter cells23 (Figure 1.3).
Here we will focus on four mechanisms that drive cell placement following
division during tissue morphogenesis: mitotic spindle placement, asymmetric cell
division, cleavage plane determination, and abscission.

1.5. Mitotic spindle placement. During mitosis, a cell needs to be able to sense its
shape in order to properly place its mitotic spindle. The majority of spindles are placed
along the longest axis of the dividing cell, which has become known as Hertwig’s rule24.
This allows cell division to align along the plane of tissue tension in some cases, where
generation of daughter cells during division will alleviate the existing tension25, or
regulate the geometry . However, the mechanism by which cells sense their shape is
unknown in contexts such as early embryo cell divisions, where the size of the cell is
disproportionately large compared to that of the spindle.
During early embryonic cell divisions, cells become smaller and smaller over time
as the number of cells increases and the overall cell mass remains constant. These
early divisions are termed cleavage divisions, and they build an embryonic cell mass of
sufficient size to begin forming functional tissues during development26. However, it has
remained unclear how the mitotic spindle adjusts to cell size to determine the longest
cell axis throughout these early divisions where drastic changes in cell size occur. One
particular study surveyed the embryos of multiple metazoan organisms to understand
how the size of mitotic spindles related to their surrounding cell size during early
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divisions. This study determined that across various organisms including nematodes,
annelids, echinoderms, chordates, and nemertea, spindle size scaled linearly with cell
size during the first few cell divisions of development. However, this study also
concluded that this finding was limited to cells below 140 microns in diameter27. Since
vertebrate organisms such as zebrafish and Xenopus begin development with cell
diameters in this range or higher, it is crucial to determine how mitotic spindles can span
these large cells in order to properly segregate genetic material in early development if
not by this type of spindle scaling mechanism.
It has been suggested that there is a limit to the size of the mitotic spindle even in
extremely large cells. For example, while early Xenopus cells can reach diameters of
over 1000 microns, spindles do not reach lengths of more than about 60 microns28. This
leaves a large cellular distance between the mitotic centrosomes and cell cortex that
needs to be spanned for the mitotic spindle to be able to separate chromosomes. One
theory is that microtubule nucleation can occur in locations other than the mitotic
centrosomes. This would allow for shorter astral microtubules to span this distance by
positioning their minus-ends between the centrosome and the cell cortex29. However,
this theory has been tested in a cell-free system, where extract from Xenopus embryo
was utilized instead of dividing cells in a live embryo. It is therefore difficult to ascertain
whether this is representative of cell divisions in the Xenopus embryo as well, or
whether these findings are specific to the cell-free system.
Several studies have sought to determine how mitotic spindles are able to sense
their shape to successfully facilitate cell division in cells that seem disproportionately
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large. For example, in early zebrafish cleavage divisions, a monolayer grid needs to be
constructed to serve as the foundation upon which three-dimensional embryo expansion
will subsequently occur. In order for complex multi-cellular structures to be built in early
embryos, a shape-sensing mechanism likely exists to facilitate spindle placement in
these disproportionately large cells.
Studies in the early zebrafish embryo have proposed that large, uniquely
structured centrosomes may account for how astral microtubules are able to span the
large distance from mitotic centrosome to cell cortex in large embryonic cells (see
Chapter 3). Here, the mitotic centrosomes decreased in size as cells decreased in size
throughout early cell divisions, providing a possible shape-sensing mechanism to aid in
mitotic spindle placement in large zebrafish embryonic cells. These dramatically
enlarged centrosomes eventually focus into smaller centrosomes in later developmental
stages, closely resembling those seen in smaller somatic cells in tissue culture settings.
This suggests that the dramatically large centrosomes (~125µm2 in diameter at 8-cell
stage) found in the early zebrafish embryo is specific to cell divisions in large embryonic
cells. In order to gain a more complete understanding of the mechanism for longest axis
sensing, it is necessary to utilize both in vivo model organisms and in vitro settings. For
example, the centrosome size and morphology found in large embryonic cells can be
more thoroughly characterized in multiple embryonic model systems to determine which
characteristics are conserved. In parallel, an in vitro setting can be utilized to study how
centrosome morphology changes under different conditions of cell size constraint, and
whether the shape-sensing mechanism of the cell is altered. In vivo studies have also
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been conducted in this manner to determine the mechanism of spindle and nucleus
centering under cell geometry constraint. Here, sea urchin embryos were placed in
chambers of various shapes and sizes to determine how effective the shape-sensing
mechanism is in various cellular aspect ratios30. Here, the nucleus positioned at the
center of the cell to divide along the longest axis of symmetry across a variety of cell
shapes and aspect ratios, demonstrating a cellular shape-sensing mechanism for
division plane positioning. Moving forward, both in vitro and in vivo studies should be
used in tandem to determine the mechanism by which a cell is able to sense its shape
and appropriately place a mitotic spindle.

1.6. Asymmetric cell division. Spindle positioning can also be regulated to produce
daughter cells of two different sizes during asymmetric cell division. This is an important
mechanism that ensures cellular diversity. Asymmetric spindle placement occurs
through the breaking of cellular symmetry, such as during the asymmetric placement of
signals in the early C. elegans embryo that causes the spindle to shift to one side31.
During the first cell division in a C. elegans embryo, proteins are asymmetrically
segregated into the two daughter cells (refer to Figure 1.6). An example of this
asymmetric protein segregation is the distribution of Par proteins, named after the
partitioning defects seen upon mutation, knockout, or mislocalization of these proteins32.
At the start of the first C. elegans cell division, PAR-3 and PAR-6 localize to the anterior
region of the one-cell stage embryo, whereas PAR-1 and PAR-2 localize posteriorly
during the one-cell stage. After the first embryo cell divides, the larger, anterior cell of
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the embryo becomes enriched for PAR-3 and PAR-6 protein and the smaller, posterior
of the embryo contains more PAR-1 and PAR-219. This asymmetry in Par protein
localization across the anterior-posterior axis of the embryo results in a downstream
asymmetry of components necessary for spindle pulling-force generation. GRP-1/2 are
proteins required to generate a pulling force through the astral microtubules during cell
division. They are also enriched at the posterior end of the embryo in a PAR-2- and
PAR-3-dependent manner. This asymmetry in protein localization translates to an
asymmetry in spindle pulling forces, which shifts the spindle towards the posterior end
of the embryo during asymmetric division. Here, mislocalization or loss of GPR-1/2,
PAR-2, or PAR-3 result in a symmetric positioning of the spindle in the one-cell embryo
33.

While early C. elegans establish polarity at the one-cell stage, this is not a common

mechanism for polarity establishment in other in vivo contexts such as vertebrate
embryos.
Asymmetric cell division is not an event specific to the early C. elegans embryo,
as vertebrates also employ it to establish cellular diversity. However, the establishment
of an anterior-posterior axis in vertebrate embryos such as mice or zebrafish does not
occur until much later in embryonic development. Axis establishment typically occurs
either hours (in zebrafish) or days (in mice) after fertilization when the embryo has
established a sizeable cell mass. In zebrafish for example, it has been suggested that
the anterior-posterior axis is determined during oogenesis through the asymmetric
distribution of maternal mRNAs34,35. After fertilization, a cell mass is constructed on top
of a large yolk through multiple synchronous rounds of cell division followed by
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asynchronous rounds of division. These early divisions occur within the first few hours
post-fertilization to help further refine the anterior-posterior axis prior to gastrulation36.
Alternatively in mouse embryos, early asymmetric divisions beginning at the 8-cell stage
result in the distinction between inner and outer cell mass cells, which lead to important
cell fate decisions in the later embryo37. The mouse anterior-posterior axis is not formed
until approximately five days after fertilization, after transitioning from the previously
established proximal-distal axis earlier in development38. When comparing these two
vertebrates to C. elegans embryos that establish their anterior-posterior axis on their
first cell divisions, it is clear that divergent mechanisms have been established to set up
an anterior-posterior axis.
In addition to the asymmetric distribution of proteins or mRNAs post-mitosis,
membrane organelles can also be segregated unequally into daughter cells. In
Drosophila sensory organ precursor (SOP) cells, fate can be determined based on the
presence of Rab11-associated recycling endosomes in daughter cells post-mitosis.
Rab11 is a small GTPase that regulates a specific compartment within the endocytic
pathway, recycling endosomes39,40. Strikingly, one daughter cell inherits a large pool of
Rab11-associated vesicles between anaphase exit and abscission which transport a
ligand in the Notch pathway to specify a certain cell fate. The other daughter cell lacks
the crucial binding partner of Rab11, nuclear fallout (Nuf), so recycling endosomes are
unable to form and transport the ligand41. This creates two different cell fates through
the asymmetric distribution of Rab11-associated endosomes in post-mitotic daughter
cells. While SOP cells are specific to the invertebrate Drosophila model, a study has
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found that a Rab11 asymmetry exists in mammalian cells grown in vitro where recycling
endosomes interact specifically with the oldest mitotic centrosome39. An additional study
has implicated Rab11 in spindle organization and orientation as well, where mitosis is
delayed, astral microtubules are disrupted, and centrosome proteins are misorganized
when Rab11 is depleted or mutated40. It is therefore possible that Rab11 plays a more
pivotal role in driving spindle orientation in asymmetric division contexts through directly
regulating the spindle itself.
The mitotic spindle is asymmetric in nature, containing an older and a younger
mitotic centrosome that assemble the microtubule based spindle (Figure 1.3).
Interestingly, this innate asymmetry has been linked to asymmetric cell division in a
stem cell niche, such as the Drosophila germline. Here, the division plane is placed
perpendicular to the stem cell niche resulting in one daughter cell that remains in the
niche and one that is positioned away from the niche (Figure 1.4). The oldest
centrosome is specifically segregated into the self-renewed stem cell, whereas the
youngest centrosome is inherited by the daughter cell fated to differentiate42. While this
work was conducted in an invertebrate system, it is similar to findings in the mouse
brain where radial glia progenitors are more likely to inherit the oldest centrosome after
division, and daughter cells destined to differentiate inherit the youngest centrosome43.
Alternatively, a separate study concluded that the opposite scenario occurs in
Drosophila neuroblasts, where the older of the two mitotic centrosomes is inherited by
the daughter cell fated to differentiate44. Another conflicting study suggested that an
asymmetry in centrosome inheritance does not exist in the developing mouse
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cerebellum, where the localization of the oldest centrosome was not correlated with cell
fate despite a stark asymmetry in centrosome composition45. Although one centrosome
contained the protein ODF2, an appendage protein that denotes the oldest centrosome,
there was no trend noted in the fate of post-mitotic cells and the age of the centrosomes
they inherited. These differences in centrosome inheritance across various tissues in
both vertebrates and invertebrates reiterate the need to conduct studies into the role of
cell division during tissue morphogenesis in various organisms and tissue types. The
caveat here is that live tracking of centrosome inheritance during asymmetric cell
divisions is difficult or impossible in many vertebrate systems like mice. However, the
optical transparency of the zebrafish embryo make it a great candidate for continued
study of asymmetric centrosome inheritance in a variety of vertebrate tissues.

1.7. Lumen establishment through cell division. Lumenogenesis in the zebrafish
Kupffer’s vesicle (KV) is one example of how the role of cell division during tissue
formation has been elucidated using the vertebrate zebrafish model (see Chapter 2). KV
is a cyst of polarized cells surrounding a fluid filled lumen and functions as the left-right
organizer in zebrafish. Within the KV lumen, motile cilia beat and produce a leftward
fluid flow within the lumen space that is thought to establish the left-right axis. This
organ is conserved across most vertebrates and is analogous to the node in
mammals46. Interestingly, the formation and function of the KV lumen is analogous to
lumens in other tissue and organ contexts. The main function of a lumen is to move air
or fluid through an organ. This movement allows for processes such as digestion,

21

filtering, and transport of components to different regions of an organism47. Some
lumens like that within KV remain as small sphere-shaped hollows, while many other
are elongated into tubules such as blood vessels or the intestine. Defects in lumen
formation can cause a variety of diseases, such as polycystic kidney disease48,
hypertension from vascular lumen defects49, and reversed organ placement due to leftright organizer lumen defects50. One contributor to defective lumen formation is
defective cell division, where either inappropriate placement of the mitotic spindle or
inappropriate timing of cytokinetic bridge cleavage result in disrupted lumenogenesis51.
Lumens can form through a variety of different mechanisms. One such
mechanism is called cavitation, where apoptosis at the center of a polarizing cell mass
creates a hollow lumen or tubule. This occurs in contexts such as mammary glands52,53
and salivary glands54,55. Conversely, hollowing is a separate process of lumen
formation, where directed membrane trafficking during cell division brings membrane to
the future apical membrane56,57, which gives rise to a lumen in contexts such as blood
vessels58–60 and the zebrafish left-right organizer, KV46,61–63. A third mechanism of
lumen formation occurs in the neural tube64, where an epithelial sheet invaginates,
seals, and separates itself from the original cell sheet to form an elongated lumen tube.
All three of these mechanisms result in a hollow lumen surrounded by an epithelial
sheet. However, the role of cell division in each of these contexts has not been carefully
explored.
To understand the mechanisms that contribute to lumen formation, in vitro threedimensional mammalian tissue culture systems have been frequently employed. These

22

ex vivo systems are advantageous because they allow cellular and intracellular events
to be easily monitored using live cell imaging unlike many in vivo mammalian models.
In these systems, the placement of the cytokinetic bridge is correlated with the initiation
of an apical membrane. One cell in a matrix suspension divides into two cells, and a
lumen begins to form where the cytokinetic bridge is positioned and likely cleaved
between these cells (modeled in Figure 1.7)65,66. While cytokinetic bridge cleavage has
yet to be clearly resolved in this context, the directed membrane trafficking of apical
polarity components such as tight junctions and aPKC has been clearly defined46,50,67–
69.

These proteins are transported to the cytokinetic bridge between two dividing cells in

a three-dimensional culture, and this location will eventually become the apical
membrane of the nascent lumen65,70,71. This directed membrane transport requires the
small GTPase Rab11 and its associated effector protein, FIP3 (Family of Rab11Interacting Proteins 3), for appropriate delivery of apical polarity proteins to the bridge
and membrane remodeling at this site72. Once remodeling occurs on either side of the
cytokinetic midbody, bridge cleavage (abscission) occurs through the use of ESCRT73.
After the lumen is formed during this first cell division, subsequent cell divisions occur
with mitotic spindles oriented parallel to the plane of the lumen74. Ingression then occurs
asymmetrically with the furrow constricting towards the apical membrane75 (modelled in
Figure 1.7). This ex vivo system created a testable model in which the first cell division
initiates lumen formation and subsequent divisions are oriented appropriately to expand
the lumen.
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a

Ex vivo:

b

In vivo:

Lumen formation

Lumen formation

Lumen expansion

Lumen expansion

Cytokinetic Midbody
Apical Membrane
DNA

Figure 1.7. Cell division drives lumen formation ex vivo and in vivo. (a) Model depicting
lumen formation ex vivo from single cell (left) to lumen formation within two cells (center)
and subsequent lumen expansion (right). (b) Model depicting lumen formation in vivo from
group of cells (left) to lumen formation from a rosette intermediate (center) and subsequent
lumen expansion (right). Note position of cytokinetic bridge marked by midbody (orange).
Cytokinetic midbody (orange), apical membrane (magenta), and nuclei (blue) shown within
cell boundaries (black).
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The idea that apical membranes could be expanded through alignment of the
mitotic spindle along the face of a lumen originated with studies using MDCK (MadinDarby canine kidney) monolayer cultures. In this system, molecular cues were identified
that are required to orient the spindle in polarized cells76–78. It was determined that astral
microtubules are anchored to the cell cortex via cadherins, where LGN binds and
recruits NuMA. The location of this interaction is dictated by the Cdc42-dependent
positioning of aPKC, as the NuMA-LGN complex is excluded by aPKC. Astral
microtubules are able to anchor to the NuMA-LGN complex through the interaction of
dynein with NuMA79. Astral microtubules therefore connect the centrosome to the cell
cortex through these proteins to position the spindle within the confines of the cell.
When centrosome appendage proteins14, cadherins76–78, aPKC80, Cdc4274, NuMA81, or
LGN9 are mutated or mislocalized, the mitotic spindle misorients in relation to the cells
substrate. In the case of an expanding monolayer, the misregulation of these proteins
would therefore result in randomized spindle placement in relation to the monolayer.
Daughter cells would instead protrude away from the monolayer instead of incorporating
into and expanding the monolayer76–78. When using MDCK cells in a three-dimensional
culture, a single MDCK cell resuspended in an extracellular matrix will expand into a
multi-cellular cyst with a hollow lumen. Studies in this system found that in order for the
cells to organize into a cyst with a single lumen, spindles needed to orient parallel to the
apical membrane. Here, disruptions in components such as Cdc4282 or the centriole
appendage protein cenexin14 result in spindle misorientation and subsequent multi-
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lumen phenotypes. Studies in this system introduced the idea that spindle orientation
was essential in the development, specifically expansion, of a lumen.
The connection between proper spindle orientation and lumenogenesis originally
studied in in vitro settings was corroborated by several in vivo mouse studies as well.
For example, defects in spindle orientation caused by disruption of E-cadherins resulted
in randomized spindle orientation in relation to the luminal plane in mouse prostate
development83, and similar phenotypes were observed in mouse seminiferous tubules
upon depletion of a centrosome scaffold protein, Gravin84. Additional studies were
performed in a developing zebrafish, where depletion of the spindle pole protein IFT88
resulted in misoriented spindles in the developing zebrafish pronephric duct85. One
caveat here is that these studies are correlative, since live imaging of a misoriented
spindle could not be accomplished to determine if a multi-lumen phenotype resulted. In
order to definitively determine whether spindle orientation defects results in disrupted
lumenogenesis, live imaging would have to be feasible. This suggests that zebrafish are
an ideal model to investigate the role of spindle orientation during lumenogenesis.
Additionally, further studies would be necessary to determine whether proper spindle
orientation is required for lumen formation, lumen expansion, or both.

1.8. Studies in zebrafish have demonstrated a separate mechanism for lumen
formation and expansion. The zebrafish KV utilizes a transient rosette as a
prerequisite structure before transitioning to polarized cells surrounding a fluid filled
lumen. Rosettes are common intermediate structures that consist of five or more cells
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interfacing at a single locus (Figure 1.1 and 1.7). The cells that make up the rosette
adopt wedge shape through actomyosin contractility at the apical membrane1. Rosette
formations are seen in a variety of organs and tissue types in vivo such as the eye86,
kidney87, pancreas88, KV, and lateral line89. In cases such as pancreas branching, the
rosette structure will resolve and contribute to tissue elongation. Conversely, in cases
like KV or kidney tubule formation, a lumen will open and expand at the central locus
where the rosette cells interface. Interestingly, while rosettes are seen prior to lumen
formation in vivo, the rosette intermediate is not seen in in vitro contexts. The transition
from rosette to lumen likely uses conserved intracellular mechanisms similar to the ex
vivo models described (and modeled in Figure 1.7), however it is also likely that unique
mechanisms exist that need to be identified through in vivo exploration.
In our recent studies, we identified for the first time that the placement and
severing of the cytokinetic bridge at the center of the rosette drives KV lumen formation
(Chapter 2). One of the most striking advances in this study was the live imaging of an
abscission event in vivo, which has not been accomplished before. Similarly, we were
able to follow live mitotic cells during KV development, and we determined that spindle
positioning from metaphase to anaphase was random with respect to the lumen. If
spindle orientation was the driving factor in lumen expansion, we would expect that
mitotic spindles to be placed parallel to the apical membrane or plane of the lumen14,74.
However, since spindle orientation was determined to be random, we concluded that
spindle orientation was not a driving factor in lumen establishment or maintenance as
was seen in in vitro contexts. Instead, we observed that daughter cells are repositioned
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as they enter cytokinesis in order to project the cytokinetic bridge towards the center of
the rosette (modeled in Figure 1.7). It is therefore likely that various mechanisms of
lumen expansion are utilized across different tissue types, requiring the study of lumen
expansion in many in vivo and in vitro settings to fully understand the process.
In addition to these mechanistic differences, our studies also identified similarities
between ex vivo and in vivo lumen formation. For instance, we determined that Rab11mediated vesicle motility is required in the KV to bring apical polarity proteins such as
CFTR (cystic fibrosis transmembrane conductance receptor)50 to cytokinetic bridges at
the center of the rosette (refer to model Figure 1.7) to aid in the establishment of the
apical membrane and a subsequent lumen. This is similar to findings in ex vivo threedimensional acini71. We expanded upon both the ex vivo and our in vivo models by
acutely inhibiting abscission or by prematurely severing the cytokinetic bridge. In both
instances, a lumen was unable to form or was much decreased in size61. Our studies
are unique in that they demonstrate the importance of comparing ex vivo and in vivo
studies to identify cellular and intracellular mechanisms of cell division during
construction of a three-dimensional tissue.

1.9. Implications of tissue morphogenesis studies in an in vivo model. Overall, it is
becoming clear that a move towards the use of various in vivo models that can be
coupled with live-cell imaging approaches is necessary to elucidate both the conserved
and unique mechanisms by which cell division contributes to tissue morphogenesis. The
research detailed in the subsequent chapters of this dissertation highlight the various
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imaging, optogenetic, pharmacological, and molecular toolsets that can be utilized to
unravel how cell division is regulated during vertebrate development. Future research in
model systems such as zebrafish will ensure a greater understanding of the tissuespecific mechanisms that build complex three-dimensional structures through mitosis.
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Chapter Two:
Cytokinetic bridge triggers de novo lumen formation in vivo
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2.1. Abstract. Multicellular rosettes are transient epithelial structures that serve as
intermediates during diverse organ formation. We have identified a unique contributor to
rosette formation in zebrafish Kupffer’s Vesicle (KV) that requires cell division,
specifically the final stage of mitosis termed abscission. KV utilizes a rosette as a
prerequisite before forming a lumen surrounded by ciliated epithelial cells. Our studies
identify that KV-destined cells remain interconnected by cytokinetic bridges that position
at the rosette’s center. These bridges act as a landmark for directed Rab11 vesicle
motility to deliver an essential cargo for lumen formation, CFTR (cystic fibrosis
transmembrane conductance regulator). Here we report that premature bridge cleavage
through laser ablation or inhibiting abscission using optogenetic clustering of Rab11
result in disrupted lumen formation. We present a model in which KV mitotic cells
strategically place their cytokinetic bridges at the rosette center, where Rab11associated vesicles transport CFTR to aid in lumen establishment.

2.2. Introduction. Tissue morphogenesis is a fundamental process that contributes to
building and maintaining organs, as well as orchestrating overall embryogenesis90. How
these morphogenic changes are coordinated at a molecular and cellular level remains a
central question to developmental biology. One common cellular rearrangement that
occurs during tissue morphogenesis is the generation of a transient epithelial rosette
that remodels to form a finalized organ with apical-basal polarity and a central lumen.
Rosettes are multicellular structures that interface at a central point. Rosette formation
has been observed in many contexts including Drosophila eye morphogenesis,
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zebrafish lateral line development, mouse and Xenopus kidney tubule formation, and
pancreatic branching in mice86–89. Our studies here utilize the left-right organizer,
Kupffer’s vesicle (KV), in the vertebrate model Danio rerio to characterize a mechanism
of rosette and subsequent lumen formation.
KV is a conserved organ of asymmetry that is required in all vertebrates to place
visceral and abdominal organs with respect to the two main body axes and requires the
formation of a rosette structure before it fully develops91,92. The mechanism of
asymmetry establishment in some mammals (humans, mouse, rabbit), fish, and
amphibians is that the organ of asymmetry creates a leftward flow through motile cilia in
the extracellular lumen to initiate the asymmetrical expression of 3 genes, Nodal, Lefty,
and Pitx2, across the embryo93. Due to the conservation of this organ, the ease of
transgenics, and live cell imaging of a transparent embryo, KV was used as an in vivo
model for lumen formation. The current framework for KV development is that nonpolarized mesenchymal cells organize into a two-dimensional (2D) rosette-like structure
that will assemble into a three-dimensional (3D) sphere with a fluid-filled lumen. During
rosette assembly the individual cells start to establish apicobasal polarity46. While
events downstream of KV’s leftward fluid flow have received much attention94, little is
known about the mechanism required for KV assembly.
KV rosette formation may require the actin-myosin network at the apical
membrane46. This same actin-myosin network drives contractile ring formation during
cytokinesis, a process of separating the two daughter cells following mitosis95. Following
cytokinesis, a cytokinetic bridge remains between the two daughter cells for a duration
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of 1-3 hours depending on cell type96,97. The remaining bridge is cleaved in a process
called abscission. To accomplish this, the bridge is first resolved to a diameter of
approximately 1-2 micrometers permitting the Endosomal Sorting Complexes Required
for Transport (ESCRT) to sever the bridge98,99. In 3D kidney epithelial cell cultures that
form a sphere with a central lumen, the cytokinetic bridge furrow ingression occurs
towards the center of the sphere where the apical membrane is established75,100.
Here, our studies demonstrate that the cytokinetic bridge acts as a symmetry
breaking event to signal where the apical membrane of the dividing cell is positioned.
We find in the developing zebrafish embryo that the process of cell division is required
for KV morphogenesis. Specifically, the placement of the cytokinetic bridge and its
appropriate cleavage is involved in KV transition from a rosette structure to a sphere
with a fluid filled lumen.

2.3. Results and Discussion
2.3.1. Mitosis is required for lumen formation. KV uses a rosette intermediate before
forming a lumen (Figure 2.1a-b)46. KV precursor cells are visualized in live embryos by
decorating the plasma membrane with GFP (Sox17:GFP-CAAX, Figure 2.1b). The
current framework for KV development is that mesenchymal precursor cells transition to
epithelial KV cells (MET), which requires establishment of apicobasal polarity, apical
clustering, and the expansion of apical cell surfaces to facilitate the formation of a
central lumen101 (Figure 2.1a-b). To investigate the contribution of cell division to KV
development, we first calculated the mitotic index of cells destined to form KV compared
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Figure 2.1. Mitosis is required for
lumen formation. (a) Model depicting
zebrafish embryo (top) and KV
morphology (bottom) during development. Approximate location of KV
denoted by magenta spot. KV membrane (magenta) and regions of apical
polarity (black) depicted in model
below. (b) Top: maximum confocal
projections of KV at developmental
stages denoted in panel a. pH3
(mitotic nuclei, cyan) and KV membrane marker (Sox17:GFP-CAAX,
magenta) shown. Bottom: KV membrane marker (Sox17:GFP-CAAX,
gray) and lumen trace (orange)
shown. Bars, 50μm. (c) Mitotic indices
(%) represented as violin plot with
endpoints depicting minimum and
maximum values, quartiles depicted
by thin black lines, median depicted by
thick black line. n > 247 cells/stage, n
= 43 embryos, two-tailed, unpaired
Students t-test. Statistical results
detailed in Methods Table 5. (d)
Representative 3D renderings of KV
under conditions of DMSO vehicle
control, microtubule inhibition (1μM
nocodazole) or PLK1 inhibition (1μM
BI2536). Sox17:GFP-CAAX (magenta), pH3-positive nuclei (cyan), and
DAPI (blue) shown on left. Sox17:GFP-CAAX (gray) and lumen trace
(orange) shown on right. Percentages
indicate mitotic index of image, lumen
area denoted. Bar, 20μm. (e) Violin
plot depicting normalized 2D lumen
area under conditions represented in
(d) with endpoints depicting minimum
and maximum values, quartiles
depicted by thin black lines, median
depicted by thick black line. One-way
ANOVA with Dunnett’s multiple
comparison, statistical results detailed
in Methods Table 5 (****, p<0.0001 for
n>41 embryos).

to other stages of development. The mitotic index was measured during the first 24
hours post-fertilization (hpf). In this time frame, embryos transition through four basic
developmental stages: the cleavage period (0-2.25 hpf), the blastula period (2.25-5.25
hpf), the gastrula period (5.25-10 hpf), and the segmentation period102 (10-24 hpf,
Supplementary Figure 2.1a). KV formation occurs between the gastrula and
segmentation period. During the cleavage period the mitotic index is 100% and steadily
decreases to ~3% during the subsequent periods (Supplementary Figure 2.1a-c).
Between the gastrula and segmentation period, KV cells had a mitotic index between 510% as seen by pH3-positive cells in fixed embryos (Figure 2.1b-c) or with PLK1mCherry in live embryos (Polo-like Kinase 1). This index was significantly greater than
the mitotic index in cells outside the KV (Figure 2.1c), suggesting division entry is
upregulated in KV-destined cells, providing a program where division is incorporated to
contribute to KV morphogenesis.
To determine if cell division is required for KV lumen formation, we treated cells
with two different mitotic synchronizing agents: a small molecule inhibitor of an essential
mitotic kinase, Polo-Like Kinase 1 (PLK1, BI2536, used in 103,104), or a low dose of a
microtubule destabilizing drug to disrupt spindle dynamics (nocodazole, used in 105).
PLK1 inhibition can result in cells arresting in G2, prometaphase, metaphase, or
cytokinesis15. Nocodazole treatment can cause overall microtubule destabilization at
high doses leading to disruption of intracellular trafficking (usually at 10µM)106,107, but at
lower doses (100nM) the majority of microtubules are intact and defects in
prometaphase exit occur 15,103,108. During 75-90% epiboly, dechorionated embryos were
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Supplementary Figure 2.1. Mitosis is required for lumen formation. (a) Timeline depicting zebrafish embryo
development from 0-12 hours post-fertilization (hpf, top) and models with embryo morphology during these stages
(bottom). Adapted from Kimmel et al 1995. (b) Representative confocal projection of nuclei during the blastula, gastrula, and segmentation periods. Mitotic nuclei (cyan) and non-dividing nuclei (blue) displayed. Percentages indicate
mitotic index of image. Bar, 20μm. (c) Histogram displaying mitotic index from 0-12hpf. Cleavage (C, orange), blastula
(B, green), gastrula (G, purple), and segmentation (S, blue) periods highlighted. n > 80 embryos ± SEM. n=6 (0-2hpf),
10 (2-4hpf), 11 (4-6hpf), 3 (6-8hpf), 9 (8-10hpf), 32 embryos (10-12hpf) from 11 clutches. (d) Representative 3D
renderings of KV under conditions of microtubule inhibition (100nM nocodazole) or PLK1 inhibition (100nM BI2536).
Sox17:GFP-CAAX (magenta), pH3-positive nuclei (cyan), and DAPI (blue) shown on left. Sox17:GFP-CAAX (gray)
and lumen trace (orange) shown on right. Bar, 20μm. Percentages indicate mitotic index of image. (e-f) Violin plot
depicting KV mitotic index (e) or cell number (f) under conditions of DMSO (black), BI2536 (orange), or nocodazole
(blue) treatment. Endpoints depict minimum and maximum values, quartiles depicted by thin black lines, median
depicted by thick black line. (e-f) One-way ANOVA, p<0.00001 (****). (e) DMSO: n=27 embryos, 100nM BI2536: n=35
embryos, 1μM BI2536: n=30 embryos, 100nM nocodazole: n=39 embryos, 1 μM nocodazole: n=40 embryos per
treatment over four independent experiments. F(4,166)=8.733, df=166. (f) DMSO: n=32 embryos, 100nM BI2536:
n=40 embryos, 1μM BI2536: n=37 embryos, 100nM nocodazole: n=48 embryos, 1 μM nocodazole: n=45 embryos per
treatment over four independent experiments. F(4,197)=6.137, df=197. (g) Scatter plot depicting relationship
between number cells in KV (normalized to control mean, x-axis) and 2D lumen area (normalized to control mean,
y-axis). DMSO (black), BI2536 (orange), and nocodazole (blue) treatment conditions included. n>31 embryos per
treatment across five independent experiments. Pearson’s correlation: r=0.3653, p<0.0001 (****), n=206 pairs of x,y
values. Detailed statistical analysis in Methods Table 5.
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treated with a vehicle control (DMSO), nocodazole (100nM or 1μM), or BI2536 (100nM
or 1μM, Figure 2.1d and Supplementary Figure 2.1d). The embryos were allowed to
develop to 6-somite stage, where control embryos had a fully developed lumen (Figure
2.1d-e). However, lumen area was significantly lower after BI2536 or nocodazole
treatments (Figure 2.1d-e). BI2536 and nocodazole treatments resulted in significantly
increased mitotic indices compared to control DMSO-treated embryos (Supplementary
Figure 2.1d-e), as well as significant decreases in KV cell number (Supplementary
Figure 2.1f) suggesting that defects in cell proliferation resulted in abnormal lumens.
When comparing the lumen area and number of KV cells for each embryo analyzed, a
positive relationship between these two variables occurred such that an increase in the
KV cell number correlates with an increase in the KV lumen area (Supplementary
Figure 2.1g). These studies suggest that defects in lumen formation occur when cell
division is disrupted.

2.3.2. Cytokinetic midbodies localize to apical membranes. We hypothesized that
KV cell placement post-division may be driving KV development, and therefore needed
to establish both live and fixed markers of mitotic machinery during zebrafish embryo
development. In addition to the nuclear marker H2B-Dendra that marks all nuclei
(Supplementary Figure 2.2a), two markers were developed for live-cell microscopy in
zebrafish: Polo-Like Kinase 1 (PLK1-mCherry,103, Supplementary Figure 2.2b) and/or
mitotic kinesin-like protein (GFP/mKate-MKLP1, Supplementary Figure 2.2c-d). PLK1 is
an essential mitotic kinase that localizes to mitotic spindle poles, kinetochores, and
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Figure 2.2. Cytokinetic midbodies localize to
apical membranes of lumens in vivo. (a-c)
Maximum confocal projections of KV in zebrafish
embryos during apical clustering (a), lumen formation (b), and lumen expansion (c). Immunolabeled
for midbodies (MKLP1 (a) or RacGAP (b-c), cyan), a
polarity marker (aPKC (b), white), and a membrane
marker (Sox17:GFP-CAAX, magenta). Bars, 50μm
(a, c), 20μm (b), and 10μm (c, inset). Midbodies
localizing to apical membrane during KV lumen
formation and lumen expansion denoted by yellow
arrowheads (b, c). (d) Representative images of
midbody localization (RacGAP, white) within KV
(Sox17:GFP-CAAX, magenta and DAPI, blue).
Pre-rosette (top), rosette (middle), and lumen
(bottom) stages of KV development depicted.
Orange arrowheads denote apical midbodies, cyan
arrowheads denote peripheral midbodies. Bar, 50μ
m. (e) Violin plot depicting percentage of apical
midbodies in KVs at pre-rosette (n=21 embryos),
rosette (n=16 embryos), and lumen (n=35 embryos)
stages. Endpoints depict minimum and maximum
values, quartiles depicted by thin black lines, median
depicted by thick black line. n>4 independent
experiments. One-way ANOVA, p<0.0001 (****),
F(2,69)=104.7, df=69.
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Supplementary Figure 2.2. Cytokinetic midbodies localize to apical membranes of lumens in vitro and in
vivo. (a-b) Maximum confocal projections of live cell divisions shown by nuclear marker (H2B-Dendra, a) and mitotic
marker (mCherry-PLK1, b). Bars, 10μm. (c) 3D rendering of a live Sox17:GFP-CAAX-positive cell (blue) expressing
PLK1-mCherry (white) as it progresses through mitosis. Bar, 10 μm. (d) Maximum confocal projections of a live
mitotic cell as it progresses from metaphase (0 sec) to cytokinesis (720 sec). PLK1-mCherry (magenta) and
GFP-MKLP1 (cyan) depicted. Bar, 5μm. (e) Maximum confocal projections of fixed mitotic cells during metaphase,
anaphase, cytokinesis, and pre-abscission. Nuclei (blue), MKLP1 (cyan), PLK1 (magenta), and acetylated tubulin
(gold) shown. Green arrowheads depict locations of centrosomes during cytokinesis. Bar, 5μm. (f-g) Maximum
confocal projections of fixed embryos during lumen formation and lumen expansion stages of KV development.
Midbodies (RacGAP, cyan) and KV membrane (CAAX, magenta) shown. Bar, 20μm. (h) Maximum STED microscopy projections of fixed embryos depicting the cytokinetic midbody (RacGAP, cyan), apical polarity (aPKC, magenta),
and acetylated tubulin (blue). Bar, 5μm. (i) Maximum projection depicting a midbody (RacGAP, cyan) and associated
cytokinetic bridge (tubulin, magenta). Bar, 10μm. (j) MDCK 3D-acini immunolabeled for actin (magenta), midbodies
(MKLP1, cyan), and nuclei (DAPI, white). Bar, 20μm. (k) Diagram depicting the boundary between apical midbodies
(inner KV) and peripheral midbodies (outer KV) shown by dashed black line. KV cell membranes (magenta) shown at
pre-rosette (left), rosette (center), and lumen (right) shown.
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cytokinetic midbodies in dividing cells15. Following division, the separation of two
daughter cells occurs through the ingression of a cleavage furrow. A complex containing
MKLP1 and RacGAP, called centralspindlin, contributes to cleavage furrow
ingression109. After furrow ingression, dividing animal cells stay interconnected by a
narrow intercellular bridge that contains a proteinaceous structure known as the
midbody, containing RacGAP and MKLP1 (Supplementary Figure 2.2e-i). While
daughter cells remain interconnected, the PLK1-positive centrosomes stay on the far
side of the nucleus in relation to the cytokinetic bridge and associated midbody
(Supplementary Figure 2.2b-e). These studies demonstrate that PLK1-mCherry and
GFP/mKate-MKLP1 can be used for monitoring cell cycle progression in vivo due to
their similar localization patterns as in in vitro contexts103,108,110.
During zebrafish apical clustering, endogenous MKLP1 is enriched at sites where
apical membranes are initiated (as shown by antibody staining in Figure 2.2a). In KVs
with newly initiated lumens, RacGAP-positive midbodies organize at the apical
membrane (decorated with aPKC, Figure 2.2b). With stimulated emission depletion
(STED) microscopy, we noted aPKC localizing to the cytokinetic bridge adjacent to
midbody (positive for RacGAP and the bridge positive for acetylated microtubules,
Supplementary Figure 2.2h). Midbodies were also noted in the newly formed lumen still
connected to the apical membrane (using KV membrane marker GFP-CAAX,
Supplementary Figure 2.2f). During KV lumen expansion, cytokinetic bridges are
located closest to the lumen edge and have an associated midbody (Figure 2.2c).
Midbodies were noted within the lumen surrounded by membrane that were likely
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released after the bridge was abscised (Supplementary Figure 2.2g). To quantify
midbody localization throughout KV development, midbodies were scored based on
their location, either as apical or peripheral (quantification modelled in Supplementary
Figure 2.2k). We determined that the percentage of apical midbodies significantly
increases as KV develops from pre-rosette to rosette to lumen stages (Figure 2.2de).These findings are consistent with an analysis of human fetal tissues where the
accumulation of KIF14-positive midbodies were identified in the lumen of ureteric bud
tips111.
Using an in vitro 3D epithelial cell model (MDCK), we noted MKLP1-positive
midbodies organizing to the site of apical membrane assembly (Supplementary Figure
2.2j). This is consistent with previous in vitro 3D tissue culture studies demonstrating
that the cytokinetic bridge constricts towards the apical lumen71,75. This finding
corroborates our data in zebrafish embryos during KV apical clustering, lumen
formation, and lumen expansion (Figure 2.2a-c) and together suggest a role for
placement of the cytokinetic bridge in lumen formation.

2.3.3. Cytokinetic bridges are placed at lumen formation site. To examine whether
cytokinetic bridge placement is associated with lumen formation, a developing KV was
monitored where the cells expressed mKate-MKLP1 (Figure 2.3) or PLK1-mCherry
(Supplementary Figure 2.3a). Upon examination of a cell exiting mitosis, we note that
pinching of the cytokinetic bridge places the two daughter cells such that the cytokinetic
bridge is positioned where the lumen will form (Figure 2.3, Supplementary Figure 2.3a).
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Figure 2.3. Cytokinetic bridges are placed at the site of future KV lumen formation. (a) 3D rendering of a
cell (mKate-MKLP1, cyan) dividing within KV (Sox17:GFP-CAAX, magenta) over time. Bar, 20μm. (b) Cell within
KV highlighted during cytokinesis onset (left), pre-abscission (center), and cytokinetic bridge cleavage (right).
Region denoted with dashed line in (a) are shown in (b). mKate-MKLP1 (top) and Sox17:GFP-CAAX (bottom)
shown in grayscale and in merge below (mKate-MKLP1 in cyan, Sox17:GFP-CAAX in magenta). Green
arrowhead denotes the locations of cytokinetic bridge cleavage, orange regions indicate lumen location. Bars,
10μm.
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Supplementary Figure 2.3. Cytokinetic bridges
are placed at the site of future KV lumen formation. (a) 3D renderings of a mitotic cell
(PLK1-mCherry, cyan) within KV (Sox17:GFP
-CAAX, magenta) during metaphase (top) and
cytokinesis (bottom). Orange asterisk denotes
position of forming lumen during cytokinesis. Bar, 10
μm. (b) Distance between cell pairs quantified from
cytokinesis (-10 to 0 min) through pre-abscission
(0-70 min, n = 17 pairs from n = 7 embryos, range
with mean shown). (c) Representative images of
midbody localization (mKate-MKLP1, cyan) within
KV (CFTR-GFP, grayscale). Pre-rosette (top),
rosette (middle), and lumen (bottom) stages of KV
development depicted. Orange arrowheads denote
apical midbodies, cyan arrowheads denote peripheral midbodies. Bar, 20μm. (d) Violin plot depicting
percentage of apical midbodies in live KVs at
pre-rosette (n=12 embryos), rosette (n=15 embryos),
and lumen (n=15 embryos) stages. Endpoints depict
minimum and maximum values, quartiles depicted
by thin black lines, median depicted by thick black
line. n>4 independent experiments. One-way
ANOVA, p<0.0001 (****), F(2,39)=12.74, df=39. (e)
Diagram for spindle orientation calculations (left).
Angle calculation example within KV (right). Bar, 20
μm. (f-g) Individual spindle angles (f) and angle
frequency (g, n = 28 cells, n = 25 embryos) for
mitotic cells during KV development. Inset, scatterplot of individual angles ± SD.

At this time, the bridge is cleaved at one side of the midbody (Figure 2.3b, 38min.), then
on the other side (Figure 2.3b, 80min.), depositing the midbody into the lumen (Figure
2.3b). During pre-abscission (22 min, Figure 2.3b), daughter cells are noted to start at
>10 μm apart and then move to <5 μm apart (Supplementary Figure 2.3b), suggesting
that daughter cells remain interconnected to pack next to each other into the forming
KV.
To quantify changes in cytokinetic bridge/midbody positioning during KV
development, we expressed live midbody markers (mKate/mCherry-MKLP1 or PLK1mCherry) in zebrafish embryos with a KV marker (Sox17:GFP-CAAX or CFTR-GFP). In
the same manner as previously used in fixed embryos (Figure 2.2d-e, Supplementary
Figure 2.2h), midbodies were scored based on their location (Supplementary Figure
2.2h). We calculated a similar trend in live embryos, where the percentage of apical
midbodies increased as embryos progressed through pre-rosette, rosette, and lumen
formation stages of KV development (Supplementary Figure 2.3c-d).
While spindle orientation is generally thought to be a deciding factor in the
placement of daughter cells post-division14,51,95, we found that daughter cell positioning
continues to change throughout cytokinesis and abscission suggesting that spindle
orientation is not always the deciding factor (Figure 2.3a-b, Supplementary Movie 5). To
directly test whether spindle orientation is utilized in KV development, spindle
orientation was measured during the apical clustering and lumen formation stages
(Supplementary Figure 2.3e-g). If metaphase spindle positioning was a deciding factor
in daughter cell placement as in other in vitro and in vivo contexts11,14,65, we would
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predict a Gaussian distribution of spindle orientation values where the majority of
spindles orient at a 90° angle to a line passing through the center of a developing KV
lumen (predicted Gaussian drawn in Supplementary Figure 2.3g, grey line). However, a
random distribution of spindle angles in relation to the center of KV was calculated
(Supplementary Figure 2.3f-g), suggesting that the placement of the cytokinetic bridge
is a driving factor in daughter cell positioning during KV development as opposed to
spindle positioning.

2.3.4. Cytokinetic bridge ablation disrupts lumen formation. Since the cytokinetic
bridge is placed at the site of future lumen formation, and that from cytokinesis to
abscission it takes one to three hours in vitro12,13, we hypothesized that proper
spatiotemporal control of abscission is required for lumen formation in KV. To test this
idea, we utilized laser ablation to prematurely sever cytokinetic bridges during rosette
formation/apical clustering (see Supplementary Figure 2.4a for diagram of ablation
experiment conditions). In a control embryo, lumen formation begins approximately 20
minutes after the apical clustering stage, where cytokinetic midbodies can be seen
decorating the site of future lumen formation (Figure 2.4a, top). However, when the
cytokinetic bridge is prematurely severed through the targeting of a single midbody at
the site of lumen formation during apical clustering, lumen formation is either severely
diminished or fails altogether (Figure 2.4a bottom, 4d-f). Successful ablation was
marked by the lack of mKate-MKLP1 fluorescence recovery, with failed midbody
ablations resulting in a recovery of midbody fluorescence (Figure 2.4b, Supplementary
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Figure 2.4. Premature cleavage of the cytokinetic
bridge via laser ablation results in disrupted lumen
formation. (a) Top: Unablated control embryo during
apical clustering (left) and lumen formation (center,
right). Bottom: central KV midbody ablated during
apical clustering from experimental ablation group
(left). Subsequent failed lumen formation shown
(center, right). KV membrane (Sox17:GFP-CAAX,
magenta) and midbody marker (mKate-MKLP1, cyan)
shown in left and center panels, KV membrane
(Sox17:GFP-CAAX, gray) and lumen trace (orange) on
right. Bar, 20 μm. (b) Midbody ablated in (a). Pre-ablation, immediately post-ablation, and at 5- and 10-minutes post-ablation shown. KV cell membrane
(Sox17:GFP-CAAX, magenta) and midbodies
(mKate-MKLP1, cyan) shown. Additional unablated
midbodies depicted with asterisks. Bar, 10μm. (c)
Representative 3D renderings of KV pre-ablation (left),
immediately post-ablation (center), and after lumen
formation (right) in control groups. Ablation control
conditions shown: midbody ablation outside KV (top),
KV cell cytosol ablation (middle), KV cell-cell interface
ablation (bottom). KV membrane (Sox17:GFP-CAAX,
magenta or grayscale), midbodies (mKate-MKLP1,
cyan), and lumen trace (orange) shown. Ablation
location shown by dotted white circle. Grayscale inset
in bottom panel depicts ablation at cell-cell interface
within KV (Sox17:GFP-CAAX). (d-e) Graphs depicting
average lumen area over time for unablated (gray)
embryos and embryos with midbody ablated outside
KV (blue, d), or for embryos with ablation at midbody
outside KV (blue, e), KV cell cytosol (green, e), KV cell
membrane (purple, e), and midbody within KV (red, e).
Lumen areas averaged and binned every 30 minutes.
(f) Bar graph depicting rate of lumen area expansion
over time. Dots represent individual values. (d-f): n>6
embryos/condition across n>3 experiments. ANOVA
with Dunnett’s multiple comparison test completed for
panels d-f, compared to embryos with midbody ablated
outside KV (blue). Mean displayed ± SEM (f). Statistical results detailed in Methods Table 5.
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Supplementary Figure 2.4. Premature cleavage of the cytokinetic bridge via laser ablation results in
disrupted lumen formation. (a) Diagram depicting locations of laser ablation for unablated embryos and
embryos with ablation of midbody outside KV (blue), KV cell-cell interface (purple), KV cell cytosol (green), or
midbody inside KV (red). KV cell membrane (magenta), midbody marker (cyan), and ablation location (orange
arrowhead) shown. (b) Maximum projections depicting a successful (top) and failed (bottom) midbody
ablation. KV marker (CFTR-GFP, magenta) and midbodies (mKate-MKLP1, cyan) shown. Pre-ablation and
post-ablation images shown on right of panels (mKate-MKLP1, grayscale). Bar, 10μm. (c) Time lapse images
depicting a single cytokinetic bridge(mKate-MKLP1 magenta) within KV (CFTR-GFP, cyan). Inset shows
cytokinetic bridge magnified at 3x. Cyan arrowheaddepicts midbody with ablation location shown with magenta
dashed line. Bar, 20μm.
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Figure 2.4b). An additional example of a successful cytokinetic bridge ablation is under
conditions where the cytokinetic bridge is resolved and the section next to the midbody
is ablated (Supplementary Figure 2.4c). Control ablation experiments were conducted to
ensure that lumen formation failure was due to premature bridge severing and not solely
to embryo ablation trauma. Control ablation conditions included ablating cytokinetic
bridges/midbodies outside KV, ablating KV cell-cell interfaces, and ablating KV cytosol
(Figure 2.4c-f, modeled in Supplementary Figure 2.4a). While control ablations result in
slightly delayed lumen formation compared to unablated controls (Figure 2.4d-e), there
is no significant difference in lumen formation between control ablation conditions
(Figure 2.4d-f). However, lumen growth rate was significantly decreased in embryos
where a KV cytokinetic bridge was severed during apical clustering compared to control
groups (Figure 2.4c-f). These experiments suggested that cytokinetic bridges during
rosette formation/apical clustering are required for lumen formation.

2.3.5. Rab11-vesicles are required for abscission in vivo. Since premature severing
of the cytokinetic bridge perturbed lumen formation, we sought to establish whether
blocking abscission altogether would perturb lumen formation as well. Previous work in
an in vitro model has identified that apical-targeted endosomes containing the
Par3/aPKC polarity complex assemble adjacent to the cytokinetic midbody65. These
endosomes contain a small monomeric GTPase, Rab11, required to initiate
abscission72, making inhibition of the Rab11 vesicle trafficking pathway an ideal method
to block abscission in KV development. In zebrafish, Rab11-depletion is associated with
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KV morphology defects such as lumen size depletion69,112. To determine the role of
Rab11-associated vesicles in lumen formation and abscission, we acutely inhibited
Rab11-associated membrane vesicles through an optogenetic oligomerization approach
(modeled from 113, Supplementary Figure 2.5a).
To test the efficacy of this system we expressed cryptochrome 2-mCherry
(CRY2-mCherry) and CIB1-mCerulean-Rab11 in HeLa cells. A blue-light-inducible (488
nm) hetero-interaction between CRY2 and CIB1 is induced within a specific Region of
Interest (ROI) to initiate cellular aggregation of Rab11-associated membranes
(Supplementary Figure 2.5a-b). To examine whether the cellular aggregation of Rab11associated membranes disrupts function, HeLa cells expressing the optogenetic
constructs in pre-abscission were treated with normal light conditions or 488nm blue
light (Figure 2.5a-b). Under control conditions, where cells are imaged in the absence of
blue light, cells can progress through cytokinesis to abscission within approximately 90
min. (Figure 2.5a). Note CIB1-Cerulean-Rab11 transporting into the cytokinetic bridge
where a cleavage event occurs at one side of the midbody (blue arrow, Figure 2.5a),
and another event occurs on the other side of the midbody 10 min. later (blue arrow,
Figure 2.5a). This is consistent with the events we find in KV with cytokinetic bridge
cleavage during lumen formation (Figure 2.3b). When cells are exposed to 488nm light
throughout the 90-minute time course, Rab11-associated vesicles are unable to move
into the cytokinetic bridge and remain clustered within the cell body, inhibiting the ability
of this cell to abscise (Figure 2.5b). Under conditions of CRY2-mCherry and CIB1mCerulean-Rab11 expression with 488nm blue light exposure, a significant increase in

50

c

a No exposure to 488 nm Light

**

50

CIB1-Cerulean-Rab11

0 min

20 min

55 min

b Exposed to 488 nm Light

95 min
85 min
CIB1-mCerulean-Rab11 + CRY2-mCherry

% of binucleate cells

40
30
20

CIB1-Cerulean-Rab11

10

d

20 min

CRY2
+ CIB1-mCh-Rab11
Cells with
single nuclei

55 min

95 min
85 min
CIB1-mCerulean-Rab11 + CRY2-mCherry

CRY2 + CIB1-mCh-Rab11
+ 488nm light

e

f
Single
nucleus

Binucleate

0

488nm
light

% of binucleate/multinucleate
cells per KV

0 min

50
40

Binucleate

-

+
****

30
20

Binucleate

Sox17:GFP-CAAX DAPI
CIB1-mCherry-Rab11

Sox17:GFP-CAAX DAPI
CIB1-mCherry-Rab11

Binucleate

Binucleate

10

0
CRY2
CIB1-mCh
-Rab11
Multinucleate 488nm light
DAPI

- - - - ++
- - ++++
- + - + - +

Figure 2.5. Optogenetic clustering of Rab11-associated vesicles results in failed
abscission in vitro and in vivo. (a-b) Time-lapse of cytokinetic HeLa cells transfected with CRY2-mCherry and CIB1-mCerulean-Rab11 (black) in the absence (a) or
presence of 488 nm light (b). Bar, 10 μm. Note cleavage events of cytokinetic bridge
(blue arrows, a), but not in (b). (c) Bar graph depicting the percentage of total HeLa
cells displaying a binucleate phenotype after being released from a metaphase
synchronization for two hours in the presence or absence of 488nm light. Cells were
transfected with CRY2-mCherry and CIB1-mCerulean-Rab11 as in (a). Unpaired,
two-tailed Mann-Whitney test, p=0.0043 (**). Mean displayed ± SEM. n=100 cells per
treatment for n>5 experiments. Dots represent individual values. Statistical results
detailed in Methods Table 5. (d) 3D rendering of embryos expressing CRY2 and
CIB1-mCherry-Rab11 in the absence (left) and presence (right) of 488nm light.
Sox17:GFP-CAAX (magenta), CIB1-mCherry-Rab11 (cyan) and nuclei (DAPI, white)
shown. Bar, 5 μm. (e) Representative images of single nuclei, binucleate, or multinucleate cells. Nuclei shown in grayscale (DAPI). Bar, 5 μm. (f) Bar graph depicting
percentage of binucleate and/or multinucleate cells per KV in uninjected embryos and
embryos expressing CIB1-mCherry-Rab11 or CRY2 and CIB1-mCherry-Rab11 plus or
minus 488nm light. One-way ANOVA with Dunnett’s multiple comparison test used,
compared to uninjected embryos in the absence of 488nm light exposure. Statistical
results detailed in Methods Table 5. Analyses performed in n>5 embryos over three
experiments. Mean displayed ± SEM. Dots represent individual values.
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Supplementary Figure 2.5. Optogenetic clustering of Rab11-associated vesicles results in failed abscission in
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shown. Bar, 5μm. (c) Western blot depicting Rab11 protein expression in wild-type (left) and Rab11-null CRISPR
HeLa cells (right). Rab11 (25kDa) and GAPDH (37kDa) loading control shown. (d) Representative maximum projections of nuclei in wild-type (left) and Rab11-null CRISPR cells (right). Brightfield (grayscale) and nuclei (DAPI, cyan)
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Rab11-null CRISPR cells (Rab11-negative, cyan). Two-tailed Mann-Whitney p=0.0079 (**), u=0. n=100 cells across
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embryos +/- 488nm light exposure (purple, n=555 embryos from 4 clutches) shown. Mean ± SEM shown.
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the percentage of binucleated cells occurred when compared to cells not exposed to
blue light (Figure 2.5c). Previous in vitro studies reported that increases in binucleate
formation can be indicative of cytokinesis or abscission failure114. We generated Rab11null cells (Supplementary Figure 2.5c-d), and found that while cytokinesis occurred as
expected, binucleate formation occurred after the formation of the cytokinetic bridge due
to abscission failure (Supplementary Figure 2.5d-f, Supplementary Movie 8). Rab11-null
cells had a significantly higher percentage of binucleate cells when compared to control
(Supplementary Figure 2.5d-e), similar to clustering Rab11 in vitro using optogenetics
(Figure 2.5a-c).
We next sought to determine whether this binucleate phenotype could be
recapitulated in zebrafish. We injected mRNA into zebrafish embryos to express CRY2Fluorescent Protein (FP, mCherry or no FP) and CIB1-FP-Rab11 (FP, either mCerulean
or mCherry, Supplementary Figure 2.5g). Uninjected embryos (control), embryos
injected with CRY2-FP mRNA only (control), CIB1-FP-Rab11 mRNA only (control), or
injected with both CRY2-FP and CIB1-FP-Rab11 mRNA (experimental) were exposed
to normal light or 488nm blue light conditions starting at 50-60% epiboly until a late
lumen expansion stage (14 hpf, experimental protocol diagram in Supplementary Figure
2.5g). Embryonic lethality during optogenetic experiments was similar in all injection
groups (Supplementary Figure 2.5h), suggesting that acute clustering of Rab11membranes did not result in embryo mortality. Embryos were fixed and the number of
binucleate cells were evaluated (Figure 2.5d-f). Strikingly we found a significant

53

increase in the number of binucleated cells in KV under experimental conditions (Figure
2.5f), suggesting that clustering Rab11 vesicles in vivo blocks abscission.

2.3.6. Rab11 vesicles are required for lumen formation. We next examined whether
the clustering of Rab11-membranes resulted in KV lumen formation defects. Due to the
mosaic nature of mRNA expression in zebrafish, embryos were categorized into five
groups: uninjected (control), CRY2-FP mRNA only (control), CIB1-FP-Rab11 mRNA
only (control), CRY2-FP plus CIB1-FP-Rab11 mRNA without KV expression (control),
and CRY2-FP plus CIB1-FP-Rab11 mRNA with KV expression (experimental). Injected
embryos were exposed to 488nm light at either 50-60% epiboly or 75-90% epiboly
(Figure 2.6b, Supplementary Figure 2.5g). Zebrafish developmental speed can vary due
to variations in ambient room temperature115. To control for this, lumen area was
normalized to the mean of uninjected control embryos within each clutch. This
minimized the variation in lumen area due to differences in clutch developmental speed,
since control groups demonstrated a range in basal lumen area dependent on the clutch
(Supplementary Figure 2.6b).
In double injected embryos where KV cells have clustered Rab11-associated
membranes (488 nm exposure beginning at 50-60% or 75-90% epiboly), significant
defects in KV lumen formation occurred such as decreased lumen area or an inability to
form a lumen at all (Figure 2.6a-b, Supplementary Figure 2.6b) compared to control
conditions (Figure 2.6b, Supplementary Figure 2.6a-b). When clustered Rab11membranes only occurred in a proportion of KV cells, lumen formation in the non-
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Figure 2.6. Optogenetic clustering of Rab11 during KV development results in abnormal lumen formation and
perturbed polarity establishment. (a) Representative 3D renderings of KV under conditions of CRY2-mCherry/CIB1-mCerulean-Rab11 plus 488nm light with partial (top) or majority KV mRNA expression (bottom). 3D rendering
with lumen trace (orange), cell membrane (GFP-CAAX, white), CRY2-mCherry (magenta), and CIB1-mCerulean-Rab11 (cyan) shown. Bar, 50 μm. (b) Box and whisker plot depicting two-dimensional lumen area normalized to
uninjected control values plus or minus 488 nm light beginning at 50-60% epiboly (left, n>15 embryos) or 75-90%
epiboly (right, n>21 embryos). Dots represent individual KV values. Whiskers denote minimum and maximum values,
25th and 75th percentiles denoted by box boundaries. Median denoted by line within box, mean denoted by plus sign.
One-way ANOVA with Dunnett’s multiple comparison test, compared to uninjected embryos. Statistical results
detailed in Methods Table 5. (c) Representative 3D renderings of KV in CFTR-GFP (magenta) embryos under
conditions of CIB1-mCherry-Rab11 (cyan, top) or CRY2 + CIB1-mCherry-Rab11 (cyan) + 488nm light exposure
(bottom). Dashed box represents insets shown at right. Bars, 20μm. (d) Bar graph depicting the Pearson’s coefficient
for CFTR-GFP and CIB1-mCherry-Rab11 in embryos treated plus or minus 488nm light exposure. ANOVA with
Dunnett’s multiple comparison test, compared to embryos expressing CIB1-mCherry-Rab11 minus 488nm exposure.
Statistical results detailed in Methods Table 5. Mean displayed ± SEM. Dots represent individual values. (e) Bar
graph depicting the percentage of puncta per KV expressing CFTR-GFP (magenta), CIB1-mCherry-Rab11 (cyan), or
both (white). One-way ANOVA with Dunnett’s multiple comparison test completed for each cluster type, compared to
percentages from embryos expressing CIB1-mCherry-Rab11 under normal light conditions. Statistical results detailed
in Methods Table 5. (d-e) n>10 embryos analyzed from five experiments. Mean displayed ± SEM. Dots represent
individual values.
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Supplementary Figure 2.6. Optogenetic clustering of Rab11 during KV development results
in abnormal lumen formation and perturbed polarity establishment. (a) Representative 3D
renderings of KV under conditions of CRY2-mCherry mRNA only, or CRY2-mCherry + CIB1-mCerulean-Rab11 with KV-positive mRNA expression. KV cells (CFTR-GFP, white), CRY2-mCherry
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comparing raw (left) and normalized (right) lumen area resulting from optogenetic experiments
(Figure 2.6b). Normalized data shown as a ratio compared to uninjected control mean. Whiskers
denote minimum and maximum values, 25th and 75th percentiles denoted by box boundaries.
Median denoted by line within box, mean denoted by plus sign. Data from 10 individual clutches
shown by colors described in legend. n>15 embryos per treatment. Results from unpaired,
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One-way ANOVA, p = 0.0023 (**), F(2,33) = 7.323, df=33.
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clustered areas occurred (Figure 2.6a, left). In embryos with clustered Rab11 in cells
surrounding KV, but not KV cells, KV lumen size was comparable to unclustered-Rab11
control conditions (Figure 2.6b). Overall, these findings suggest that acute inhibition of
Rab11-associated vesicles within KV-destined cells disrupts lumen formation.
Rab11 is involved in the targeted apical exocytosis of cystic fibrosis
transmembrane conductance regulator (CFTR) to the apical membrane in mammalian
tissue culture116. In zebrafish, CFTR apical localization is required for KV lumen
expansion50. When monitoring the positioning of cytokinetic bridge/midbody in relation
to CFTR in KV, we found that CFTR organizes on either side of the cytokinetic bridge
midbody during MET (Supplementary Figure 2.6c). CFTR-GFP was highly dynamic
within regions proximal to the midbody, where a significant increase in CFTR-GFP
integrated intensity was measured over time adjacent to the midbody (Supplementary
Figure 2.6d-e). These findings suggest a model that cytokinetic bridges provide a locale
for directed membrane transport of apical polarity proteins (e.g. CFTR) for lumen
establishment.
To test whether CFTR utilizes Rab11 for its apical distribution in KV, we
examined whether Rab11-associated vesicles trapped CFTR when optogenetically
clustered during KV formation. CIB1-FP-Rab11 mRNA-injected embryos were
compared to embryos injected with CRY2 plus CIB1-FP-Rab11 mRNA. Both groups of
embryos were exposed to 488nm light during late epiboly until a fully developed KV
should be formed (described in Supplementary Figure 2.5c). Under conditions where
only CIB1-FP-Rab11 mRNA was injected, CFTR-GFP clearly organizes to the apical
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membrane surrounding the lumen and a population of it colocalizes with CIB1-FPRab11 (Figure 2.6c, top). However, under conditions of optogenetic clustering of Rab11,
CFTR-GFP is trapped in Rab11-membrane associated clusters and is unable to
organize at the apical membrane (Figure 2.6c, bottom). Under these conditions, there is
a significant increase in CFTR-GFP colocalization with CIB1-FP-Rab11 compared to
non-clustered controls (Figure 2.6d). Under control conditions (CIB1-FP-Rab11 plus or
minus 488nm light, CRY2 + CIB1-FP-Rab11 minus 488 nm light), we found that the
percentage of puncta per KV that contained both CIB1-FP-Rab11 and CFTR was <40%.
However, under experimental conditions of CRY2 plus CIB1-FP-Rab11 plus 488nm light
exposure, we found a significant increase in CIB1-FP-Rab11 puncta that contained
CFTR (79.4 ± 9.87%, Figure 2.6e). These findings suggest that CFTR-GFP utilizes
Rab11-associated vesicles for its delivery to the apical membrane during KV formation.
This is likely occurring both during abscission and in cells post-abscission. It also
presents an interesting model, where premature severing of the cytokinetic bridge
(Figure 2.4) limits the time for CFTR trafficking to the cytokinetic bridge to create an
apical membrane. CFTR is a master regulator of fluid secretion through control of
chloride transport to generate osmotic gradients that drive the movement of water
through a tissue117. Here, we propose that when abscission occurs prematurely or
Rab11-associated vesicles carrying CFTR are clustered, CFTR cannot assemble at the
apical membrane resulting in a loss of fluid flow and defects in lumen formation and/or
expansion.
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2.3.7. CFTR transport to cytokinetic bridge aids in lumenogenesis. In conclusion,
these studies have highlighted the importance of cell division during the development of
KV and the de novo formation of its lumen. We provide evidence that cell division is
upregulated in cells destined for KV, and these cells retain their cytokinetic bridges postdivision. The cytokinetic bridges are then projected to the site of future lumen formation
during rosette formation/apical clustering, where Rab11-associated vesicles can traffic
important apical polarity components to the bridge during epithelialization to allow for
lumen formation (Figure 2.7).

2.4. Materials and Methods
2.4.1. Fish Lines. Zebrafish lines were maintained using standard procedures approved
by the Syracuse University IACUC committee (protocol #18-006). Embryos were staged
as described in 1. See Supplementary Table 4 for list of transgenic zebrafish lines used.

2.4.2. Plasmid and mRNA Constructs. Plasmids were all made using Gibson Cloning
methods (NEBuilder HiFi DNA Assembly Cloning Kit (NEB no E5520S)) and maxiprepped before injection (BioBasics Cat: 9K-006-0023). mRNA was made using
mMESSAGE mMACHINE™SP6 transcription kit (Invitrogen AM1340). See
Supplementary Table 3 for list of plasmid constructs used and concentrations injected.

2.4.3. Imaging. A SP5 or SP8 (Leica, Bannockburn, IL) laser scanning confocal
microscope was used throughout this manuscript. An HC PL APO 20x/0.75 IMM CORR
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Figure 2.7. Targeted membrane transport of CFTR towards the cytokinetic bridge
is used to establish a lumen. Model depicting lumen formation through Rab11mediated vesicle transport to the cytokinetic bridge. KV membrane (GFP-CAAX,
magenta), midbodies (RacGAP/MKLP1/PLK1, cyan), vesicles (CFTR/Rab11, green),
and nuclei (blue) shown.
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CS2 objective, HC PL APO 40x/1.10 W CORR CS2 0.65 water immersion objective,
and an HCX Plan Apochromat 63×/1.40-0.06 NA OIL objective were used. Images were
acquired using LAS-X software. A Leica DMi8 (Leica, Bannockburn, IL) with a X-light v2
confocal unit spinning disk was also used, equipped with an 89 North – LDI laser and a
Photometrics Prime-95B camera. Optics used were either 10x/0.32 NA air objective, HC
PL APO 63X/1.40 NA oil CS2, HC PL APO 40X/1.10 NA WCS2 CORR, a 40X/1.15 N.A.
Lamda S LWD, or 100×/1.4 N.A. HC Pl Apo oil emersion objective. Additionally, a Nikon
Eclipse Ti-E microscope using a Hammamatsu C9100-50 EMCCD camera coupled to a
PerkinElmer spinning disk confocal system was used with a CFI Apo LWD Lambda S
20x water immersion objective or a CFI Apo Lambda S LWD 40x water immersion
objective. Images were acquired using Volocity software. STED imaging was performed
using a Leica TCS SP8 (Leica, Bannockburn, IL) equipped with STED 3X, a
supercontinuum laser (white light laser 470–670 nm) for excitation, 592/546/600-nm
STED depletion lasers, and an HCS PL APO 100x/1.40 oil STED white objective.
Images were acquired using the Leica LAS software and post image processing of
STED images was performed using SVI Huygens deconvolution software.

2.4.4. Laser Ablation. Tg(sox17:GFP-CAAX) zebrafish embryos were injected with 300
picograms of MKLP1-mKate mRNA at the 1-cell stage. Embryos were embedded in
agarose at the 1-somite stage and imaged on either an Andor Dragonfly spinning disk
confocal microscope with a pulsed nitrogen pumped tunable dye laser at 100%, or Xlight v2 Confocal Unit spinning disk with VisiView kinetics unit coupled to a 355 nm
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pulsed laser used at 50% both equipped with a 40x 1.15NA water objective. An image
was obtained prior to laser ablation to record midbody positioning within the embryo.
Ablation conditions included midbodies ablated within KV or outside KV, KV cytosol, or
KV cell-cell interfaces. Images of KV post-ablation were captured using the 488nm and
561nm lasers, obtained a z-stack with a 0.8 μm step size every 2 min.

2.4.5. Zebrafish Optogenetics Experiments. Optogenetic experiments were
performed by injecting CRY2-mCherry and/or CIB1-mCerulean-Rab11 (or CRY2 and/or
CIB1-mCherry-Rab11) mRNA into zebrafish embryos at the 1-cell stage. Embryos were
exposed to 488nm light using the NIGHTSEA fluorescence system from 60% or 75-90%
epiboly (late exposure experiments) until 6-8 somite stage. Embryos were either fixed
with 4% paraformaldehyde + 0.5% Triton-X 100 in PBS or incubated overnight in the
absence of 488nm light to evaluate death rates. Fixed embryos were then imaged on a
confocal microscope as described above.

2.4.6. Pharmacological treatments. For Nocodazole and BI2536 treatments, zebrafish
embryos were dechorionated and soaked in the desired concentration of drug diluted in
zebrafish embryo water (refer to Figure 2.2.1 and Supplementary Figure 1.1). Embryos
were manually dechorionated and treated from 60% epiboly until 6-8 somite stage on
petri plates coated with 3% agarose, when they were washed with embryo water and
fixed in 4% paraformaldehyde containing 0.5% Triton-X 100 overnight at 4°C. Staining,
imaging, and lumen size quantification were then completed as described.
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2.4.7. Immunofluorescence of zebrafish embryos. Zebrafish embryos were fixed
using 4% paraformaldehyde containing 0.5% Triton-X 100 overnight at 4°C. Zebrafish
were then dechorionated and incubated in PBST (phosphate buffered saline + 0.1%
Tween) for 30 minutes. Embryos were blocked using a Fish Wash Buffer (PBS + 1%
BSA + 1% DMSO + 0.1% Triton-X 100) for 30 minutes followed by primary antibodies
incubation (antibodies diluted in Fish Wash Buffer in concentrations stated in
Supplementary Table 2) either overnight at 4°C or 3 hours at room temperature.
Embryos are then washed five times in Fish Wash Buffer before incubating with
secondary antibodies for 3 hours at room temperature. After five more washes, embryos
were incubated with 4',6-diamidino-2-phenylindole (NucBlue® Fixed Cell
ReadyProbes® Reagent) for 30 minutes. For imaging, embryos were either halved and
mounted on slides using Prolong Diamond (Thermo Fisher Scientific cat. # P36971) or
whole-mounted in 2% agarose (Thermo-Fisher cat. # 16520100).

2.4.8. Cell Culture. 3D Madin-Darby canine kidney (MDCK) cultures were grown in
Dulbecco’s Modified Eagle Medium (DMEM, Gibco™) supplemented with 10%
Seradigm FBS (VWR) and 1% penicillin-streptomycin (10,000U/ml) (Gibco™) with 40%
Matrigel (Fisher cat no CB40234C; Corning no 356237). Rab11 Optogenetic
clustering in HeLa cells: HeLa cells were transfected with CIB1-mCerulean-Rab11
and CRY2-mCherry using Mirus TransIT-LT1 and then synched at prometaphase in
nocodazole (100nM) and released after 6 hours in the presence or absence of 488nm
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light. Cells were imaged on a spinning disk confocal microscope. Images of dividing
cells were acquired for a time lapse series, or cells were imaged two hours post-release
to quantify binucleate cells.

2.4.9. Rab11 CRISPR. HeLa cells expressing FIP3-GFP stably were used throughout
the study, maintained at 37oC with 5% CO2. Rab11A CRISPR vector (Santacruz SC400617) and Rab11A HDR vector (Santa Cruz SC-400617-HD) were transfected into
cells using the Mirus TransIT-LT1 transfection reagents (Cat# MIR2305) using
manufacturers specifications. Cells were grown in puromycin selection medium
(5ug/ml). Three single clones were isolated and tested for Rab11 levels using Western
blot. HeLa cells are maintained at 37°C with 5% CO2.

2.4.10. Immunofluorescence of 3D acini. Using a pipette, media was carefully
removed from cultures. Cultures were rinsed with PBS and fixed with 4%
paraformaldehyde (PFA) at room temperature for 30 minutes with light shaking. The
PFA was removed and replaced with fresh PFA for an additional 30 minutes with light
shaking. After PFA was removed, 50mM NH4Cl was added for 10 minutes. Cells were
washed with PBS for 30 minutes, with light shaking, and then treated for 5 minutes with
0.1% Triton-X, blocked with PBSΔT (PBS, 1% BSA, 0.5% Triton X-100), and incubated
with primary antibodies for 4 hrs at room temperature. Cultures were washed three
times with PBSΔT and incubated with secondary antibodies for 4 hours at room
temperature. For actin and DAPI staining, acini were incubated with ActinRed
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555vReady Probes reagent (Thermo Fisher Scientific R37112) and NucBlue Fixed Cell
Stain from Ready Probes (Thermo Fisher Scientific R37606) for 30 minutes. Cultures
were kept in PBS containing DABCO (1,4-Diazabicyclo [2.2.2] octane) antifade reagent
(200μM) for imaging. See Supplementary Table 2 for list of antibodies and
concentrations used.

2.4.11. Image and Data Analysis. Images were processed using both FIJI/ImageJ
software, IMARIS (Bitplane), and/or Adobe Photoshop. Angles were calculated using
FIJI/ImageJ software and Microsoft Excel. All graphs were generated, and statistical
analysis performed using GraphPad Prism software. 3D images, movies, and surface
rendering were performed using Bitplane IMARIS (Surface, Smoothing, Masking, and
Thresholding functions). Surface renderings: Imaris surface renderings were created
through the manual surface protocol by outlining fluorescence regions of interest using
the Isoline function for each z-plane and timepoint. Once the surface rendering was
created for each cell, individual cell renderings were pseudocolored and each frame
was captured. To isolate and pseudocolor specific cells, the same surface rendering
protocol was completed, and masks were created from the surface renderings to isolate
the new channel. CFTR intensity measurements: To measure the integrated density
of CFTR at the cytokinetic midbody, rectangular regions of interest (ROIs) were drawn
around the midbody (MKLP1). The larger ROI (ROIL) is used to measure background
whereas the center, smaller ROI (ROIS) measures the CFTR signal. The following
equation was used: integrated intensity of ROIS -((integrated intensity of ROIL –
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integrated intensity of ROIS)*(area ROIS /(area ROIL -area ROIS)))118. Intensities were
normalized to the final intensity at 4 minutes (percentage). Calculation of spindle
orientation in relation to lumen: Spindle orientation was measured during the apical
clustering and lumen formation stages of KV development. As shown in Supplementary
Figure 2.2.3e, a line was drawn through the DNA plate of a metaphase cell in KV (solid
black line). A second line was then drawn perpendicular to the first line to denote the
position of the mitotic spindle poles (dashed black line). A third line was drawn passing
through the center of KV and the center of the metaphase DNA plate (dashed gray line).
Lastly, the angle between the dashed gray line and the dashed black line were
calculated to determine the spindle position in relation to the KV center. Lumen area
quantifications: Prior to lumen area measurements, images were turned using Imaris
software such that the equatorial plane of the lumen could be measured, resulting in a
representative lumen area measurement regardless of initial embryo positioning during
imaging. This dataset was then transferred to FIJI/ImageJ for lumen area calculations. A
region was drawn around the lumen perimeter and area calculated using the measure
function. Where applicable, values were normalized to the control mean by dividing
each lumen area by the mean value of the control lumens for that particular experiment.
This controlled for KV size fluctuations based on slight differences in ambient room
temperature and difference growth rates of clutches in different experimental setups.
Mitotic index and cell number calculations: Mitotic index and cell number counts
were completed with embryos after a DAPI stain and/or antibody staining with a
phospho-H3 antibody. For mitotic index, the number of mitotic cells was divided by the
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total number of cells to result in a percentage of mitotic cells out of the entire population.
Colocalization quantification: For optogenetic experiments, colocalization
quantification was performed using Imaris software. In the “Colocalization” menu, a
Region of Interest (ROI) around Kupffer’s vesicle was defined by masking the channel
depicting CFTR fluorescence. CFTR was defined as Channel 1, and CIB1-FP-Rab11
was defined as Channel 2. Threshold values were calculated with the “Automatic
Threshold” option to define colocalization parameters, and the “Pearson’s coefficient in
colocalized volume” was recorded for each embryo. Additionally, optogenetic clusters
were scored for presence of CFTR, CIB1-FP-Rab11, or both and this was presented as
percentages per embryo.

2.4.12. Statistics and Reproducibility. Unpaired, two-tailed Student’s t-tests, MannWhitney, and one-way ANOVA analyses were performed using GraphPad Prism
software. **** depicts a p-value <0.0001, *** p-value <0.001, **p-value<0.01, *p-value
<0.05. See Supplementary Table 5 for detailed information regarding statistics.
All graphs, micrographs, images, and blots in this paper are representative of at
least three independent experiments.

67

2.4.13. Methods Table 1: Key Resources Table
Reagent Type (species or
resource)
General Genes Examined
(zebrafish)

Designation

Source

Mitotic kinesin-like protein
(MKLP1), Histone H2B (H2B)

Gene ID #: MKLP1- 30627
H2B- 100334869, 100334559, 100329560,
100329290

Organ of Asymmetry
localized genes
Commercial Assay/Kit

cystic fibrosis transmembrane
conductance regulator (CFTR)
NEBuilder HiFi DNA Assembly
Cloning Kit (NEB no E5520S),
mMESSAGE mMACHINE™SP6
transcription kit (Invitrogen
AM1340)
ImageJ/FIJI, Bitplane IMARIS
BI2536, nocodazole

Gene ID #:
CFTR- 559080
-https://www.neb.com/products/e5520nebuilder-hifi-dna-assembly-cloningkit#Product%20Information
-https://www.thermofisher.com/order/
catalog/product/AM1340
Bitplane
BI2536 (Selleck Chemicals S1109),
nocodazole (ACROS Organics 358240500)

Software/Algorithm
Drugs

2.4.14. Methods Table 2: Antibodies
Name
Anti-GFP
phospho-Histone 3 (ser10)
MKLP1 (N-19)
aPKC (zeta)
RacGAP
a-tubulin conjugated with FITC
PLK1
Acetylated tubulin
ZO-1
Rab11
GAPDH-HRP

Dilution
1:200
1:200
1:200
1:200
1:200
1:200
1:200
1:200
1:200
1:500
1:40000

Company/Cat. No
Abcam
Cell Signaling (9701S)
Santa Cruz (sc-867)
Santa Cruz (sc-216)
Abcam (ab2270)
Sigma Aldrich (F2168)
Cell Signaling Technology (4513S)
Sigma-Aldrich (45-T6793-100UL)
Invitrogen (484333A)
Cell Signaling Technology (3539S)
Sigma-Aldrich (45-G9295-25UL)

2.4.15. Methods Table 3: Plasmid Constructs
Construct
H2B
MKLP1
MKLP1
CRY2
CIB1-Rab11
PLK1

Backbone
pCS2
pCS2
pCS2
pCS2
pCS2
pCS2

Tag
Dendra
GFP/mKate/ mCherry
mKate/ mCherry
mCherry/untagged
mCerulean/mCherry
mCherry

Injection Type
mRNA
Plasmid
mRNA
mRNA
mRNA
mRNA

Concentration [pg]
95
15
300
100
100
100

2.4.16. Methods Table 4: Zebrafish Transgenic Lines
Type
Wild-Type
Transgenic
Transgenic
Transgenic
Transgenic

Name
TAB
Tg(sox17:GFP-CAAX)sny101
Tg(sox17:GFP)
Tg(sox17:dsRED)
TgBAC(cftr-GFP)

Source
Zebrafish International Resource Center (ZIRC)
Dasgupta et al., 2018
Sakaguchi et al., 2006
Chung et al., 2008
Navis et al., 2013
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2.4.17. Methods Table 5. Detailed statistical analysis results
Figure
2.1c

2.1e

Supp2.1e

Supp2.1f

Supp2.1g
2.2e

Supp2.3d

2.4f

2.5c

2.5f

Supp2.5e
2.6b/Supp2.6b
early

late
Supp2.6b
(nonnormalized
data)

2.6d

2.6e (CFTRpositive)

2.6e (CIB1positive)

2.6e (CFTR +
CIB1-positive)

Category
migratory
MET
AC
LF
LE
DMSO
100nM NOC
1uM NOC
100nM BI
1uM BI
DMSO
100nM NOC
1uM NOC
100nM BI
1uM BI
DMSO
100nM NOC
1uM NOC
100nM BI
1uM BI
lumen area vs. cell number
pre-rosette
rosette
lumen
pre-rosette
rosette
lumen
MB outside KV
KV cell cytosol
KV cell-cell interface
MB inside KV
CRY2 + CIB1-mCherry-Rab11
CRY2 + CIB1-mCherry-Rab11 + 488nm light
uninjected
uninjected + 488nm light
CIB1-mCh-Rab11
CIB1-mCh-Rab11 + 488nm light
CRY2 + CIB1-mCh-Rab11
CRY2 + CIB1-mCh-Rab11 + 488nm light
Control vs Rab11 CRISPR
uninjected
CRY2 only
CIB1 only
CRY2+CIB1, no KV
CRY2+CIB1, +KV
uninjected
CIB1 only
CRY2+CIB1, +KV
uninjected
CRY2 only
CIB1 only
CRY2+CIB1, no KV
CRY2+CIB1, +KV
CIB1-mCh-Rab11
CIB1-mCh-Rab11 + 488nm light
CRY2 + CIB1-mCh-Rab11
CRY2 + CIB1-mCh-Rab11 + 488nm light
CIB1-mCh-Rab11
CIB1-mCh-Rab11 + 488nm light
CRY2 + CIB1-mCh-Rab11
CRY2 + CIB1-mCh-Rab11 + 488nm light
CIB1-mCh-Rab11
CIB1-mCh-Rab11 + 488nm light
CRY2 + CIB1-mCh-Rab11
CRY2 + CIB1-mCh-Rab11 + 488nm light
CIB1-mCh-Rab11
CIB1-mCh-Rab11 + 488nm light
CRY2 + CIB1-mCh-Rab11
CRY2 + CIB1-mCh-Rab11 + 488nm light

n
10
9
8
9
7
41
50
43
58
54
27
35
30
39
40
32
40
37
48
45
206
21
16
35
12
15
15
7
9
6
7
6
5
5
6
5
9
7
6
5
73
15
29
24
47
11
8
18
73
15
29
24
47
15
16
19
24
10
13
13
22
10
13
13
22
10
13
13
22

Statistical test
Unpaired Student's t-test (twotailed)

Parameters
t=5.444, df=18
t=2.930, df=16
t=3.766, df=14
t=3.992, df=16
t=3.345, df=12

Result
****
**
**
**
**
control
****
****
****
****

p-value
<0.0001
0.0098
0.002
0.001
0.0058
n/a
<0.0001
<0.0001
<0.0001
<0.0001

One-way ANOVA with
Dunnett’s multiple comparison

df=241
F(4,241)=25.86

One-way ANOVA with
Dunnett’s multiple comparison

df=166
F (4, 166) = 8.733

****

<0.0001

One-way ANOVA with
Dunnett’s multiple comparison

df=197
F (4, 197) = 6.137

***

0.0001

Pearson's correlation

r=0.3653

****

<0.0001

One-Way ANOVA

df=69,
F (2, 69) = 104.7

****

<0.0001

One-Way ANOVA

df=39,
F (2, 39) = 12.74

****

<0.0001

One-way ANOVA with
Dunnett’s multiple comparison

df=25
F(3,25)=4.352

control
ns
ns
**

n/a
0.7495
0.9955
0.0097

Mann-Whitney test (two-tailed)

U=0

One-way ANOVA with
Dunnett’s multiple comparison

df=32
F(5,32)=41.51

Mann-Whitney test (two-tailed)

U=0

One-way ANOVA with
Dunnett’s multiple comparison

df=183
F(4,183)=15.43

One-way ANOVA with
Dunnett’s multiple comparison

df=83
F(2,83)=58.28

Unpaired Student's t-test (twotailed)

t=6.315, df=69

One-way ANOVA with
Dunnett’s multiple comparison

df=70
F(3,70)=39.97

One-way ANOVA with
Dunnett’s multiple comparison

df=54
F(3,54)=21.83

One-way ANOVA with
Dunnett’s multiple comparison

df=54
F(3,54)=23.21

One-way ANOVA with
Dunnett’s multiple comparison

df=54
F(3,54)=85.73

69

**

0.0043

control
ns
ns
ns
ns
****
**
control
ns
ns
ns
****
control
ns
****
n/a
n/a
n/a

control
0.9982
0.9795
>0.9999
0.9628
<0.0001
0.0079
n/a
0.8467
0.7293
0.9946
<0.0001
n/a
0.6908
<0.0001
n/a
n/a
n/a

****

<0.0001

control
ns
ns
****
control
ns
ns
****
control
ns
ns
****
control
ns
ns
****

control
0.6562
0.975
<0.0001
control
0.7845
>0.9999
<0.0001
control
0.9744
0.8978
<0.0001
control
0.5408
0.9366
<0.0001

Chapter Three:
A novel embryonic centrosome structure coordinates zebrafish spindle
directionality in a PLK1- and PLK4-dependent manner
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3.1. Abstract. While factors that regulate mitotic spindle positioning have been
elucidated in vitro, it still remains unclear how a spindle is placed within the confines of
extremely large cells. A previous study postulated that the presence of acentrosomal
microtubule nucleation sites would allow astral microtubules to more easily span the
large distance between spindle pole and cell cortex when the cell is disproportionately
large. Here, we expand upon this idea with the discovery of a large, novel centrosome
structure in the early zebrafish embryo. During early embryonic cell divisions when cell
size changes rapidly, we find that mitotic spindle pole area scales more closely with the
changing cell size than spindle length during consecutive rounds of cell division in C.
elegans and zebrafish. Strikingly, we also discovered that spindle poles in the zebrafish
embryo are not only much larger than expected, they are also asymmetric in size. This
asymmetry in size creates a vectoral directionality in the mitotic spindle placement that
points the larger of the two spindle poles towards the embryo center. We find that this
placement is dependent on both PLK1 and PLK4 activity during embryogenesis. With
this work, we propose a model in which large, uniquely-structured centrosomes direct
spindle placement within the disproportionately large zebrafish embryo cells to
orchestrate cell divisions during early embryogenesis.

3.2. Introduction. During early embryogenesis, rapid cell divisions increase the number
of cells in an embryo to ensure proper tissue and organ formation can proceed during
later development. However, it remains unclear how the mitotic spindle is able to
position itself within the confines of a cell when that cell is disproportionately large.

72

Previous studies have investigated whether a limit to mitotic spindle size exists in large
embryonic cells, and the overarching trend was that larger embryonic cells have larger
spindles to compensate27. Across a wide variety of organisms spanning multiple phyla,
large spindle size correlated with large cell size in cells of less than 140 microns in
diameter. However, this study has two caveats. First, many vertebrate embryos have
cells of greater than 140 microns in diameter, including Xenopus and Danio rerio
(zebrafish) embryos. Knowing this, the question still remains whether spindle scaling
applies to these large cells in order to coordinate division. Additionally, this study
focused on comparing spindle and cell sizes across a variety of organisms. This poses
the question of how the mitotic spindle adapts to the rapidly changing cell size during
early cell divisions during the development of a single organism. This study aims to
understand the previously unknown mechanism by which cell division is regulated
during early development in extremely large cells.
A previous study proposed that large embryonic cells take advantage of
microtubule nucleation sites outside the mitotic centrosomes/spindle poles in order to
span large cells to coordinate division. These sites outside the spindle poles could allow
microtubules to more easily span the large distance from spindle pole to cell cortex in
order to anchor and provide pulling forces during division29. The mitotic
centrosome/spindle pole is the traditional site that assembles the microtubule-based
spindle. In most eukaryotic systems, one spindle pole consists of two centrioles
surrounded by pericentriolar material that contains microtubule nucleation sites13. Our
studies have expanded upon the idea that acentrosomal nucleation sites contribute to
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cell division in extremely large cells29. Building on this, we propose that these remote
nucleation sites are derived from uniquely-organized spindle poles. Using the
developing zebrafish embryo as a model organism for division in giant cells, we present
a testable model where spindle pole size scales with cell size instead of the previously
proposed spindle scaling mechanism, and these large spindle poles regulate mitotic
spindle positioning during zebrafish embryo monolayer formation in a PLK1- and PLK4dependent manner.

3.3. Results
3.3.1. Spindle pole area scales with cell length in C. elegans and zebrafish
embryonic cell division. In order to elucidate a conserved mechanism of embryonic
spindle placement, we utilized the invertebrate C. elegans and vertebrate zebrafish
embryo as model systems. These organisms were chosen based on their stark
differences in size, embryo morphology, and organism complexity. Additionally, both
organisms have been extensively utilized in previous spindle positioning studies, where
C. elegans is a classic model for spindle positioning during embryonic polarity
establishment19,80,119 and zebrafish are an ideal model to study spindle positioning in
disproportionately large embryo cells28,120,121.
C. elegans embryos develop within the confines of an eggshell during their
earliest cell divisions (modeled in Figure 3.1a). These divisions occur asynchronously,
and anterior-posterior polarity is established from the first asymmetric cell division122. In
contrast, early zebrafish embryos undergo rapid cleavage stage cell divisions on top of
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Figure 3.1. Spindle and cell size decrease rapidly during early C. elegans and zebrafish cell divisions. (a)
Model of early C. elegans developmental stages (1-cell through 5-cell stage). Embryonic cells shown in gray. (b)
Model of early zebrafish developmental stages (8-, 16-, 32-, 64-, and 128-cell stage). Embryonic cells shown in gray,
yolk shown in white. (c) Representative three-dimensional rendering of a zebrafish embryo at interphase and
metaphase at the 8- and 16-cell stage. Microtubule marker (EMTB-3xGFP) shown in grayscale. Bar, 250μm. (d) Bar
graph depicting two-dimensional cell area of single cells during C. elegans (left) and zebrafish embryo development
(right). Mean ± SEM shown. One-way ANOVA, p < 0.0001 (****). n=10 C. elegans embryos and n=3 zebrafish
embryos measured. (e) Bar graphs depicting spindle length (orange) and cell length along spindle axes (gray) during
C. elegans (left) and zebrafish development (right). Mean ± SEM shown. One-way ANOVA, p < 0.0001 (****) for C.
elegans and zebrafish cell length, p = 0.0005 (***) for C. elegans spindle length, p = 0.0002 (***) for zebrafish spindle
length. n=10 C. elegans embryos and n=3 zebrafish embryos measured. (f-g) Representative images of metaphase
cell at the 1-cell (top) and 3-cell stage (bottom) in a C. elegans embryo (f), and at the 8-cell (top) and 16-cell stage
(bottom) in a zebrafish embryo (g). Chromosomes and γ-tubulin shown in white, chromosomes denoted by blue
arrowhead. Mitotic spindle poles highlighted in insets on right. Bar, 15μm. (h) Violin plot with box and whiskers
depicting two-dimensional spindle pole area (μm2) at the 1-cell and 3-cell stage in C. elegans (left), and at the 8-cell
and 16-cell stage in zebrafish (right). n>24 C. elegans embryos and n>12 zebrafish embryos quantified. Student’s
t-test, p < 0.0001 (****). (i) Violin plot depicting cell length, spindle length, and spindle pole area for C. elegans at the
1-cell and 3-cell stage (left), and zebrafish at the 8-cell and 16-cell stage (left). Values normalized to mean of earliest
developmental stage (1-cell for C. elegans, 8-cell for zebrafish), dashed line at value of 1. (j) Scaled model depicting
cell (gray), spindle (orange), and spindle pole (purple) sizes during the 1-cell and 3-cell stage in C. elegans embryos,
and the 8-cell and 16-cell stage in zebrafish embryos. Bar, 20μm. For violin plots: Plot boundaries depict minimum
and maximum, 25th and 75th quartiles represented by thin black line, median represented by thick black line.
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a yolk (Figure 3.1b). Cell divisions occur synchronously for the first ten cell divisions, at
which point the divisions begin to occur in an asynchronous wave102. During the first five
cycles of cell division, blastomeres divide along a single plane to create a cellular
monolayer on top of the yolk. Each cell division during this stage occurs perpendicular
to the plane of the previous division within this monolayer, leading to the construction of
a cellular grid (2x1 cells at the 2-cell stage, 2x2 at the 4-cell stage, 4x2 at the 8-cell
stage, 4x4 at the 16-cell stage, 8x4 at the 32-cell stage)102. This is clearly visualized
through the use of a transgenic zebrafish line, where the fluorescently labelled
microtubule binding protein ensconsin (EMTB-3xGFP) is used as a microtubule marker.
Here, the 16-cell stage embryo can be seen with mitotic spindles oriented perpendicular
to the previous division at the 8-cell stage (Figure 3.1c)
In the early development of many organisms, rapid rounds of division result in a
stark decrease in cell size during the cleavage stage123. We first measured cell area
during the 1- to 5-cell stage in C. elegans and the 8- to 128-cell stage in zebrafish
embryos. We found that while both organisms had a significant decrease in cell area
during these five rounds of division, the change was of differing magnitudes between C.
elegans and zebrafish. In C. elegans a 43.54±0.84% decrease in cell area was noted
between the 1- and 2-cell stages, and a cell area decrease of 8.08±3.89% occurred
between the 4- and 5-cell stages. This indicates that changes in cell area becomes less
drastic over time in C. elegans. In contrast, a cell area decrease of 46.62±2.25%
occurred between the 8- and 16-cell stage in zebrafish embryos, and this decrease
remained consistent from the 64- to 128-cell stage at 35.91±1.66% (Figure 3.1d). This
suggests that while a marked decrease in cell size occurs during the first several rounds
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of cell division in many organisms, the magnitude of this change is not always similar.
However, the consistent decrease in size across both organisms suggests that cells do
not expand in size between cell divisions during early proliferation (Figure 3.1d).
We next sought to determine whether the spindle adjusted to changes in cell
length and if this was conserved between C. elegans and zebrafish embryos. To
accomplish this, we measured spindle length in C. elegans embryos that stably
expressed a centrosome marker (a-tubulin-GFP), cell membrane marker (PH:mCherry)
and a nuclear marker (H2B-GFP/his-58) in order to measure cell and spindle length
specifically at metaphase (Figure 3.1f, Supplementary Figure 3.1a-b). Similarly, we
used the EMTB-3xGFP transgenic zebrafish line to visualize microtubules (Figure 3.1c,
Supplementary Figure 3.1a-b), or stained spindle poles (γ-tubulin) and nuclei (DAPI) in
fixed zebrafish embryos for measurements (Figure 3.1f) as an alternative method to
clearly label the mitotic spindle. Metaphase mitotic spindle length was measured from
spindle pole to spindle pole, and cell length was measured from cell membrane to cell
membrane along the same plane of the metaphase spindle (Supplementary Figure
3.1f). The trend calculated in cell length through the cell cycles of interest in C. elegans
and zebrafish embryos was similar to that identified for cell area (Figure 3.1d-e), where
cell length decreased with every division over time (Figure 3.1d, gray). Interestingly, we
found that while spindle length also decreased through multiple rounds of cell division in
C. elegans and zebrafish embryos, this decrease was not as drastic as the decrease in
cell length (Figure 3.1d, orange). When considered as a ratio between spindle length
and respective cell length, this results in mitotic spindles occupying a higher percentage
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of the cell length in later cell divisions compared to earlier divisions in both organisms
(Supplementary Figure 3.1c). Additionally, this leads to a significant decrease in the
distance from mitotic spindle poles to the cell membrane with each cell division
(Supplementary Figure 3.1d). Despite the stark size difference between C. elegans
embryo cells (22μm cell with 8μm spindle at 8-cell stage) and zebrafish embryo cells
(127μm cell with 18μm spindle at 8-cell stage, Figure 3.1i, Supplementary Figure 3.1f),
this data suggests a conserved trend of disproportional changes in cell and spindle
dimensions during early cell divisions.
Previous studies theorized that acentrosomal nucleation sites made it possible
for astral microtubules to more easily span the distance from spindle pole to cell cortex
in disproportionately large cells29. Based on this idea, we next measured the size of
mitotic spindle poles in C. elegans and zebrafish embryos to determine whether they
scaled to the changes in cell size. Spindle pole area was measured using γ-tubulin
signal (live transgenic fluorescence, Figure 3.1f, or antibody staining, Figure 3.1g) in 1and 3-cell stage C. elegans (Figure 3.1f) and 8- and 16-cell stage zebrafish embryo
cells (Figure 3.1g). In both organisms, we found a significant decrease in spindle pole
area over time (Figure 3.1h). In C. elegans, spindle pole area decreased from
6.75±0.28μm2 at the 1-cell stage to 4.06±0.14μm2 at the 3-cell stage, and zebrafish
embryos decreased from 391.5±27.79μm2 at the 8-cell stage to 173.6±6.64μm2 at the
16-cell stage (Figure 3.1h). We were surprised that the mitotic spindle poles in zebrafish
embryos were so large, as we expected to see condensed punctate spindle poles
similar to those seen at the zebrafish 512-cell stage (Supplementary Figure 3.1e) or
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with C. elegans embryos (Figure 3.1f). Instead, we noted giant, uniquely-structured
spindle poles at the 8- and 16-cell stages of zebrafish development that often
resembled a wheel-like structure (Figure 3.1g).
The values obtained from cell length, spindle length, and spindle pole area
measurements were normalized to determine the relative change in these parameters.
Size values in C. elegans were normalized to the mean value at the 1-cell stage, and
values from zebrafish embryos were normalized to the mean value at the 8-cell stage.
In both C. elegans and zebrafish embryos, we determined that the change in cell length
scaled more closely with the change in mitotic spindle pole area than that of spindle
length (Figure 3.1i). This is interesting since spindle size has been suggested to scale
with cell size during early development27. We found that both cell length and spindle
pole area decreased by approximately 30-40% over time. Cell length decreased
39.96±1.23% in C. elegans and 27.24±1.37% in zebrafish embryos during the cell
cycles measured, and spindle pole area decreased 33.12±1.99% in C. elegans and
35.34±6.03% in zebrafish during the same time frame. Spindle length, however,
decreased less than 20% during this time, 18.22±3.05% in C. elegans and 19.21±2.37%
in zebrafish (Figure 3.1i). Taken together, these data suggest that decreases in cell size
scale more closely with spindle pole size than spindle length. This regulation of spindle
pole area during changes in cell size seem to be conserved between both organisms
measured. This leads to a model where spindle poles adjust to cell size changes during
early cleavage stage divisions (Figure 3.1j).
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3.3.2. Centrosomes in early zebrafish development are uniquely-structured. In
order to further characterize the spindle positioning and spindle pole morphology during
early zebrafish development, we employed two transgenic lines to follow mitotic cells in
a live zebrafish embryo. One line specifically marks microtubules (bactin::EMTB3xGFP) and the second line marks spindle poles (bactin::centrin-GFP). We employed
both lines to monitor spindle and spindle pole shape changes as cells transition from a
4x2 grid at the 8-cell stage to a 4x4 grid at the 16-cell stage (modeled in Figure 3.2a).
Using a spinning disk confocal microscope, a four-dimensional time series of EMTB3xGFP embryos was obtained and presented as a volumetric projected micrograph of
depth-coded EMTB-3xGFP embryos (Figure 3.2b). The positioning of the labelled
mitotic spindles within the depth-coded image indicated that spindles were positioned
parallel to the yolk boundary during the 8- and 16-cell stage. We also visualized labelled
mitotic spindles positioning perpendicular to the previous plane of division within the
plane of the monolayer when using both EMTB-3xGFP marking the microtubule based
spindle (Figure 3.2b) and centrin-GFP embryos that denote the mitotic spindle pole
positioning (Figure 3.2c).
Through the use of these transgenic lines, we are able to determine the mitotic
stage of dividing cells through changes in microtubule spindle morphology (Figure 3.2d)
and identify novel changes in early embryo centrosome morphology (Figure 3.2e).
Microtubule spindle morphology is similar to that documented in tissue culture
settings84,124, with a clear central spindle and astral microtubules (Figure 3.2d).
However, the centrosome morphology visualized through centrin-GFP fluorescence is
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(cyan/inverted grayscale), and nuclei (DAPI, blue) shown. Bar, 20μm.
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distinct compared to tissue culture settings. Here, mitotic centrosomes are uniquelystructured and much larger within the cell compared to cell culture settings103,108 (Figure
3.2e). During prophase, centrin-GFP wraps around the nucleus as a condensed
structure, accumulating on the polar ends where the mature spindle pole will form from
prometaphase to metaphase (Figure 3.2e). During prometaphase, the centrin-GFP
remains moderately focused but as the dividing cell transitions into metaphase, the
spindle pole reaches its maximum area and starts to present with a wheel-like structure
(Figure 3.2e). Once the cell transitions to anaphase, the spindle poles begin to
fragment and enlarge to the approximate size of the nucleus. They then disperse and
start to reform during telophase to prepare for immediate re-entry of the daughter cells
into the cell cycle (Figure 3.2e). This pattern of centrin morphology throughout mitosis
was found to be similar to that of γ-tubulin (Figure 3.2f). Centrin is traditionally enriched
at centriole barrels that are surrounded by pericentriolar matrix (PCM). γ-tubulin is a
microtubule nucleating protein enriched at the PCM125. When we fixed centrin-GFP
embryos and additionally immunostained for γ-tubulin, we found that both proteins
exhibited a similar structure at the centrosome throughout each mitotic stage (Figure
3.2f), suggesting that a significant population of centrin resided within the PCM in
dividing cells in the zebrafish embryo. Later at the 512-cell stage of zebrafish
development, both proteins localize to centrosomes that appear smaller and more
punctate at various mitotic stages (Supplementary Figure 3.2a). We analyzed images
with centrin-GFP signal and γ-tubulin immunostaining and performed a Pearson’s
correlation coefficient to determine colocalization between the two proteins over time.
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division plane in early zebrafish divisions. (a) Maximum confocal projections of fixed mitotic zebrafish cells at
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Methods Table 4.
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We found that from the 8- to 16- to 512-cell stages of development, there was a
significant increase in the colocalization of centrin-GFP and γ-tubulin (Supplementary
Figure 3.2b). This suggests that the localization of centrin-GFP may change over time
during early zebrafish development, adopting a dispersed localization in the PCM of
dividing cells in early cell divisions (8-, 16-cell stage). However, during later divisions
when cells become smaller in size (512-cell stage embryos and later), centrin may
localize more predominantly with the centriole as seen in mammalian somatic cells103
with the PCM tightly organizing around the two centrioles13.

3.3.3. Spindle poles are asymmetric during early zebrafish cell divisions. An
asymmetry in spindle pole size was identified across a single spindle during early
zebrafish embryonic divisions (8- and 16-cell stage embryos in Figure 3.1g, 16-cell
stage embryos in Figure 3.3a) that wasn’t identified in C. elegans embryos (Figure 3.1f).
We quantified the area of zebrafish spindle poles using both centrin-GFP signal and γtubulin immunofluorescence labelling at the 8-cell and 16-cell stage (Figure 3.3b-e). We
binned these values based on size, separating the larger and smaller spindle poles
within each spindle. We calculated a significant different between the area of the larger
and smaller spindle poles within a cell at both the 8- and 16-cell stage using both γtubulin (Figure 3.3b) and centrin-GFP (Figure 3.3d). When considered as a ratio
between the larger and smaller pole area, the larger pole is approximately two-fold
larger than that of the smaller pole when measured with γ-tubulin signal (2.21±0.12 at 8cell, 2.16±0.08 at 16-cell stage, Supplementary Figure 3.3a) and approximately 1.5-fold
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when measured with centrin-GFP signal (1.48±0.08 at 8-cell, 1.64±0.09 at 16-cell stage,
Supplementary Figure 3.3c). No significant difference was noted between ratios when
comparing the two cell cycles (Supplementary Figure 3.3a, 3.3c), suggesting that
spindle poles maintained a consistent asymmetry despite changing cell and spindle pole
sizes from the 8- to 16-cell stages.
When considering the position of the asymmetric mitotic spindle poles within the
embryo itself, we identified that the larger of the two poles more frequently pointed
towards the center of the embryo (Figure 3.3a). We first identified the embryo midline,
which is the line that passes through either the 4x2 cell grid (8-cell stage embryo) or 4x4
cell grid (16-cell embryo, refer to dashed orange line in Figure 3.3a, modeled in Figure
3.3f). We found that the largest spindle pole always pointed towards this embryonic
midline. When binning spindle pole area values as either toward the midline (noted as
inner) or away from the midline (noted as outer), we calculated that γ-tubulin-decorated
spindle poles were significantly larger in size towards the midline (313.16±16.80μm2)
compared to those positioned away from the midline (180.63±13.10μm2) at an 8-cell
embryonic stage (Figure 3.3c). This asymmetry was also calculated at the 16-cell stage
(222.96±10.71μm2 at inner pole, 124.26±5.75μm2 at outer pole, Figure 3.3c). A ratio
was calculated to represent the inner pole area over the outer, identifying more than a
two-fold difference in the two areas (2.14±0.13 at 8-cell, 2.09±0.09 at 16-cell stage,
Supplementary Figure 3.3b), which is very similar to the values obtained when binning
pole areas by size. This indicated that more often than not, the larger of two mitotic
spindle poles within a spindle is positioned closest to the center of the embryo.
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This trend was not consistent when considering pole area based on centrin-GFP
signal. Here, spindle pole area was not significantly different at the 8-cell stage when
binning values based on position (p-value of 0.1183, Figure 3.3e). Additionally, pole
areas at the 16-cell stage were not nearly as significant (p-value of 0.003, Figure 3.3d)
compared to those generated from values binned by size (p-value < 0.0001, Figure
3.3e). When a ratio between inner and outer poles was generated based on centrinGFP, these ratio values were closer to a value of 1 (1.25±0.09 at 8-cell, 1.43±0.11 at
16-cell stage, Supplementary Figure 3.3d) suggesting that the pole with the larger area
based on centrin-GFP localization is not as consistently placed at the center of the
embryo compared to the data obtained with γ-tubulin signal. Taken together, these data
suggest a model in which zebrafish spindle poles present with an asymmetry in PCM
components such as γ-tubulin across a single spindle, and this asymmetry creates a
vectoral directionality that positions the larger spindle pole towards the embryo center at
the 8- and 16-cell stage (Figure 3.3f).

3.3.4. Spindle positioning, but not asymmetry, is PLK1- and PLK4-dependent. To
determine the mechanism by which the spindle pole asymmetry is governed, we
targeted the mitotic kinases PLK1 (Polo-like kinase 1) and PLK4 (Polo-like kinase 4).
PLK1 is an essential mitotic kinase that regulates many aspects of cell division such as
spindle assembly, checkpoints, and centrosome maturation. The related kinase PLK4
regulates centriole duplication prior to the assembly of the mitotic spindle15. Transcripts
for PLK1 and PLK4 have been detected as early as the 1-cell stage in zebrafish
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embryos, indicating that they are maternally supplied prior to zygotic genome
activation126. Inhibitors for PLK1 (BI2536) and PLK4 (centrinone) have been previously
published and have been effective in the inhibition of these kinases in vitro 103,108,127,
and BI2536 has recently been used in early zebrafish embryo studies103,124.
PLK1 has been implicated in the phosphorylation of pericentriolar matrix proteins
such as pericentrin and CEP215 at the centrosome which aids in their organization at
this site. Pericentrin and CEP215 anchor the γ-TURC (γ-tubulin ring complex) to the
PCM, a structure containing γ-tubulin that is responsible for microtubule nucleation at
the centrosome15,128. This occurs in a PLK1-dependent manner129. Additionally, it has
been determined that PLK1 localizes asymmetrically to centrosomes in later zebrafish
embryos103, leading us to ask whether the stark asymmetry in γ-tubulin distribution
across the spindle could be dependent on PLK1 in the early zebrafish cell divisions.
With PLK4 inhibition, in monopolar spindles, acentrosomal spindle poles, and mitotic
delay have been reported to occur in vitro15. Given the unique architecture of the
zebrafish spindle poles noted by γ-tubulin and centrin-GFP morphology, we sought to
determine the response to either PLK1 or PLK4 inhibition.
When injecting a vehicle control (1% DMSO), two concentrations of BI2536
(100nM or 1 μM), or two concentrations of centrinone (100nM or 1 μM) at the 1-cell
stage, spindle pole asymmetry was not disrupted under any of the conditions. This was
determined by measuring spindle pole areas in fixed embryos at the 16-cell stage after
immunstaining for g-tubulin. We binned spindle pole areas by size and separated the
smaller and larger spindle pole areas. We found that the larger spindle poles were
significantly larger than the smaller spindle poles (Figure 3.4b). When we converted
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these values into a ratio to compare the area of the largest pole to that of the smallest,
we found a slight but significant decrease in the asymmetry under conditions of PLK1 or
PLK4 inhibition compared to vehicle control (Supplementary Figure 3.4a). Interestingly,
spindle pole area for both small and large poles increased under conditions of PLK1inhibition in a dose-dependent manner (100nM BI2536: 127.25±7.14μm2 large poles,
83.59±5.00μm2 small poles; 1μM BI2536: 141.63±5.87μm2 large poles, 91.17±3.44μm2
small poles) compared to DMSO-treated control embryos (101.65±4.91μm2 large poles,
52.28±272μm2 small poles, Figure 3.4b). However with centrinone treatment, spindle
pole area increased similarly with both drug concentrations (100nM centrinone:
199.33±9.96μm2 large poles, 120.58±6.35μm2 small poles; 1μM centrinone:
151.01±9.25μm2 large poles, 97.80±6.62μm2 small poles, Figure 3.4b). Contrary to
findings in tissue culture settings127,130, we did not observe instances of monopolar
spindle formation or loss of centrin signal at centrosomes in zebrafish embryos upon
PLK4 inhibition with centrinone. This could be due to the observed centrin localization in
the PCM and not to an identifiable centriole. However, both PLK1 inhibition and PLK4
inhibition cause structural changes within the PCM architecture, causing a significant
increase in PCM size while still able to retaining the asymmetry, albeit not as well as
under control conditions (ratios calculated in Supplementary Figure 3.4a).
We next examined whether there was still a vectoral directionality in spindle
placement under conditions of PLK1 and PLK4 inhibition, with large spindle poles
pointed towards the midline and smaller spindle poles pointed away. When binning
spindle pole area calculations based on position in relation to the midline, the difference
in spindle pole area based on position was not significant under BI2536 conditions
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Supplementary Figure 3.4. Placement of asymmetric zebrafish spindle poles is PLK1- and PLK4-dependent.
(a-b) Violin plot depicting the ratio of spindle pole areas binned by size (larger-to-smaller pole ratio, a) or position in
relation to the midline (inner-to-outer pole ratio, b) under conditions of DMSO (gray), BI2536 (100nM or 1μM, blue), or
centrinone (100nM or 1μM, gold) exposure. Spindle pole areas measured from γ-tubulin signal from fixed zebrafish
embryos at the 16-cell stage. One-way ANOVA with Dunnett’s multiple comparison test, n>10 embryos quantified. (c)
Violin plot depicting mitotic spindle pole area measured from γ-tubulin signal from fixed zebrafish embryos at the
16-cell stage under conditions of DMSO (gray), BI2536 (100nM or 1μM, blue), or centrinone (100nM or 1μM, gold)
exposure. One-way ANOVA, p<0.0001 (****). n>96 cells quantified. (d) Violin plot depicting spindle angle in relation to
midline fixed zebrafish embryos at the 16-cell stage under conditions of DMSO (gray), BI2536 (100nM or 1μM, blue),
or centrinone (100nM or 1μM, gold) exposure. One-way ANOVA, p=0.0514. n>48 cells quantified. For all plots: Plot
boundaries depict minimum and maximum, 25th and 75th quartiles represented by thin black line, median represented by thick black line. Detailed statistical analysis in Methods Table 4.
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compared to DMSO controls (Figure 3.4c). With centrinone treatment, there was a
slight but significant difference noted in 100nM centrinone injections (p-value of 0.0341,
Figure 3.4c). This was corroborated by the calculation of a ratio between the inner and
outer pole areas, where ratios for BI2536 (100nM: 1.425±0.12, 1μM: 1.142±0.06) and
BI2536 (100nM: 1.418±0.11, 1μM: 1.29±0.15) approached a value of 1 whereas DMSO
control injections demonstrated a ratio of 2.00±0.14 (Supplementary Figure 3.4b). When
calculating the percentage of spindles with the larger spindle pole positioned towards
the embryonic midline, we determined that 79.65±4.56% of embryonic cells injected
with the vehicle control positioned the largest pole towards the midline. This value
represents the majority of cells evaluated. However, a dosage-dependent decrease in
this value was noted under conditions of PLK1 (BI2536) or PLK4 (centrinone) inhibition.
With BI2536 conditions, 60.87±4.07% (100nM) and 48.12±5.02% (1μM) of spindles
positioned larger poles towards the midline, and 66.07±9.13% (100nM) and
54.52±7.76% (1μM) did so with centrinone treatment (Figure 3.4d). When considering
that a 50% rate of positioning towards the midline would represent a random
distribution, these percentages indicate that vectoral spindle placement becomes
deregulated under PLK1 or PLK4 inhibition (Figure 3.4a, d). While the inherent
asymmetry in spindle pole size functions under a PLK1-/PLK4-independent mechanism,
these studies suggest that the placement of the asymmetric spindle poles with respect
to the center of the embryo require PLK1 and PLK4 function (Figure 3.4e).

94

3.4. Discussion. In previous studies, PLK1 has been proposed to regulate PCM
architecture by facilitating its phase separation in C. elegans. Additionally, PLK1 has a
defined role in recruiting the pericentrin-CEP215 complex that anchors the γ-TURC at
the centrosome15,128. Based on this information, it is possible that PLK1 is working to
orchestrate proper PCM architecture in the large cells of the early zebrafish embryo as
well. This could explain why spindle pole area increased in a dosage-dependent
manner with BI2536 treatment. Here, the loss of PLK1 activity would result in a loss of
this PCM architecture regulator, causing the surrounding PCM to lose its tight matrix
configuration and occupy a larger space.
Strikingly, centrinone treatment did not exhibit the same dosage-dependent
change in spindle pole area, instead a similar increase was seen regardless of
treatment dosage. A possible explanation is that PLK4 is present at much lower
concentrations in the early zebrafish embryo compared to PLK1126. It is therefore likely
that lower drug concentrations are needed to target the small pool of embryonic PLK4,
leading to a similar phenotype with various drug concentrations above this small
threshold. The opposite would then be true for PLK1, where dosage-dependency was
observed because the larger pool of PLK1 would take a higher drug concentration to
completely render inactive. Further studies would be required to determine whether
these two proteins behave similarly in zebrafish compared to previous tissue culture
studies, and how the relative quantities of these proteins may change during
development.
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These studies aimed to understand how mitotic spindles are able to coordinate
cell division in disproportionately large cells. One striking finding was that spindle
orientation was not significantly impacted under inhibition of PLK1 or PLK4
(Supplementary Figure 3.4d). We theorized that the large mitotic spindle poles
characterized in zebrafish embryos would allow for astral microtubules to be projected
closer to the cell cortex to anchor and generate necessary pulling forces to orchestrate
division in giant cells. We were therefore surprised to note that spindle orientation was
not significantly changed in relation to the embryonic midline under drug treatment
(Supplementary Figure 3.4d). A possible explanation is that although spindle
directionality was changed through the randomization of larger pole placement in
relation to the midline, Hertwig’s rule may still apply here and regulate spindle
positioning independent of PLK1 or PLK4 activity. Hertwig’s rule describes how a
spindle is typically placed along the longest axis of a dividing cell24, and it is possible
that spindles are placed at specified angles that follow this rule and are PLK1- and
PLK4-independent. Further studies will be necessary to understand the exact
mechanism that placed the mitotic spindle at a defined angle in relation to the embryo
midline.
Overall, these data contribute to a model where asymmetricly-structured spindle
poles position themselves within the zebrafish embryo with vectoral directionality in
respect to the embryo center (Figure 3.3f). We determined spindle pole asymmetry is
governed by a PLK1- and PLK4-independent mechanism, but PLK1 and PLK4 are
required to properly place the asymmetric poles with respect to the center of the
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embryo. Through these studies, a novel centrosome structure has been characterized
that may contribute to a better understanding of how mitotic spindles are able to
coordinate cell division in disproportionately large cells.

3.5. Materials and Methods
3.5.1. Fish Lines. Zebrafish lines were maintained using standard procedures approved
by the Syracuse University IACUC committee (protocol #18-006). Embryos were stages
as described in Kimmel et al 1995. See Supplementary Table 3 for list of transgenic
zebrafish lines used.

3.5.2. Zebrafish Imaging. A Leica SP5 or SP8 (Leica, Bannockburn, IL) laser scanning
confocal microscope was used throughout this manuscript. An HC PL APO 20x/0.75
IMM CORR CS2 objective, HC PL APO 40x/1.10 W CORR CS2 0.65 water immersion
objective, and an HCX Plan Apochromat 63×/1.40-0.06 NA OIL objective were used.
Images were acquired using LAS-X software. A Leica DMi8 (Leica, Bannockburn, IL)
with a X-light v2 confocal unit spinning disk was also used, equipped with an 89 North –
LDI laser and a Photometrics Prime-95B camera. Optics used were either 10x/0.32 NA
air objective, HC PL APO 63X/1.40 NA oil CS2, HC PL APO 40X/1.10 NA WCS2
CORR, a 40X/1.15 N.A. 19 Lamda S LWD, or 100Å~/1.4 N.A. HC Pl Apo oil emersion
objective.
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3.5.3. C. elegans imaging. Live cell imaging of C. elegans embryos was performed on a
spinning disk confocal system that uses a Nikon Eclipse inverted microscope with a 60X
1.40NA objective, a CSU-22 spinning disc system and a Photometrics EM-CCD camera
from Visitech International. Images were obtained every 2 minutes with a 1 micron z-stack
step size. See Supplementary Table 3 for list of transgenic lines used.

3.5.4. Pharmacological treatments. Embryos were injected with either 1% DMSO, or
BI2536 or centrinone (final concentration 100nM or 1µM) at the 1-2-cell stage. Embryos
are incubated at 30°C until they reach the developmental stage of interest, at which time
they are fixed with 4% paraformaldehyde in PBS. Immunohistochemistry then proceeds
as detailed below.

3.5.5. Zebrafish immunohistochemistry. Zebrafish embryos were fixed using 4% PFA
containing 0.5% Triton-X 100 overnight at 4°C. Zebrafish were then dechorionated and
incubated in PBST (phosphate buffered saline + 0.1% Tween) for 30 minutes. Embryos
were blocked using a Fish Wash Buffer (PBS + 1% BSA + 1% DMSO + 0.1% Triton-X
100) for 30 minutes followed by primary antibodies incubation (antibodies diluted in Fish
Wash Buffer in concentrations stated in table above) either overnight at 4°C or 3 hours at
room temperature. Embryos are then washed five times in Fish Wash Buffer before
incubating with secondary antibodies for 3 hours at room temperature. After five more
washes, embryos were incubated with 4',6-diamidino-2-phenylindole (NucBlue® Fixed
Cell ReadyProbes® Reagent) for 30 minutes. For imaging, embryos were either halved
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and mounted on slides using Prolong Diamond (Thermo Fisher Scientific cat. # P36971)
or whole-mounted in 2% agar (Thermo-Fisher cat. # 16520100).

3.5.6. Image and Data Analysis. Images were processed using both FIJI/ImageJ
software and Adobe Photoshop. Angles were calculated using FIJI/ImageJ software and
Microsoft Excel. All graphs were generated and statistical analysis performed using
Graphpad Prism software. 3-D images, movies, and surface rendering were performed
using Bitplane IMARIS software (Surface, Smoothing, Masking, and Thresholding
functions). For mitotic spindle angle calculations, a line was drawn in ImageJ/FIJI to
measure the angle of the midline or yolk boundary in relation to the image boundary.
Next, a second line was drawn along the mitotic spindle to measure its angle in relation
to the image boundary. The difference between these two values was then calculated
to represent the angle of the mitotic spindle in relation to the midline or yolk boundary.
To calculate two-dimensional area, a boundary was drawn around the structure of
interest (cell, spindle pole, etc.) in ImageJ/FIJI and the area within this shape was
calculated. To calculate spindle length, cell length, aspect ratio, etc., a line was drawn in
ImageJ/FIJI from one end of the structure of interest to the other. This length was then
measured and recorded. To calculate aspect ratios, the length along the plane of the
mitotic spindle was divided by the length perpendicular to the mitotic spindle and
displayed as a ratio.
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3.5.7. Statistical analysis. Unpaired, two-tailed Student’s t-tests and one-way ANOVA
analyses were performed using GraphPad Prism software. **** depicts a p-value
<0.0001, *** p-value <0.001, **p-value<0.01, *p-value <0.05. See Supplementary Table
4 for detailed information regarding statistics.

3.5.8. Methods Table 1: Key Resources Table
Reagent Type
Designation
(species or resource)
Software/Algorithm
ImageJ/FIJI, Bitplane
IMARIS
Drugs
BI2536, centrinone
3.5.9. Methods Table 2: Antibodies
Name
Dilution
Gamma-tubulin
1:200
DAPI
1:1000
NucBlue
1 drop/mL

Source
Bitplane
BI2536 (Selleck Chemicals S1109),
centrinone (R&D Systems, 5690)

Company/Cat. No
Abcam (11316)
SigmaAldrich (D9542-10MG)
ThermoFisher (R37606)

3.5.10. Methods Table 3: Transgenic Lines
Type
Name
Zebrafish
TAB (wild-type)

Zebrafish

Tg(-5actb2:cetn4-GFP)

Zebrafish
C. elegans

Tg(actb2:Hsa.MAP7-EGFP)
JAB23: ojIs51 [air-2::GFP]; weIs21 [pie1::tubulin::mCHERRY]
JAB24: zen-4(or153ts); Zen-4:GFP rescue construct
complex weIs21 [pJA138 (pie-1::mCherry::tub::pie-1)]
JAB52
γ-tubulin::GFP; H2B::GFP; a-tubulin::mCherry
JAB141: ojls2[alpha-tubulin::GFP]; ltIs37 [Ppie1::mCherry::his-58]
JAB142: ojls2[alpha-tubulin::GFP]; ltIs37 [Ppie1::mCherry::his-58]; ltIs44 [Ppie-1::mCherry::PH
PLC1delta1]

C. elegans
C. elegans
C. elegans
C. elegans
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Source
Zebrafish
International
Resource
Center (ZIRC)
Solnica-Krezel
Lab
Megason Lab
Bembenek Lab
Bembenek Lab
Bembenek Lab
Bembenek Lab
Bembenek Lab

3.5.11.Methods Table 4: Detailed statistical analysis results
Figure
1d

1e

1h
Supp1c
Supp1d
Supp2b
3b
3c
3d
3e
Supp3a
Supp3b
Supp3c
Supp3d

4b

4c

4d

Supp4a

Supp4b

Supp4c

Supp4d

Category
C. elegans
zebrafish
C. elegans cell
C. elegans spindle
ZF cell
ZF spindle
C. elegans
ZF
C. elegans
ZF
C. elegans
ZF
8-cell
16-cell
512-cell
8-cell
16-cell
8-cell
16-cell
8-cell
16-cell
8-cell
16-cell
8-cell
16-cell
8-cell
16-cell
8-cell
16-cell
8-cell
16-cell
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone
DMSO
100nM BI2536
1uM BI2536
100nM centrinone
1uM centrinone

n
10
3
10
10
3
3
13
13, 16
10
3
10
3
23
19
14
73
172
73
172
41
45
41
45
73
172
73
172
41
45
41
45
107
93
128
52
28
107
93
128
52
28
13
12
13
9
7
107
93
128
52
28
107
93
128
52
28
214
186
264
66
56
105
48
60
66
35

Statistical test

Parameters
F (4, 45) = 611.6
F (4, 10) = 105.5
F (4, 69) = 88.18
F (4, 81) = 5.558
F (4, 10) = 109.6
F (4, 10) = 16.69
t=8.975, df=92
t=5.519, df=489
F (4, 69) = 16.57
F (4, 10) = 26.35
F (9, 308) = 83.44
F (4, 10) = 114.8

Result
****
****
****
***
****
***
****
****
****
****
****
****

p-value
<0.0001
<0.0001
<0.0001
0.0005
<0.0001
0.0002
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

F (2, 53) = 3.198

*

0.0488

t=7.258, df=144
t=9.509, df=342
t=6.231, df=145
t=8.119, df=332
t=4.337, df=80
t=6.406, df=88
t=1.579, df=80
t=3.052, df=88

****
****
****
****
****
****
ns
**

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.1183
0.003

Two-tailed Student's t-test

t=0.3721, df=238

ns

0.7101

Two-tailed Student's t-test

t=0.3561, df=238

ns

0.7221

Two-tailed Student's t-test

t=1.287, df=84

ns

0.2015

t=1.274, df=84

ns

0.2063

t=8.973, df=212
t=5.006, df=184
t=7.418, df=254
t=6.668, df=102
t=4.678, df=54
t=6.026, df=212
t=0.7575, df=184
t=0.1376, df=254
t=2.147, df=102
t=0.7782, df=54

control
****
****
****
****
control
ns
ns
*
ns
control
ns
***
ns
*
control
**
****
*
*
control
***
****
**
**
control
ns
***
****
**

control
<0.0001
<0.0001
<0.0001
<0.0001
control
0.4497
0.8907
0.0341
0.4398
cotrol
0.0609
0.0004
0.3157
0.0258
control
0.0011
<0.0001
0.0275
0.0218
control
0.0007
<0.0001
0.0052
0.0066
control
0.3125
0.0004
<0.0001
0.0042

ns

0.1209

One-way ANOVA

One-way ANOVA

Two-tailed Student's t-test
One-way ANOVA
One-way ANOVA
One-way ANOVA
Two-tailed Student's t-test
Two-tailed Student's t-test
Two-tailed Student's t-test
Two-tailed Student's t-test

Two-tailed Student's t-test

Two-tailed Student's t-test

Two-tailed Student's t-test

One-way ANOVA with Dunnett's multiple comparison

F (4, 49) = 4.865

One-way ANOVA with Dunnett's multiple comparison

F (4, 403) = 5.814

One-way ANOVA with Dunnett's multiple comparison

F (4, 403) = 9.881

One-way ANOVA with Dunnett's multiple comparison

F (4, 781) = 11.95

One-way ANOVA

F (4, 309) = 1.841
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Chapter Four:
PLK-1 regulates spindle organization and mitotic progression during
zebrafish development
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This chapter features work from two publications:

Part I: Evaluating the localization and activity of PLK1 in mammalian cells and
vertebrate zebrafish embryos.
Adapted from Colicino, E. G. et al. Chromosome misalignment is associated with
PLK1 activity at cenexin-positive mitotic centrosomes. Mol. Biol. Cell 30, 1598–
1609 (2019).
Author contributions:
E.C. and H.H. designed and E.C., M.B., L.R., K.S., J.M. and H.H. conducted
experiments and analyzed the data. J.A. provided zebrafish embryos and
husbandry knowledge. J.F. constructed all vectors utilized. E.C. and H.H. wrote
the manuscript, contributing to multiple rounds of edits.
Lindsay Rathbun conducted and analyzed zebrafish studies in Figure 4.2d-f.

Part II: Development of an inhibitor to selectively target centrosomal PLK1.
Adapted from Bucko, P. J. et al. Subcellular drug targeting illuminates local kinase
action. Elife 8, 1–29 (2019).
Author contributions:
Paula J Bucko, Conceptualization, Data curation, Formal analysis, Supervision,
Validation, Investigation, Visualization, Methodology, Writing—original draft,
Project administration, Writing—review and editing; Chloe K Lombard, Data
curation, Formal analysis, Investigation, Methodology; Lindsay Rathbun, Data
curation, Formal analysis, Investigation; Irvin Garcia, Data curation, Formal
analysis, Validation, Investigation; Akansha Bhat, Validation, Investigation; Linda
Wordeman, Conceptualization, Resources, Formal analysis; F Donelson Smith,
Conceptualization, Supervision; Dustin J Maly, Conceptualization, Supervision,
Funding acquisition, Methodology; Heidi Hehnly, Data curation, Supervision,
Funding acquisition, Methodology; John D Scott, Conceptualization, Supervision,
Funding acquisition, Visualization, Writing—original draft, Project administration,
Writing—review and editing
Lindsay Rathbun conducted and analyzed zebrafish studies in Figure 4.4-6.
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4.1. Abstract. PLK1 is an essential mitotic kinase that regulates spindle assembly,
microtubule nucleation, and centrosome maturation. During mitosis, it localizes to the
centrosomes, kinetochores, and cytokinetic midbody. However, it is not known if PLK1
populations at these distinct subcellular locales have different functions, and how these
populations function in a vertebrate model system. In this chapter, studies are presented
that demonstrate similar asymmetric localization in zebrafish PLK1 to previous studies in
tissue culture models, and that this asymmetry is altered by the presence of a
missegregated chromosome. Additionally, a new pharmacological tool termed LoKI
(localized kinase inhibition) is introduced, where PLK1 inhibition is targeted directly to the
centrosomal pool. With the LoKI system, a PLK1 inhibitor, BI2536, is attached to a CLP
moiety, which binds to a SNAP-tag that is localized to the centrosome through the use of
the PACT domain. With the use of this system, it was determined that the centrosomal
pool of PLK1 functions in spindle maintenance and mitotic progression, as monopolar,
multipolar, and misorienting spindles were observed along with mitotic delays under
conditions of targeted PLK1 inhibition. This chapter highlights a new toolset to determine
the mechanisms regulating cell division in a vertebrate model system.

Part I: Evaluating the localization and activity of PLK1 in mammalian cells and
vertebrate zebrafish embryos.
4.2. Introduction. Mitotic cell division is a process whereby genetic material is duplicated,
separated, and packaged to yield two daughter cells. This process relies heavily on the
spatial and temporal synchronization of signaling activity at the mitotic spindle, a structure
that segregates the chromosomes and guides them towards the daughter cells. The
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mitotic kinase, polo-like kinase 1 (PLK1), is a major regulator of this process that works
to ensure bipolar spindle formation and chromosome alignment at the metaphase plate.
This is accomplished by PLK1-scaffold interactions at the mitotic centrosomes/spindle
poles which modulate the recruitment of centrosome components SAS-4, γ-tubulin, γTuRC, pericentrin, and CEP215 (reviewed in

108).

Their recruitment is initiated after

PLK1-dependent SAS-4 phosphorylation131. This phosphorylation allows SAS-4
expansion to occur, followed by the recruitment of CEP215 and γ-tubulin and subsequent
expansion of the pericentriolar material (PCM), playing a crucial role in mitotic
centrosome/spindle pole formation during division131. However, it is unclear whether
PLK1 is additionally regulated between the two spindle poles during cell division.
Due to the nature of centriole duplication, the two spindle poles are inherently
asymmetric from one another. The oldest (mother) spindle pole is enriched with the
centriole appendage protein cenexin, compared to the youngest spindle pole
(daughter)14,51. During interphase, mother centriole appendages assist in centrosome
positioning14 and primary cilia formation by anchoring the oldest centriole (known here as
the basal body) to the cell membrane to form the primary cilia (reviewed in

132,133).

Prior

to mitotic onset, PLK1 is recruited to the basal body where it assists in ciliary
disassembly134. Cenexin regulates appendage formation and has also been identified as
a PLK1 binding partner135,136. Previous work utilizing Ground State Depletion (GSD)
identified a modest, but significant, enrichment of PLK1 at the mother (cenexin-positive)
spindle pole in fixed in vitro metaphase cells84. This study suggests an inherent
asymmetry in PLK1 distribution that is dependent on centrosome age. During division,
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cenexin has been implicated in multiple processes, including modulating preferential
chromosome misalignment toward the oldest spindle pole in the event of mitotic error137.
Knowing this, we wanted to test the hypothesis that PLK1 localization and activity is
asymmetrically regulated between the two spindle poles through the presence of cenexin
at the mother spindle pole, which can modulate directional chromosome misalignment.
Using a multidisciplinary approach, we found a significant asymmetry in PLK1
localization and activity between spindle poles in in vivo zebrafish studies and in vitro
tissue culture. From here, we tested whether the propensity for chromosomes to misalign
towards one spindle pole altered PLK1 activity. Lastly, we developed a tool to specifically
inhibit the PLK1 population at the centrosome and determined that this population
regulates spindle organization and mitotic progression.

4.3. Asymmetric distribution of PLK1 in mammalian cells and zebrafish. In
mammalian dividing cells, PLK1 is upregulated during mitosis. During this time, it is
enriched at spindle poles and kinetochores, specifically from prometaphase to
metaphase15,138. Following metaphase exit, PLK1 transitions from kinetochores to the
cytokinetic furrow, where it is subsequently concentrated at the forming midbody
(108,138,139, modeled in Figure 4.1a). The subcellular distribution of PLK1 in mammalian
cells has predominately been studied in in vitro cell culture models. However, in vitro
systems do not always represent what is happening in vivo. Here, we examine the
temporal and spatial regulation of PLK1 during division first in live mammalian cells to
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Figure 4.1. PLK1 asymmetric distribution between
spindle poles is conserved in vivo (zebrafish) and in
vitro (mammalian cell culture). (a) Model depicting
PLK1 (magenta) localization to spindle poles, kinetochores, and cytokinetic midbody. DNA = blue. (b-c) are
data from human retinal pigment epithelial (RPE) cells
stably expressing GFP-PLK1. (b) Representative images
of fluorescence recovery after photobleaching (FRAP) of
GFP-PLK1 expressing RPE cells at spindle poles during
metaphase. (Fire-LUT, ImageJ). 3-D surface plot of a
single metaphase cell displaying GFP-PLK1 integrated
intensity between the two spindle poles. Spindle pole 1
and 2 are marked. (c) GFP-PLK1 integrated intensity at
the highest spindle pole (pole 1) was normalized to
100% and compared to the lowest spindle pole within a
single mitotic spindle, over n=44 cells in n=3 experiments + S.E.M, Student’s paired t-test, p<0.001. (d)
Model depicting zebrafish embryo 4.5 hours post
fertilization (hpf). Drawn inset represents area imaged in
(e) along the yolk boundary. (e) A maximum confocal
projection is presented for PLK1-mCherry. Bar = 50μm.
Inset of single metaphase cell. Bar = 5μm. Magenta
dotted line represents yolk boundary. (f) PLK1-mCherry
expression at 4.5hpf. Cells positive for PLK1-mCherry
are indicative of dividing cells. Bar = 10μm. Inset (bottom
panel): A maximum confocal projection of a single
metaphase cell expressing PLK1-mCherry at spindle
poles and kinetochores. Bar = 5μm. (g) Confocal
maximum projections from a 4.5 hpf embryo expressing
PLK1-mCherry. Single mitotic cell shown from prometaphase through cytokinesis. Images taken every 30
seconds, over 6 minutes. Bar = 10μm. (h) Maximum
projection of single metaphase cell expressing PLK1mCherry (left panel), Bar = 5μm. 3-D surface plot of
metaphase cell (right panel) displaying PLK1-mCherry
integrated intensity measurements ranging between 0
and 250. Spindle poles marked 1 and 2. Fire-LUT
(ImageJ). (i) PLK1-mCherry integrated intensity at the
highest spindle pole (pole 1) was normalized to 100%
and compared to the lowest spindle pole within a single
mitotic spindle, (n=49 cells measured across 10 embryos
+ S.E.M, Student’s t-test p<0.0001). (j) Shown is a single
prometaphase cell expressing PLK1-mCherry with pole 1
and 2 marked by a region of interest (ROI) at time point
0 sec. PLK1-mCherry integrated intensity is displayed
through a Fire-LUT where high intensity white pixels are
35000 and lower intensity black pixels are 0. The ROIs
where PLK1 intensity between pole 1 and 2 is symmetric
is highlighted in gray (0 sec). Where PLK1 intensity is
asymmetric is highlighted in blue 120 sec. Bar = 5μm. (k)
Line graph of PLK1 intensity over 2.5 minutes at pole 1
(magenta) and 2 (cyan) featured in (j), illustrating periods
of symmetric (gray) and asymmetric (blue) PLK1
intensity between the spindle poles.
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establish its in vitro localization (Figure 4.1), then validate in a developing vertebrate
embryo (Figure 4.2-3).
Previous work using GSD (ground-state depletion) in fixed in vitro cells suggests
that an inherent asymmetry exists in the amount of PLK1 between the two spindle poles84.
To determine whether this inherent PLK1 asymmetry between metaphase spindle poles
is conserved in live mammalian cells, we employed a retinal pigment epithelial (RPE) cell
line that stably expresses GFP-PLK1 at endogenous levels108. Fluorescence recovery
after photobleaching (FRAP) was performed. To do this, a ROI was placed over both
spindle poles (Figure 4.1b), where a 488 nm laser was applied. Upon application of the
laser, GFP-PLK1 fluorescence within the regions was bleached. After 1.6 seconds, GFPPLK1 signal returns to that region (Figure 4.1b). A 3-D surface plot was performed for the
metaphase cell pre-FRAP (-1.2 seconds), during the FRAP (0 seconds), and post-FRAP
(1.6 seconds) (Figure 4.1b). At -1.2 seconds (pre-FRAP), pole 1 contained significantly
more GFP-PLK1 than the other (pole 2). At 0 seconds, GFP-PLK1 at both poles was
successfully bleached. At 1.6 seconds, the pole 1 returned to have an elevated amount
of GFP-PLK1 compared to spindle pole 2 (Figure 4.1b), suggesting an increased
exchange of GFP-PLK1 at pole 1. Along these same lines, we determined over multiple
metaphase cells that spindle pole 2 contained 14.70±4.12% less GFP-PLK1 compared
to pole 1 (Figure 4.1c). This suggests a mechanism for an asymmetric distribution of PLK1
between the two spindle poles.
We next tested whether this asymmetry was conserved in the dividing cells of the
vertebrate zebrafish embryo. Fertilized embryos were injected with 100pg PLK1-mCherry
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mRNA. Injected embryos were imaged using confocal microscopy 4.5 hours post
fertilization (hpf, modelled in Figure 4.1d). At this time, embryonic cells are proliferating
asynchronously102, and proliferating cells can be distinguished via PLK1 expression
(Figure 4.1e-g). By magnifying the PLK1-mCherry-positive sub-population, a distinct
subcellular distribution of PLK1-mCherry at spindle poles and kinetochores was noted
(Figure 4.1e-f). The spatial and temporal distribution of PLK1-mCherry in a single dividing
cell was monitored over a 360 second time span. PLK1-mCherry transitions from spindle
pole and kinetochore localization in metaphase to cytokinetic furrow localization during
cytokinesis where it becomes concentrated at the cytokinetic midbody. (Figure 4.1g).
Upon investigation of the integrated intensity of PLK1-mCherry between spindle
poles in metaphase cells within the zebrafish embryo, we noted that one spindle pole has
a significantly larger proportion of PLK1-mCherry compared to the other (Figure 4.1h, Fire
look up table (LUT)). This is clearly demonstrated when the maximum projection of a
single metaphase cell (Figure 4.1h, left panel) is presented as a three-dimensional (3-D)
surface plot (Figure 4.1h, right panel), where each peak represents a spindle pole (labeled
with 1 and 2). The spindle pole peak on the left (1) presents with 10% greater PLK1
fluorescence intensity than its partnering spindle pole peak on the right (2, Figure 4.1h).
To validate this finding, we measured PLK1 fluorescence intensity between spindle pole
pairs over 49 dividing metaphase cells from 10 embryos. The spindle pole with the highest
intensity was binned as pole 1 and the pole with the lowest intensity was binned as pole
2. From this dataset, one spindle pole consistently contained 10.31± 1.14% less PLK1mCherry compared to the other (Figure 4.1i). We then examined whether this asymmetry
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was present throughout a 150 second time course of a prometaphase cell transitioning
through metaphase (Figure 4.1j-k). This was measured by placing a region of interest
(ROI) over spindle pole 1 and 2. The integrated intensity of PLK1-mCherry within this
region was plotted over 150 seconds with images taken every 30 seconds. The graph
demonstrates that spindle poles present with asymmetric PLK1 distribution as cells exit
prometaphase (Figure 4.1k, beginning at 60 second timepoint). These findings are
strikingly similar to the differences in GFP-PLK1 between the two spindle poles observed
in metaphase cells within mammalian cells, where one spindle pole contained
14.70±4.12% less PLK1 than the other (Figure 4.1c). Together, this suggests a conserved
mechanism for an asymmetric distribution of PLK1 between the two spindle poles.

4.4. Chromosome misalignment drives asymmetry in PLK1 distribution. A possible
mechanism to respond to misaligned chromosomes is to adjust PLK1 distribution
between spindle poles. During prometaphase exit and metaphase, misaligned
chromosomes can be found that realign with the metaphase plate (Figure 4.2a). During
these situations, we imaged GFP-PLK1 RPE cells every 2 minutes across the full volume
of the cell until it passed through anaphase (approximately 20 minutes in duration). GFPPLK1 intensity was then measured at each spindle pole over time. The spindle pole with
the misaligned chromosome in closest proximity was binned as spindle pole 1 and the
other as spindle pole 2. When a misaligned chromosome occurred, spindle pole 1
contained an elevated GFP-PLK1 signal compared to spindle pole 2 (Figure 4.2a-b). To
examine if this was a consistent phenomenon, a ratio was calculated for GFP-PLK1
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intensity at the spindle pole with a misaligned chromosome (pole 1) over the spindle pole
without the misaligned chromosome (pole 2) during time points of misalignment
compared to time points post misalignment over 10 dividing cells (Figure 4.2c). During
misalignment, a mean ratio of 1.33 occurs compared to post misalignment where a mean
ratio is at 1.01 (Figure 4.2c), suggesting that asymmetry in PLK1 between mitotic spindle
poles is due to adjustments in chromosome alignment.
Next, we tested whether this occurs in vivo by examining division in a zebrafish
embryo expressing PLK1-mCherry and chromosomes stained with DAPI. In a fixed, 50%
epiboly embryo (Figure 4.2d), we noted metaphase cells with misaligned chromosomes
compared to cells with a clearly aligned metaphase plate (Figure 4.2e). Under these
conditions, we calculated a ratio of the spindle pole with highest intensity over the pole
with lowest intensity and determined that the mean ratio is significantly higher under
conditions of misaligned chromosomes (mean at 1.27) compared to dividing cells with an
aligned plate (mean at 1.12, Figure 4.2f). Taken together, these studies suggest that
chromosome misalignment is causing an elevated asymmetric distribution of PLK1 at
spindle poles both in tissue culture and in vivo.

Part II: Development of an inhibitor to selectively target centrosomal PLK1
4.5. Targeting a PLK1 inhibitor to the centrosomal population of PLK1. Protein
kinase inhibitor drugs are an emerging class of therapeutics for a variety of clinical
indications140. These small molecules are also powerful research tools that can be used
to discover new aspects of kinase signaling141. While “drugging” individual kinases can
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establish their role in cellular events, this global approach cannot discriminate where or
when these signaling enzymes operate inside the cell. Thus, designing pharmacological
strategies that influence the spatial and temporal action of kinases is at the frontier of
precision medicine.
Polo-like kinase 1 (PLK1) is an important regulator of cell division142–144.
Accordingly, ATP-competitive drugs that block its activity, such as BI2536, ascribe
functions to these kinases and are promising anticancer therapies145,146. However,
elucidating the spatial and temporal action of PLK1 remains challenging as enzymes like
PLK1 continually change their location and activity throughout mitosis147–149. As a result,
global drug delivery strategies mask the unique contributions of each kinase at distinct
mitotic structures. Moreover, standard drug regimens that saturate dividing cells with
these compounds may increase off-target effects and toxicity150.
PLK1 has been implicated in the control of mitotic progression142–144. During cell
division, PLK1 becomes enriched at the centrosomes, kinetochores, and midbody.
Scaffold proteins such as Gravin and cenexin anchor PLK1 to the centrosome, creating
a specific subcellular locale for PLK1 signalling15. While the subcellular localization of
PLK1 has been characterized, it is unclear whether each locale represents a specific
subpopulation of PLK1 and whether these populations regulate different aspects of
mitosis. To investigate this, a tool was developed to test the function of PLK1 at a specific
subcellular locale, the centrosome.
In the present study develop a novel chemical-biology tool, LoKI (Localized Kinase
Inhibition), to probe the actions of PLK1 at a defined subcellular location. We next
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demonstrate that local inhibition of PLK1 kinase at centrosomes disrupts spindle
formation and mitotic duration. Together, these studies decipher how activities of
individual kinases at precisely defined microenvironments contribute to the global
signaling events that underlie mitosis.

4.6. LoKI platforms direct kinase inhibitor drugs to specific subcellular locations.
To decipher how centrosome-associated pools of PLK1 coordinate mitotic signaling
events, we needed to selectively target drugs to this location. This led to the development
of the LoKI tool which allows us to target kinase inhibitor drugs to specific subcellular
locations. In this case, we utilized the pericentrin AKAP450 centrosomal-targeting (PACT)
domain151 to target the LoKI system to the centrosome. This domain was fused to a
SNAP-tag moiety which can be covalently labeled with chloropyrimidine (CLP)-linked
substrates inside cells152 (Figure 4.3a). A CLP-conjugated analog of BI2536 (CLPBI2536) was generated to selectively target PLK1 (Figure 4.3a-b). In vitro kinase activity
measurements demonstrated that CLP-BI2536 potently inhibits PLK1 (IC50 = 49 ± 26
nM; Figure 4.3c).
To generate stable cell lines, U2OS osteosarcoma cells were infected with
lentiviral constructs encoding the SNAP-PACT moieties fused to an mCherry reporter.
Inducible protein expression was accomplished by a doxycycline-inducible promoter.
Immunoblot detection of mCherry-SNAP-PACT persisted up to 4 hours upon removal of
doxycycline. As anticipated, mCherry-SNAP-PACT associates with centrosomes during
interphase and mitosis. Super-resolution structured illumination (SIM) imaging revealed
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that the SNAP-PACT construct (magenta) was labeled by CLP-fluorescein (yellow) at
centrosomes (Figure 4.3d-e). Counterstaining with α-tubulin (green) revealed the mitotic
spindle and DAPI (blue) detected DNA (Figure 4.3d). Collectively these results
demonstrate that centrosomal targeting of SNAP-PACT creates a platform for the delivery
of CLP-conjugates. This new drug targeting method is herein referred to as LoKI-on
(Localized Kinase Inhibition-on). In parallel a LoKI-off vector containing an inactivating
mutation (C144A) in SNAP-tag was constructed. LoKI-off is unable to incorporate CLPconjugates and serves as the control platform (Figure 4.3e).
Pulse-chase experiments were used to determine how efficiently CLP-BI2536
labeled SNAP-PACT. U2OS cells were treated with CLP-BI2536 (over a range of
concentrations) to block CLP-rhodamine conjugation (Figure 4.3f). Incubation with 250
nM CLP-BI2536 for 4 hours at 37°C was defined as the optimal drug regimen (~50%
labeling of SNAP-PACT; Figure 4.3f). Next, we measured the pT210-PLK1
immunofluorescence signal as an index of active kinase153 (Figure 4.3g-j). In mitotic cells
expressing LoKI-off, incubation with 250 nM CLP-BI2536 reduced pT210-PLK1
immunofluorescence to 58.1% of DMSO-treated controls (Figure 4.3g, i). Strikingly, the
pT210-PLK1 signal was reduced to 21.4% in cells expressing LoKI-on (Figure 4.3h, i).
This trend persisted with lower CLP-BI2536 concentrations and even after a 1-hour
washout of drug (Figure 4.3i-j). Further validation confirmed that the reduction of pT210PLK1 does not result from a loss in total PLK1 protein at centrosomes. Additional controls
established that inducible expression of LoKI-on was necessary to attenuate the pT210PLK1 signal. Immunoblot analyses of nocodozole-synchronized cells collected via mitotic
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shake-off further support these findings. Parallel analyses were conducted in HeLa and
hTERT-immortalized RPE retinal pigment epithelial cells124. Collectively, these findings
establish LoKI as a new pharmacological tool to selectively block PLK1 activity at
centrosomes.

4.7. Implementation of LoKI in live zebrafish embryos implicates PLK1 activity at
centrosomes in coordinating mitoses during early development. Zebrafish provide
an excellent model organism to test local drug action using the LoKI system because their
transparency simplifies imaging analysis154. Zebrafish embryos were microinjected with
mCherry-LoKI-on mRNA and allowed to develop for 5 hours until they reached ~50%
epiboly (Figure 4.4a-b). Detection of mCherry fluorescence confirmed expression of the
local drug-targeting construct (Figure 4.4b). Higher resolution imaging of fixed embryos
confirmed accumulation of LoKI-on at centrosomes during interphase and mitosis (Figure
4.4c). Co-distribution of the SNAP moiety (magenta) with CLP-647 dye (yellow) confirmed
assembly of the drug-targeting platform at centrosomes (Figure 4.4c).
Microinjection of the PLK1 inhibitor adduct CLP-BI2536 (250nM) permitted local
drug delivery. Live-cell imaging 5 hours post injection exposed a range of adverse mitotic
phenotypes. Mitotic spindles were visualized using a microtubule binding protein, EMTB3xGFP (Figure 4.5a-d). Multipolar spindles, monopolar spindles, spindle orientation
defects, and prolonged mitoses were evident in drug-treated embryos expressing LoKIon (Figure 4.5a-d). Fixed-cell imaging of whole embryos revealed intact microtubule
organization and few mitotic cells in LoKI-off embryos treated with CLP-BI2536 (Figure
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4.6a). In contrast, drug-treated LoKI-on embryos exhibited microtubule abnormalities and
a higher incidence of mitotic cells (Figure 4.6b). Fluorescent detection of the SNAP moiety
confirmed centrosomal targeting of LoKI platforms (Figure 4.5D, E). Additional analyses
correlated centrosomal inhibition of PLK1 with increased mitotic indices in LoKI-on
embryos (Figure 4.6c-d). Conversely, control experiments in LoKI-off embryos showed
that CLP-BI2536 had minimal effect, as indicated by a significantly higher proportion of
interphase cells (Figure 4.6c-d). Thus, targeted delivery of kinase inhibitor drugs to mitotic
centrosomes induces a range of adverse mitotic phenotypes in developing embryos
relative to global drug application.

4.8. Discussion. Cells have evolved a highly organized architecture that is segregated
into functionally distinct microenvironments. However, traditional methods of drug
delivery do not account for this exquisite degree of molecular organization. Conventional
approaches flood cells with bioactive compounds, masking the unique contributions of
individual kinases at distinct subcellular locations. Although it is well established that
PLK1 coordinates various aspects of cell division, current drug-targeting strategies limit
our ability to decode the spatiotemporal regulation of these events142–144. Studying
molecular scaffolds that form complexes with these key mitotic enzymes provides
important mechanistic insight into how these processes are coordinated84. Moreover,
designing pharmacological tools that restrict the spatial and temporal action of kinase
inhibitor drugs is paramount to deciphering local kinase action. In this study, we
determined similarities between PLK1 localization and activity in mammalian cells and
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zebrafish embryos. We then developed a novel chemical-biology tool, LoKI, to more
precisely probe the actions of PLK1 at centrosomes. By combining biochemical
approaches, quantitative imaging, and live-cell microscopy we uncover that local targeting
of PLK1 kinase inhibitor drugs disrupts spindle formation and mitotic duration more
profoundly than global drug distribution. Thus organellar targeting of drugs offers a new
means to advance the investigation of broad-spectrum kinases at precise locations.
Previous studies suggest that PLK1 phosphorylates pericentriolar substrates that
coordinate γ-tubulin accumulation at mitotic centrosomes to facilitate microtubule
nucleation129,155,156. We advance this concept and extend these findings by demonstrating
that centrosomal inhibition of PLK1 prevents correct assembly of bipolar mitotic spindles
in zebrafish. Thus, by using the LoKI system we are able to definitively establish that
PLK1 activity at mitotic centrosomes is a driver in these processes. Furthermore, the utility
of LoKI drug targeting was underscored by our in vivo studies using zebrafish embryos.
We provide evidence that embryos treated with centrosome-targeted PLK1 inhibitors
have more microtubule abnormalities than those treated with a non-localized inhibitor
(Figure 4.5-6). These data implicate centrosomal-localized pools of PLK1 in coordinating
mitotic events such as spindle organization and mitotic progression during early zebrafish
development. In a broader context we have been able to show that local targeting of PLK1
inhibitors in developing organisms offers an innovative precision technique to probe local
drug action.
The versatility of this new chemical-biology platform is demonstrated in three ways.
First, this approach works in a variety of cell types and microinjection of LoKI mRNA into
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live zebrafish embryos permits local drug targeting in vivo (Figure 4.4-6). We foresee that
LoKI platforms will be adapted to acutely probe local signaling in other genetically
tractable organisms. Second, while derivatized PLK1 drugs delineate roles for the mitotic
kinase, conjugation of chloropyrimidine (CLP) to other ATP analogs offers a general
method to synthesize localizable inhibitors for additional members of the kinome157.
However, it is worth noting that the reduced cell permeability of certain CLP-drug
conjugates, including CLP-BI2536, may necessitate their use at approximately 10-fold
higher concentrations than the unmodified drugs. Additionally, derivatization of certain
inhibitors may sterically hinder their access to the ATP-binding pockets of some kinases
or, as is the case of the PKA antagonist H89, the lack of a functional groups prevents
CLP derivatization. Third, plasma membrane and mitochondrial targeting domains from
AKAP79 and dAKAP1 expand the repertoire of subcellular compartments reached by
LoKI platforms. By exploiting our knowledge of how AKAPs compartmentalize signaling
enzymes we have developed tools that define the local kinase terrain at the angstrom
level. This will allow investigators to probe local signaling events at a level of precision
that has not been possible before.

4.9. Materials and Methods: Part I
4.9.1. Zebrafish. Zebrafish embryos (provided by Dr. Jeffrey Amack’s laboratory, SUNY
Upstate Medical University) were injected with 100-150pg PLK1-mCherry mRNA
immediately following fertilization. Injected zebrafish were then grown at 30°C until 4.5hrs
post-fertilization. For live-imaging, embryos were mounted in MatTek dishes using 2%
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agar and imaged at 30°C. For fixed imaging, embryos were fixed at 4.5hpf in 4% PFA +
0.5% TritonX-100 overnight at 4°C. The following day, embryos were washed in
PBS+0.5% Tween for 20 minutes, dechorionated, and placed in NucBlue Fixed Cell Stain
from Ready Probes (Thermo Fisher Scientific R37606) for 30 minutes prior to imaging.

4.9.2. Cell culture. PLK1-GFP RPE cells were used in this study. All cultures were grown
in 1X Dulbecco’s Modified Eagle Medium (DMEM, Gibco™) supplemented with 10%
Seradigm FBS (VWR) and 1% penicillin-streptomycin (10,000U/ml) (Gibco™) and
maintained at 37°C with 5% CO2.

4.9.3. Imaging. Zebrafish and tissue culture cells were imaged using a Leica SP8
scanning confocal microscope (Leica, Bannockburn, IL) or a Leica DMi8 equipped with a
X-light V2 Confocal Unit spinning disk. The Leica SP8 was equipped with an HC PL APO
40x/1.10 W CORR CS2 objective equipped with Leica LAS-X software (Leica). The Leica
DMi8 STP800 (Leica, Bannockburn, IL) equipped with a Lumencor SPECTRA X
(Lumencor, Beaverton, Or) with a Hamamatsu ORCAflash 4.0 V2 CMOS C11440-22CU
camera or 89 North – LDI laser with a Photometrics Prime-95B camera taken with a Crest
Optics: X-light V2 Confocal Unit spinning disk. Optics used were either HC PL APO
63X/1.40 NA oil CS2, HC PL APO 40X/1.10 NA WCS2 CORR, a 40×1.15 N.A. Lamda S
LWD, or 100×/1.4 N.A. HC Pl Apo oil emersion objective. Metamorph or VisiView software
was used to acquire images.
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4.9.4. Image Analysis. 0.2 μm Z-steps of cell volumes are presented as maximum
projections using ImageJ. Integrated intensities were measured on sum projections as
described in

118.

Spindle pole integrated intensities were measured from sum confocal

projections. Graphs and statistical analysis (unpaired-student t-tests or ANOVA analysis
as labeled) were completed using Graphpad Prism software. Error bars represent ± SEM,
p < 0.05 were considered to be statistically significant.
To quantify PLK1 intensity ratios between poles in zebrafish embryos, a maximum
projection was created using a z-stack that encompassed both spindle poles of a
metaphase cell. A region of interest (ROI) was drawn around one pole of a single cell
within an embryo using FIJI/ImageJ. The same ROI was used for all images. The mean
intensity was calculated by subtracting the minimum intensity from that measured region.
A ratio was calculated by dividing the value of the pole with the smaller intensity by the
value of the pole with the larger intensity. This yielded a value greater or equal to 1.
Graphs and statistical analysis (unpaired-student t-tests or ANOVA analysis as labeled)
were completed using Graphpad Prism software.

4.10. Materials and Methods: Part II
4.10.1. Reagents:
Anti-α-Tubulin mouse mAb, clone DM1A (Sigma-Aldrich, T9026)
Anti-α-Tubulin−FITC mouse mAb, clone DM1A (Sigma Aldrich, F2168)
Anti-centromere human polyclonal antibody (Antibodies Inc,15-234-0001)
Anti-gamma Tubulin rabbit antibody (abcam, 11317)
Anti-phospho PLK1 (T210) antibody (Biolegend, 6186)
Anti-PLK1 mouse mAb 35-206 (Millipore, DR1037)
Anti-GAPDH−Peroxidase mouse mAb, clone GAPDH-71.1(Sigma Aldrich)
Anti-Gravin mouse mAb, clone JP74 (Sigma Aldrich, G3795)
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Anti-phospho-Gravin (T766), rabbit antibody (Canton et al., 2012)
Anti-phospho-Hec1(S69), rabbit antibody (Deluca et al., 2018)
Anti-SNAP-tag® rabbit antibody (New England Biolabs, P9310S)
Anti-rabbit, anti-mouse, anti-goat Alexa Fluor 488, 647, 568 secondary antibodies
(Invitrogen)
DyLight™ 405 AffiniPure Donkey Anti-Human IgG (H+L) antibody (Jackson Labs,
2340553)
Anti-rabbit, anti-mouse, anti-goat HRP-conjugated secondary antibodies (GE Healthcare)
DAPI Solution (Thermo Fisher 62248)
ProLong® Diamond Antifade Mountant (Life Technologies).
SNAP-Cell® 647-SiR (New England Biolabs, S9102S)
SNAP-Cell® Fluorescein (New England Biolabs, S9107S)
CLP-rhodamine (made in-house, see “synthesis of CLP-reagents”)
CLP-BI2536 (made in house, see “synthesis of CLP-reagents”)
CLP-MLN8237 (made in house, see “synthesis of CLP-reagents”)
BI2536 (AdooQ, A10134-50)
Dimethylsulfoxide (DMSO), Sequencing Grade (Pierce, TS-20688)
DMEM, high glucose (Life Technologies, 11965118)
DMEM/F-12, Hepes (Life Technologies, 11330057)
DMEM FluoroBrite™ (Life Technologies, A1896701)
Opti-MEM® I Reduced Serum Medium, no phenol red (Life Technologies, 11058021)
Puromycin dihydrochloride (Santa Cruz, 58-58-2)
Polybrene (Santa Cruz 134220)
Doxycycline hyclate (Sigma-Aldrich 24390-14-5)
Lipofectamine 2000 Transfection Reagent (Invitrogen, 11668027)
TransIT®-LT1 Transfection Reagent (Mirus)
Scienceware cloning discs (Sigma-Aldrich Z374431)
QuikChange II XL kit (Aligent 200522)
1.5 poly-D-lysine coated coverslips (neuVitro GG-12-1.5-pdl)
μ-Slide 4 Well Glass Bottom: # 1.5H (170 μm +/- 5 μm) D 263 M Schott glass
(Ibidi)Pierce™
BCA Protein Assay Kit (Thermo Fisher 23227)
Bolt® 4-12% Bis-Tris Plus Gels (Invitrogen)
AnykD™ Criterion™ TGX™ Precast Midi Protein Gel (Biorad, 5671124)
NuPAGE™ LDS Sample Buffer 4X (Thermo Fisher, NP0008)
β-mercaptoethanol, BME (Sigma-Aldrich, M6250)
shRNA lentiviral particles (Santa Cruz Biotech)
SuperSignal™ West Dura Extended Duration Substrate (Thermo Fisher, 34075)

4.10.2. Plasmid constructs. SNAP, mCherry, eGFP, PACT, Mis12, AKAP79, and
dAKAP1 components and were individually PCR amplified with overlapping ends and/or
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Gateway “att” sites and assembled using Gibson Cloning. Gateway cloning was carried
out to subclone SNAP constructs into pLIX402 (a gift from David Root; Addgene plasmid
#41394) for PACT and Mis12 studies or pcDNA3.1+ (Life Technologies) for AKAP79 and
dAKAP1. To generate mutant SNAP, site-directed mutagenesis was performed with a
QuikChange II XL kit (Aligent). GFP-H2B and EMTB-3xGFP constructs were used for
live-cell imaging studies. Gravin-SNAP was cloned into pEYFP-N1 (Clontech) and used
for Gravin experiments. Constructs were verified by Sanger sequencing.

4.10.3. Cell culture and virus generation. U2OS, HeLa, HEK293, and immortalized
MEF, generated as described in

84,

cells were maintained in DMEM, high glucose and

hTERT-RPE cells were maintained in DMEM/F-12, Hepes (Life Technologies) at 37°C
and 5% CO2. All media was supplemented with 10% FBS. Infections for generation of
stable SNAP cells were performed using lentiviral particles created in-house. In brief,
SNAP pLIX402 vectors were transfected alongside pMD2.G and psPAX2 plasmids (gifts
from Didier Trono; Addgene plasmid #12259 [RRID:Addgene_12259] and plasmid
#12260 [RRID:Addgene_12260])) into HEK293 cells using Lipofectamine 2000 reagent
(Invitrogen) in Opti-MEM® (Life Technologies) media. Virus-containing supernatant was
collected, passed through a .45 μm filter, and transduced into cells in the presence of
1μg/ul Polybrene (Santa Cruz). Cells were selected and maintained in supplemented
media with 4 μg/mL Puromycin dihydrochloride (Santa Cruz). Single clones were isolated
using Scienceware cloning discs (Sigma-Aldrich). Infections for generation of stable
knockdown in HEK293 cells were performed with shRNA lentiviral particles (Santa Cruz

127

Biotech). For expression of AKAP79, dAKAP1, and Gravin constructs in U2OS cells,
transient transfections were performed using TransIT-LT1 reagent (Mirus) in Opti-MEM®
(Life Technologies) media according to manufacturer’s instructions.

4.10.4. CLP-linker synthesis:

1a CLP-Amine, created as previously described (Hill et al. 2012), 1 Eq of 1a (0.2 M) and
1.1 Eq of 1b (Abachemscene) were dissolved in DMF at RT. The reaction was placed on
ice. While stirring, 1.3 Eq HOAt (1-Hydroxy-7-azabenzotriazole) and 3 Eq DIEA (N,NDiisopropylethylamine) were added. After 5 minutes on ice, 1.3 Eq of EDCI (1-Ethyl-3-(3dimethylaminopropyl)carbodiimide) was added. The reaction was allowed to stir for 24
hours (letting the ice melt and the reaction slowly come to RT). Reaction was dissolved
in ethyl acetate, washed with NaHCO3 and brine, and dried with Na2SO4. Remaining
solvent and DMF were removed via rotovaping and lyophilization. 1c was deprotected
with 30% TFA in DCM (0.2 M 1c final). Solid 1c was dissolved in CH2Cl2 and cooled on
ice. TFA was added dropwise until it reached 30% v/v. Reaction was stirred for 1 hour at
RT. Toluene was added (to help remove TFA) and the reaction was rotovapped to near
dryness. Reaction was dissolved in ethyl acetate, washed with K2CO3, dried Na2SO4
and dried via rotovapping and lyophilization. Identity at each step was verified with MS.
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4.10.5. BI2536 functionalization (+CLP-linker):

1 Eq 1d (0.2 M) and 1.1 Eq of 2a (Chem Scene) were dissolved in DMF at RT. The
reaction was placed on ice. While stirring, 1.3 Eq HOAt and 3 Eq DIEA were added. After
5 minutes on ice, 1.3 Eq of EDCI was added. The reaction was allowed to stir for 24 hours
(letting the ice melt and the reaction slowly come to RT). DMF was removed and 2b
(BI2536-CLP) was purified with HPLC. Identity was verified with MS. [M+H]+ = 817.7 m/z.

4.10.6.

CLP-rhodamine

Preparation.

1

Eq

1a

(0.2

M)

and

1

Eq

5(6)-

carboxytetramethylrhodamine N-succinimidyl ester (Thermo Fisher) were dissolved in
DMF at RT. While stirring, 3 Eq DIEA were added. The reaction was allowed to stir for 24
hours. DMF was removed and product was purified with HPLC. Identity was verified with
MS. [M+H]+ = 676.2 m/z.

4.10.7. Protein expression and purification. His6-SNAP-tag in pMCSG7 (Addgene)
was expressed in Escherichia coli BL21(DE3) cells in 250 mL LB Miller broth. The evening
prior to expression, 5 mL LB Miller broth, containing 50 μg/mL Ampicillin, was inoculated
with transformed cells, and they were grown at 37 °C overnight. The following day, the
starter culture was used to seed 250 mL LB Miller broth in a 500 mL baffle flask. Cells
were grown to OD600 ~0.3 and the temperature was then reduced to 20°C. Cells were
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allowed to grow to OD600 ~0.8, and then induced with 500 μM isopropyl β-Dthiogalactopyranoside. Induced cells were grown at 20 °C overnight. Subsequent
purification steps were carried out at 4 °C. Cells were spun down at 6500 g, suspended
in 10 mL of wash/lysis buffer [50 mM HEPES (pH 7.5), 300 mM NaCl, 20 mM imidazole,
and 1 mM phenylmethanesulfonyl fluoride], and lysed via sonication. The lysate was
centrifuged at 10000 g for 20 minutes, and the supernatant was allowed to batch bind
with 0.7 mL of Ni-NTA (Ni2+-nitrilotriacetate) beads for 60 minutes. The resin was
collected by centrifugation at 500 g for 5 minutes and washed with 10 mL of wash/lysis
buffer. The wash step was repeated three times. The Ni-NTA/His6-SNAP-tag was added
to a BioRad purification column, and washing was continued until the wash showed no
remaining protein by Bradford. The protein was eluted using ∼ 5 mL of elution buffer [50
mM HEPES (pH 7.5), 300 mM NaCl, 200 mM imidazole]. The eluate was dialyzed against
50 mM HEPES (pH 7.5), 200 mM NaCl, 5% glycerol, and 1 mM fresh dithiothreitol (DTT).
Protein was aliquoted, flash-frozen in liquid N2, and stored at − 80 °C.

4.10.8. SNAP Labeling experiments and pulse-chase labeling assays:
In vitro labeling: 50 μM SNAP-tag was incubated with 75 μM CLP-linker-inhibitors (or
DMSO alone for control reactions) [2.5% (v/v) final DMSO concentration] in buffer [20 mM
Tris-Cl (pH 8), 200 mM NaCl, 1 mM DTT (added fresh)] at 26 °C for 1.5 hours. The
reactions were purified using Zeba columns (Thermo Fisher) and exchanged into a MS
compatible buffer (50 mM NH4HCO3, 0.2% HCO2H). Ratios of unlabeled to labeled
protein were determined using Native MS (Thermo Scientific LTQ Orbitrap XL/Bruker
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Esquire LC-Ion Trap). Cellular labeling: SNAP expressing (dox-induced) cells were
treated with SNAP-Cell® Fluorescein or SNAP-Cell® 647-SiR (NEB) for 30 minutes in
serum free DMEM at 37°C and 5% CO2. Cells were washed one time and incubated in
fresh serum free DMEM for 30 minutes. Cells were fixed and stained as described under
“immunofluorescence”. For pulse-chase labeling experiments, SNAP expressing (doxinduced) cells were treated with DMSO or increasing doses of CLP-BI2536 or CLPMLN8237 for 1, 2, or 4 hours in serum free DMEM at 37°C and 5% CO2. Cells were
washed one time and incubated in fresh serum free DMEM for 30 minutes. Cells were
treated with 3 μM CLP-rhodamine (made in-house) in serum free DMEM for 30 minutes.
Cells were washed one time and incubated in fresh serum free DMEM for 30 minutes.
One wash with PBS was carried out and cells were lysed using immunoblotting protocol.
Samples were resolved on an AnykD™ Criterion™ TGX™ Precast Midi Protein Gel
(Biorad). Gels were scanned and fluorescence was measured with a GE Typhoon FLA
9000 scanner. Fluorescence measurements and densitometry was performed using NIH
ImageJ (Fiji) software.
Total SNAP labeling was determined by normalizing fluorescence signal of rhodamine
bands to total SNAP protein expression as determined by densitometry.
% SNAPs Labeled by CLP-rhodamine = CLP-rhodamine signal/SNAP western blot signal
% SNAPs Labeled by CLP-inhibitor = 100 - % SNAPs Labeled by CLP-rhodamine

4.10.9. Drug treatments. For induction of SNAP expression cells were treated for 48-72
hours in FBS-supplemented DMEM with 1 μg/mL (for SNAP-PACT) or 4 μg/mL (for
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SNAP-Mis12) doxycycline hyclate (Sigma-Aldrich) prior to inhibitor treatments. For
degradation assays, cells were dox-induced for 72 hours after which doxycycline was
washed out (cells were incubated in normal media). At selected time point plates were
collected, cells were washed once with PBS, plates were dried quickly, and frozen at 80°C until lysis. For nocodozole synchronization experiments, dox-induced cells were
treated for 16 hr with nocodozole and 4 hr with nocodozle plus DMSO, 250 nM CLPBI2536, or 100 nM CLP-MLN8237. Cells were washed once with PBS, collected via
mitotic shake-off, and spun at 2000 rpm for 5 minutes at 4°C. Supernatants were
discarded and pellets were kept for lysis. All lysates were prepared as described under
“immunoblotting”. For fixed cell experiments, both dox-induced and non-induced cells
were grown on 1.5 poly-D-lysine coated coverslips (neuVitro) for at least 16 hours in
complete DMEM and then treated with DMSO or CLP-compounds in serum-free DMEM
for 1-4 hours. For washout experiments (pT210-PLK1 1 hour washout and γ-tubulin data),
cells were incubated in serum-free DMEM without inhibitors for an additional 1 hour. Cells
were washed once with PBS prior to fixation. For live-imaging experiments, cells were
treated with CLP-compounds for 18 hours (see “microscopy” for more details).

4.10.10. Zebrafish Studies. Zebrafish were bred and embryos were collected. Embryos
were injected with EMTB-3xGFP (100pg mRNA or 20pg pCS2 plasmid construct), SNAPCell® Fluorescein (300 μM final embryo concentration), and/or CLP-BI2536 (250 nM final
embryo concentration), and/or SNAP-PACT active or dead (200pg mRNA) at the 2-cell
stage using a microinjector (Warner Instruments PLI-100A) with a Kanatec magnetic base

132

(MB-B), and a micromanipulator (Marzhauser Wetzlar MM33). Embryos were raised at
30°C until ~50% epiboly, at which point they were imaged on stereoscope, mounted in
2% agarose for live confocal imaging, or fixed using 4% paraformaldehyde + 0.5% TritonX overnight at 4°C. Embryos were dechorionated in PBST (phosphate buffered saline +
0.1% Tween-20) and incubated in DAPI solution (1 μg/mL in PBS) for 2 hours at room
temperature. Fixed embryos were then mounted in 2% agarose and imaged on confocal
microscope.

4.10.11. Immunoblotting. Cells were lysed in RIPA lysis buffer (50 mM Tris HCl pH 7.4,
1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 50 mM NaF, 120 mM NaCl, 5
mM β-glycerophosphate) supplemented with protease and phosphatase inhibitors (1 mM
benzamidine, 1 mM AEBSF, 2 μg/mL leupeptin, 100 nM microcystin-LR). Lysed samples
were boiled for 5 minutes at 95°C in NuPAGE™ LDS Sample Buffer 4X (Thermo Fisher)
+ 5% BME (Sigma-Aldrich). Protein concentration was determined using a Pierce™ BCA
Protein Assay Kit (Thermo Fisher). Samples were resolved on Bolt® 4-12% Bis-Tris Plus
Gels (Invitrogen) or AnykD™ Criterion™ TGX™ Precast Midi Protein Gel (Biorad).
Proteins were transferred to nitrocellulose for immunoblotting and probed with AntiSNAP-tag® rabbit antibody (NEB) and Anti-GAPDH−Peroxidase mouse mAb, clone
GAPDH-71.1(Sigma Aldrich). Detection was achieved with a HRP-conjugated rabbit
secondary antibody (GE Healthcare) followed by enhanced chemiluminescence with
SuperSignal™ West Dura Extended Duration Substrate (Thermo Fisher). Densitometry
was performed using NIH ImageJ (Fiji) software.

133

4.10.12. Immunofluorescence. Cells grown on 1.5 poly-D-lysine coated coverslips
(neuVitro) for at least 16 hours were fixed for 10 minutes in 4% paraformaldehyde in PBS
or in ice-cold methanol. Cells were permeabilized and blocked in PBS with 0.5% Triton
X-100 and 1% BSA (PBSAT) for 30 minutes. Primary antibodies were diluted in PBSAT
and cells were stained for 1 hour. Secondary antibodies conjugated to Alexa Fluor dyes
(Invitrogen) were diluted in PBSAT and applied for 1 hour. Staining with FITC-tubulin
antibodies and/or DAPI staining always followed secondary incubation step and was
carried out for 10-45 minutes in PBSAT. Washes (quick on and off) with PBSAT were
carried out 10X between antibody and/or dye incubation steps and prior to mounting.
Coverslips were mounted on slides using ProLong® Diamond Antifade Mountant (Life
Technologies).

4.10.13. Spindle Classification Measurements. To de-identify cell type and doxtreatment conditions and allow for blinded analysis of mitotic spindle differences, all
identifying information on microscope slides was masked by a third-party individual. All
mitotic cells within a coverslip were classified as either having normal bipolar, abnormal
bipolar, or monopolar spindles based on morphology of the DNA and microtubules.

4.10.14. Microscopy:
Fixed cell: Super-resolution 3D-SIM images were acquired on a Deltavision OMX V4
(GE Healthcare) system equipped with a 60x/1.42 NA PlanApo oil immersion lens
(Olympus), 405-, 488-, 568-, and 642-nm solid-state lasers and sCMOS cameras
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(pco.edge). For SIM,15 images per optical slice (3 angles and 5 phases) were acquired.
For both SIM and widefield (conventional) acquisitions, image stacks of 2.5-7 um with
0.125-um optical thick z-sections were acquired using immersion oil with a refractive
index 1.516 or 1.518. Z-stacks were generated using the SNAP-PACT or SNAP-Mis12
channel to define the upper and lower regions of the plane with a 0.5 μM step size. SIM
images were reconstructed using Wiener filter settings of 0.003 and optical transfer
functions measured specifically for each channel with SoftWoRx software (GE
Healthcare) to obtain super-resolution images with a twofold increase in resolution both
axially and laterally. Images from different color channels were registered using
parameters generated from a gold grid registration slide (GE Healthcare) and SoftWoRx.
Widefield images were deconvolved using SoftWoRx. Live-cell: For LoKI experiments
cells were first induced with doxycycline for 48-72 hours prior to transfection. For all timelapse experiments cells were reverse transfected with GFP-H2B plasmid and plated onto
μ-Slide 4 Well Glass Bottom: # 1.5H (170 μm +/- 5 μm) D 263 M Schott glass (Ibidi) in
complete DMEM. Transient transfections were performed using TransIT-LT1 reagent
(Mirus) with Opti-MEM® (Life Technologies) media. The next day all cells were treated
with 2 mM thymidine for 24 hours. The following day thymidine was washed out and after
4 hours cells were incubated with DMSO or CLP-inhibitors (LoKI experiments) or with no
reagents (WT/KO Gravin experiments) in serum-free FluoroBrite™ DMEM. Time-lapse
images were acquired on a Keyence BZ-X710 microscope using a 10X objective with
25% transmitted light and 100% aperture stop, with 1/60s exposure for 488 channel.
Images were captured every 5 minutes for 18 hours. Zebrafish imaging: Images were
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acquired on a Leica DMi8 (Leica, Bannockburn, IL) equipped with a Crest Optics X-light
v2 Confocal Unit spinning disk, an 89 North – LDI laser with a Photometrics Prime-95B
camera using a Nikon 40×1.15 N.A. Lamda S LWD objective. Stereoscope images were
acquired on a Leica M165 FC stereoscope with a DFC9000 GT camera and a PLANAPO
10X objective.

4.10.15. Image Analysis. Maximum intensity projections from z-stack images were
generated using SoftWoRx (GE Healthcare) or NIH ImageJ (Fiji) software. All
immunofluorescence signal measures were carried out using Fiji software. Sum slice 32bit

Tiff

projections

were

generated

from

z-stack

images

for

analysis

of

immunofluorescence at centrosomes. For kinetochore measurements the ImageJ
"Subtract Measured Background" macro was first applied and sum slice 32-bit Tiff
projections were generated. For centrosomes measurements, the oval selection tool in
Fiji was used to draw a circle (ROI) around the centrosome in the 568 (SNAP-PACT)
channel. The area of the circle remained consistent for all measurements and all
replicates of an experiment. Measurements were taken in the 647 channel (which
contained pT210-PLK1, Total PLK1, or γ-tubulin) using the predefined centrosome ROI.
Using the measure function in Fiji, with “Area” and “Raw Integrated Density” predefined
as measurements, values were determined for each centrosome and for an arbitrarily
selected background region. The raw integrated density was recorded for each
centrosome and the background. The average raw integrated density for the centrosomes
was determined by adding together the raw integrated densities for each centrosome in
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a cell and dividing that value by 2. The integrated density for the background was
subtracted from the average centrosome integrated density to yield a backgroundsubtracted average integrated density signal for a centrosome. For kinetochore
measurements, the selection tool in Fiji was used to draw an arbitrary region (ROI) around
the kinetochore in the 405 (ACA, centromeric DNA) channel or in the 568 (SNAP-Mis12)
channel. Measurements were taken in the 647 channel (which contained pS69-Hec1)
using the predefined kinetochore ROI. Using the measure function in Fiji, with “Area” and
“Raw Integrated Density” predefined as measurements, values were determined for each
kinetochore. The raw integrated density was recorded for each kinetochore. For both
centrosome and kinetochore experiments and average was calculated for each control
and experimental condition. To do this the normalized average integrated densities were
added together and divided by the total number of cells for that condition. This yielded a
value that represents the background-normalized average integrated density at a
centrosome or at the kinetochore for a particular condition. Values for drug-treated cells
were then normalized to their respective DMSO-treated control. Integrated intensity
surface plots were generated from sum-slice 32-bit Tiff projections of representative
images using the 3D Surface Plot function in Fiji software. Maximum intensity heat maps
were generated from maximum projection representative images using the 3D Surface
Plot function with Fire LUT in Fiji software. Zebrafish three-dimensional renderings:
Three-dimensional renderings were created using Imaris software (Bitplane). Individual
mitotic cells were isolated and assigned a new color channel using the “Surfaces” function
to create a surface rendering. Surface renderings were created through the use of the
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Isoline function, where regions of individual mitotic cells were isolated based on intensity.
Completed surface renderings were then merged and masked to create a channel that
encompassed the mitotic cells of each embryo.

4.10.16. Statistical analysis. Statistics were performed using an unpaired two-tailed
Student's t-test in GraphPad Prism software. All values are reported as mean ± standard
error of the mean (s.e.m) with p-values less than 0.05 considered statistically significant.
Number of independent experiments (N) and number of individual points over several
experiments (n) are presented. For γ-tubulin experiments a ROUT (Q=1%) outlier test
was performed and two values were removed prior to performing an unpaired Student’s
t-test.

4.10.17. Sample size and replicates. The sample size was not statistically determined.
Where applicable, n > 15 independent measurements were conducted across N ≥ 3
independent experiments. For doxycycline removal experiments, at least 2-3 independent
experiments were conducted per time point.
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Chapter Five:
Discussion and Future Directions:
Examining the role of subcellular PLK1 populations during Kupffer’s
vesicle lumenogenesis and early zebrafish monolayer establishment
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5.1. Discussion: Overview of cell division regulation during tissue development

5.1.1. Summary of Key Findings. The overall goal of my thesis research was to
understand how cell division orchestrates tissue morphogenesis. I defined the
mechanism by which abscission (Chapter 2) and metaphase spindle positioning
(Chapter 3) lead to the assembly of complex structures in an in vivo vertebrate setting.
Additionally, my research established a protocol to utilize a system for localized kinase
inhibition in a vertebrate setting to elucidate the role of an essential mitotic kinase at a
specific subcellular locale (Chapter 4). With this chapter I will discuss the most novel
points of these studies and consider possible future directions for each project.

5.1.2. Chapter 2 Summary. In Chapter 2, I presented a testable model in which
cytokinetic bridges position at the site of future KV lumen formation where apical polarity
proteins are transported in a Rab11-dependent manner. Here, I provided evidence that
cell division was not only occurring during KV formation, but also that it was essential for
lumen establishment. Additionally, I determined that while spindle orientation was not a
driving factor in lumen growth, the later mitotic process of abscission was essential. This
study was the first to visualize the cleavage of a cytokinetic bridge in an in vivo
vertebrate model, as well as utilize an optogenetic approach to disrupt abscission in live
animals. From a broader perspective, this work represents an important transition to
studying lumen formation in an in vivo context to investigate tissue-specific
mechanisms.
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5.1.3. Chapter 3 Summary. The research featured in Chapter 3 utilized the early
zebrafish embryo to determine how mitotic spindles are able to position themselves
within the confines of disproportionately large cells. As cell size rapidly decreases
during consecutive cell divisions, I determined that the mitotic spindle poles scale with
the changing cell size rather than the spindle as previously suggested (Chapter 3).
Mitotic spindle poles in the early zebrafish embryos are uniquely-ordered structures that
contain a large, novel pericentriolar matrix to facilitate cell division in large cells.
Furthermore, spindle poles are asymmetric across a mitotic spindle, with a two-fold
difference in size between the large pole pointed towards the center of the embryo and
the smaller pole facing the exterior. This vectoral directionality was also found to be
dependent on PLK1 and PLK4 activity. This research introduces a novel centrosome
structure present in embryonic zebrafish cells that may explain a mechanism for cell
division in extremely large cells.

5.1.4. Chapter 4 Summary. Lastly, the research highlighted in Chapter 4 illustrates the
use of an innovative drug delivery system employed in an in vivo vertebrate context.
PLK1 kinase inhibition was targeted to the centrosomal population of PLK1 through the
use of a centrosome-localized SNAP moiety and an engineered BI2536, a PLK1
inhibitor, conjugated to a CLP-tag (LoKI system). This resulted in an efficient manner of
directing kinase inhibition to a specific subcellular locales, as verified by extensive in
vitro validation assays124. Advantages of this system include the ability to use a lower
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concentration of PLK1 inhibitor due to its specificity to the centrosomal PLK1 population,
resulting in fewer off target effects on a cellular scale. Through this system, I was able
to identify that the centrosomal PLK1 population is responsible for mitotic spindle
organization and mitotic progression. It has been previously unknown whether PLK1
populations at distinct subcellular locales serve unique purposes in vitro, and this
research was the first to inhibit the population of endogenous PLK1 at the centrosome
to determine its function. Beyond this, the function of PLK1 in a vertebrate system has
been largely undocumented prior to these publications. This research is therefore novel
in that we first characterized the localization of PLK1 during cell division in a developing
embryo, then expanded upon this and determined the distinct role of a population of
PLK1 at the centrosome locale in a zebrafish embryo. This study represents a
significant advance in the use of chemical-genetic tools to investigate molecular
mechanisms during vertebrate development for the first time.

5.2. Future Directions: Determining the function of subcellular PLK1 populations
during tissue morphogenesis

5.2.1. Chapter 2- Expanding upon the role of PLK1 during lumenogenesis. In order
to expand upon these studies, I propose to utilize the kinase inhibition system detailed
in Chapter 4 to determine the molecular mechanism by which PLK1 regulates cell
division during KV lumenogenesis. These studies would accomplish two important aims.
First, they would provide an understanding of the role of PLK1 during vertebrate tissue
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morphogenesis. KV development encompasses multiple steps such as polarity
establishment, rosette formation, and lumenogenesis, and the role of PLK1 at each of
these steps is not currently understood. Secondly, the discrete roles of PLK1 at various
subcellular locales are not currently understood. Bucko and colleagues were the first to
create the LoKI system to determine the function discrete pools of PLK1, and only the
centrosomal population of PLK1 has been targeted in vivo so far. Additional populations
such as the midbody and kinetochore pools could therefore by targeted during KV
development in zebrafish to gain a more complete understanding of PLK1 function
during tissue development.
In Chapter 2, I determined that disrupting mitosis through PLK1 inhibition
interfered with lumenogenesis in Kupffer’s vesicle. However, these studies were
conducted using a greater concentration if BI2536 that had been previously published.
While this was necessary to ensure a global inhibition of PLK1 in the zebrafish embryo,
a caveat to this approach is that off-target effects are possible. By employing the LoKI
system to target BI2536 directly to the centrosomal population of PLK1, I would use a
lower concentration of PLK1 inhibitor to minimize off-target effects, as well as elucidate
the role of centrosomal PLK1 during KV lumenogenesis. To accomplish this, I would
inject early zebrafish embryos expressing the transgenic Sox17:GFP-CAAX KV marker
with mRNA coding for SNAP-PACT, similar to studies performed in Chapter 4. Instead
of injecting the CLP-BI2536 into the embryos, I would instead dechorionated and soak
the embryos in drug during the early stages of KV development (8 hours postfertilization). Because the drug covalently binds to the centrosome via the SNAP-CLP

143

bond, I would then wash the extra unbound drug out of the embryos to increase drug
specificity to the centrosomal PLK1 population. I would then fix embryos at the 6-somite
stage (approximately 12 hours post-fertilization), at which point control embryos would
be expected to have a large KV lumen developed. Lumen area would be quantified to
determine if inhibition of centrosomal PLK1 results in decreased lumen area.
Additionally, I would image live embryos under this condition to determine whether there
is a significant change in lumen growth rate over time with localized PLK1 inhibition.
Since studies in Chapter 4 determined that centrosomal PLK1 is responsible for mitotic
progression, I predict that lumen area will be decreased in CLP-BI2536 embryos due to
the delay in mitosis. Alternatively, it is possible that I do not see a disruption in lumen
area under conditions of localized PLK1 inhibition. Since inhibition of centrosomal PLK1
resulted in misoriented spindles, it is possible that the centrosomal pool of PLK1 does
not play a crucial role during KV morphogenesis since spindle orientation is not a driving
factor in KV lumen formation. If this is the case, I would hypothesize that centrosomal
PLK1 is not as important for mitotic progression, and that pools of PLK1 at kinetochores
or midbody could instead be more crucial for KV development. a separate population of
PLK1 plays a more essential role in lumenogenesis in this particular tissue.
In order to investigate the role of PLK1 at additional subcellular locales such as
the kinetochores and midbody, I would target the LoKI system to these locations. In
Bucko et al 2020, a kinetochore-localized LoKI system was developed through the
localization of the SNAP-tag to Hec1, a kinetochore protein124. The zebrafish protein
ndc80 is a homolog to Hec1 and is present during embryogenesis, so I would target this
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protein to localize the LokI system to kinetochores158. Additionally, a midbody-localized
LoKI system could be developed through the localization of the SNAP-tag to a canonical
midbody protein such as MKLP1. I propose to utilize these two systems in the
experimental setups mentioned above to determine whether PLK1 populations at these
additional subcellular locales play a role in KV lumenogenesis. During experiments that
were featured in Chapter 2, I expressed fluorescently-tagged PLK1 in the Sox17:GFPCAAX transgenic line to follow PLK1 in a developing KV. Strikingly, I identified a
population of PLK1 that localized to the apical membrane of the developing lumen
(Figure 5.1). An additional future direction would be to specifically inhibit this novel
population of PLK1 at the apical membrane to determine if it is essential for
lumenogenesis. This could be accomplished by adapting the LoKI system to inhibit
PLK1 at the apical membrane by targeting the conjugated BI2536 to the membranelocalized motif CAAX. While CAAX would localize the CLP-BI2536 to the whole cell
membrane, it would overlap with the PLK1 population present at the apical membrane
and deliver targeted PLK1 inhibition to this site. These experiments would provide
insight as to the specific roles of PLK1 at various subcellular locales during in vivo
vertebrate lumenogenesis.

5.2.2. Chapter 3- Determining the mechanism of PLK1-dependent pole asymmetry
during monolayer construction. To continue with the project for Chapter 3, I again
propose to utilize the LoKI system for targeting PLK1 inhibition in order to gain a more
detailed understanding of how PLK1 regulates monolayer formation in early embryos.
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*
PLK1-mCherry
Sox17:GFP-CAAX

*
PLK1-mCherry

Sox17:GFP-CAAX

Figure 5.1. PLK1 population noted around apical membrane of nascent lumen
in zebrafish KV. Representative three-dimensional renderings of embryo expressing
KV marker (Sox17:GFP-CAAX, blue/inverted grayscale) and PLK1-mCherry (white/
inverted grayscale) during KV development. PLK1 populations localized to centrosomes
(magenta), kinetochores (orange), and lumen apical membrane (cyan) denoted by
arrowheads. Forming lumen denoted by purple asterisk. Bar, 10μm.
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With these studies, I determined that the vectoral directionality created by spindle pole
asymmetry pointed at the embryo center was dependent on active PLK1. When
embryos were exposed to global BI2536 conditions, spindle pole positioning was
random with respect to the embryo center. Again, a caveat to this study was that a
targeted system of PLK1 inhibition had not been developed, leaving the possibility for
off-target effects due to the higher concentration of inhibitor needed. Employing the
LoKI system here would allow for a better understanding of PLK1 regulation from
distinct subcellular locales during monolayer formation.
While mRNA injections can be used to introduce protein chimeras to embryos
during KV developmental stages, this is not a feasible method for use in the early
embryo. Therefore, a transgenic line would need to be created that expresses SNAPPACT for drug targeting to the centrosome. The line would need to maternally express
the construct so that it would be present early enough to accomplish experiments at the
16-cell stage of development. I would cross this line with the centrin-GFP transgenic
zebrafish line so that once embryos are fixed at the 16-cell stage, I could immunostain
for gamma-tubulin to evaluate spindle pole size with both markers as well as quantify
the positioning of the larger spindle pole with respect to the center of the embryo. Since
we measured a randomization of spindle pole positioning with global PLK1 inhibition in
Chapter 3, I predict that we would see a similar or more severe randomization of pole
positioning with the targeted LoKI system. This would be demonstrated by a
randomization of spindle pole positioning with respect to the center of the embryo with a
lower dose of CLP-BI2536 under the LoKI system. This result would suggest that the
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centrosomal population of PLK1 regulates positioning of the asymmetric spindle poles in
the early zebrafish embryo, which would explain why a small concentration of CLPBI2536 targeted to the centrosome would have the same effect as a large concentration
of global BI2536. If this is not the case, I would investigate whether a kinetochore or
midbody population of PLK1 was present at this early zebrafish developmental stage,
and whether this population was driving spindle pole directionality instead. Through this
proposed use of the LoKI system during monolayer formation in zebrafish, the function
of PLK1 during cell division in extremely large cells can be unraveled.

5.3. Broader implications in the field of tissue morphogenesis. Overall, the
research presented in this dissertation begins to piece together the mechanism by
which cell division contributes to tissue morphogenesis in a vertebrate system. Previous
studies have focused on determining molecular mechanisms that drive formation of
complex three-dimensional structures in in vitro contexts. While many genetic and
pharmacological tools exist to elucidate molecular mechanisms in in vitro settings, it is
becoming clear that many of these mechanisms may differ in vivo or are tissue- or
organ-specific. Therefore, studies such as those described here are necessary to gain a
full understanding of how cell division can be harnessed to build tissues, organs, and
organisms. Continued work to develop genetic and pharmacological toolsets for
vertebrate research will encourage future studies that will have translational benefits in
both basic science and medical research.
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Appendix: Rathbun et al 2020 Nature Communications Response to Reviewers

For reference, responses from the Nature Communications review of Rathbun et
al 2020 is included here. Responses and revisions from the most recent reviewer
comments are shown in orange (resubmitted 12/16/2019), those from the previous
rounds of reviewer comments are shown in blue (resubmitted 11/19/2019) and
green (resubmitted 07/22/2019). This manuscript was initially sent to reviewers by
Nature Communications on 06/05/2018.

A.1. The following Response to Reviewers is from the 12/16/2019 resubmission:
Reviewer #2 (Remarks to the Author):
“In this revised version the authors have carried out additional experiments and
expanded and clarified the text to address the concerns of the Reviewers.
I am personally still convinced that the only significant advance of this study is the
evidence that the midbody is required for lumen formation in vivo. This is why, in my
opinion, the paper would be more suitable for a specialised developmental/cell biology
journal rather than Nature Communications. However, this is ultimately an editorial
decision and therefore I will only address here the authors’ replies to my specific
comments.
I am satisfied by the authors’ replies to my comments 1, 2, 3, 7 and 8.”
Thank you.
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“As for the others:
Point 4: The authors are wrong in stating that the severing of the intercellular bridge is
“often termed abscission”. Abscission unequivocally indicates the final cut between the
two daughter cells, which often coincides with the severing of the microtubules in the
intercellular bridge. The authors incorrectly use the term abscission to indicate the
progressive thinning of the microtubule bundles at the intercellular bridge. This is
extremely confusing for both specialist and non-specialist readers and therefore I must
insist that the authors use a different term, such as ‘pre-abscission’ for example, to
indicate this stage.”
We have edited the text accordingly to achieve the terminology you request. Please see
highlighted regions of the text and Figure 3b, and Supplementary Figure 2e, 2i,
Supplementary Figure 3b, and Supplementary Figure 5f.

“Point 5: Although I appreciate the efforts to show better images of RacGAP1
immunostainings, there are still way too many dots, some even outside the sample. I
think that this antibody is not very specific and am not sure if it is actually worth
including these images.”
Please see updated Figure 2d, where we have added a nuclei marker to denote that
there are also cells that surround KV along with KV cells. In these images, the midbody
marker RacGAP is seen outside KV because there are cells undergoing division in the
surrounding tissue as well, highlighted by the presence of nuclei (see Fig. 1c for mitotic
indices). These images are also maximum projections of an approximately 100 m z-
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stack, thus capturing approximately 7-10 cell layers and subsequently many cytokinetic
bridges. In regions without a KV or nuclear marker, there are no cells present and
therefore no midbodies are seen. Additionally, please refer to Supplementary Figure 2e
and h-i, where images are included of RacGAP localizing to microtubule-rich cytokinetic
bridges to highlight antibody specificity.

“Point 6: I know from direct experience that overexpression of MKLP1 does affect
cytokinesis. Therefore I am afraid that I cannot simply trust the “confidence” of the
authors on this point and some experimental evidence in support of the authors’
“confidence” should be presented.”
To address Reviewer 2’s concern, we have provided a comprehensive overview of the
mitotic duration of zebrafish cells when expressing a variety of fluorescently tagged
markers (Rebuttal Figure 1) compared to transgenic lines (bactin::EMTB-3xGFP). We
have done these studies in both KV cells (Rebuttal Figure 1a, d, e) and cells outside of
KV (Rebuttal Figure 1b, c, f-h). The location of these panels in the manuscript are
outlined in the figure legend for Rebuttal Figure 1. Based on the similarity of mitotic
timing between these various markers including MKLP1 overexpression (~8-12 minutes
from metaphase to midbody visualization), we argue that MKLP1 is not affecting mitotic
progression and in zebrafish dividing cells can be used to monitor cytokinetic bridge
placement and abscission. We also find no developmental abnormalities nor embryonic
lethality when overexpressing MKLP1, arguing that ectopic expression of MKLP1 can
be used to follow cytokinesis and abscission in a developing embryo.
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Rebuttal Figure 1. Time lapse
images of live zebrafish cell divisions
as seen by fluorescent markers. GFPMKLP1 (a, see Fig. 3, Movie 5), PLK1mCherry + GFP-MKLP1 (b, see
Supplementary Fig. 2d, Movie 4),
H2B-Dendra (c, see Supplementary
Fig. 2a), PLK1-mCherry (d-f, see
Supplementary Fig. 2b-c, 3a, Movie
3), and EMTB-3xGFP (g-h).
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“Point 9: Just a clarification here. My comment was intended to simply point out that
multinucleation is a general readout for cytokinesis failure and not only for abscission
failure as stated in the manuscript. I did not mean to imply that Rab11 knockout would
not cause multinucleation. I was basically asking to simply change the wording, but I do
appreciate the authors’ extra effort.”
We have altered the text for this section to reflect that multinucleation can also be a
readout for abscission failure. Please refer to page 13, line 270-277.

Reviewer #3 (Remarks to the Author):
“The authors have addressed most of the concerns I had during my previous read.
I have only two comments left.
1-Supplementary Table 5 is extremely useful to follow the statistical tests performed for
most experiments. Some experiments seem to be missing from this list (for example Fig
S5e). Also, I would suggest the authors to perform a non-parametric test instead of a
Student t test when comparing percentages, such as for Fig S5e for example for which
the sample size is small (n = 3) and it is therefore difficult to assume a normally
distributed population.”
We have reanalyzed the data from Supplementary Fig. 5e and Fig. 5c with a nonparametric Mann-Whitney test and updated Supplementary Table 5 to include all
statistical analyses.

“2-While I agree that the study supports the conclusions stated in the last paragraph of
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the study:
“In conclusion, these studies have highlighted the importance of cell division during the
development of KV and the de novo formation of its lumen. We provide evidence that
cell division is upregulated in cells destined for KV, and these cells retain their
cytokinetic bridges post-division. The cytokinetic bridges are then projected to the site of
future lumen formation during rosette formation/apical clustering, where Rab11associated vesicles can traffic important apical polarity components to the bridge during
epithelialization to allow for lumen formation (Fig. 7).”;
I think the statement about rosette packaging which the authors use to motivate the
study in the introduction is no longer appropriate or relevant:
“One identified molecular mechanism for rosette formation is actin-myosin dependent
apical constriction to form a rosette structure. Herein, our studies examining the
formation of Kupffer’s Vesicle (KV) in Danio rerio (zebrafish) have identified another
unclassified mechanism where cells packaged into a rosette utilize the last stages of
cell division, cytokinesis and abscission.””
We agree that this statement may no longer provide the most appropriate rationale for
this study given the removal of the theoretical model. Please see page 3, line 55-59 for
our updated introductory text.

Best wishes
Jean-Léon Maître
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A.2. The following Response to Reviewers is from the 11/19/2019 resubmission:
Reviewers' comments:

Reviewer #1 (Remarks to the Author):
“The authors have revised their original manuscript in depth, adding several new
experiments that addressed satisfactorily all my original concerns and, in my opinion,
also concerns from the other reviewers. The text has also been greatly improved and
now reads and flows very well.
Overall, this is a comprehensive and very interesting study that reports new in vivo
findings that should be of interest to cell and developmental biologist.
Well done!”
Thank you.

Reviewer #2 (Remarks to the Author):
“This new version of the manuscript by Hehnly and co-workers presents some new data
in support of their claim that the midbody/cytokinetic bridge is involved in the formation
of the lumen during the development of the Kupffer’s Vesicle (KV) in zebrafish embryos.
As I no longer have access to either the previous version of the manuscript or my full
review, I have to consider this manuscript as a new submission.”
We apologize for using an abbreviated version of your previous comments in our
first rebuttal letter, we’ve attached your full review here. This rebuttal includes your
review in its entirety as requested:
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Previous comments from Reviewer #2:
“The midbody is an organelle that forms at the center if the intercellular bridge
during cytokinesis. Recent studies have indicated that the midbody is not only
required for the final abscission of the two daughter cells, but it is also involved in
establishing cell fate, apical-basal polarity, lumen and cilium formation. In this
manuscript, Rathbun et al. investigates the correlation between midbody
positioning and lumen formation in the Kupffer’s vesicle (KV) of zebrafish
embryos. The authors show that KV cells assemble their intercellular bridges at
the apical site and that spindle orientation is not required for KV organization.
They then report that intercellular bridges are positioned at the site of apical
clustering and that abscission seems associated with lumen formation. Finally,
they show that prematurely severing the intercellular bridge by laser-mediated
midbody ablation prevented lumen formation.
This a very descriptive paper that does not provide any novel insights into
the role of the midbody in lumen formation, which was already described in a
different system by the Prekeris lab (Magan et al, 2016, Nat Commun., PMID:
27484926). Moreover, the only evidence that the midbody is required for lumen
formation is based on a single ablation experiment (Fig. 4). For these reasons, in
my opinion this paper does not meet the standards for publication in Nature
Communications.
I have no major technical comments, as I am not very familiar with the
system used by authors, but I can say that the images are not very clear and the
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number of markers used in this study is very limited. It is also unclear to me why
the authors did not use the zebrafish KIF23/MKLP1 gene instead of the human
homolog in their live-imaging experiments in Fig. 3.”

Original Response to Reviewer 2:
“The study mentioned above (Mangan et al, 2016)1 did not examine this process
in vivo, but instead used a 3D in vitro tissue culture system. There are some key
findings that our study highlights that are unique from an in vitro 3D culture
system: (1) unlike MDCK 3-D acini, zebrafish KV do not utilize spindle orientation
in expanding a lumen. (2) Uniquely, zebrafish KV utilizes a prerequisite
temporary rosette structure before evolving into a sphere. Our study, for the first
time, has identified that rosette formation incorporates cell division. Unlike
zebrafish, in vitro MDCK 3D acini do not utilize a rosette scenario. Instead one
cell divides, forms two daughter cells, and then a lumen forms between the two
cells where the cytokinetic bridge was once placed, bypassing the formation of a
multicellular rosette. While this system can identify many molecular players that
are involved in lumen formation, it does not define the steps of forming a de novo
lumen in vivo, which we have done in our study in regard to KV. This suggests
that there are differences between these two systems, and the importance of
identifying what is occurring in vivo. These two points make our study broadly
applicable to both developmental and cellular biologists.
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We have increased the number of mitotic markers used in this study to
denote the cytokinetic bridge and/or mitotic stages (please refer to new
Supplementary Fig. 2). We think that this comment has increased the
significance of our manuscript in that none of the sub-cellular localization
patterns of these markers have been previously described during zebrafish
development. The new data and markers we have used for this resubmission
include acetylated tubulin, RacGAP, PLK1, and MKLP1 (highlighted in our new
Supplementary Fig. 2, Fig. 2 and 3). These studies were completed through
immunostaining or fluorescently tagged constructs. We also have confirmed that
the localization of the expressed human MKLP1 localizes in the same locale as
two zebrafish midbody proteins, MKLP1 and RacGAP, by immunohistochemistry
(Supplementary Fig. 2). All of this is included in new Fig. 2, and new
Supplementary Figure 2.”
“The authors start by reporting that mitosis is required for lumen formation in KV by
showing that cells involved in KV formation have a higher mitotic index than cells
outside the KV and that lumen formation is impaired after treatment with mitotic
drugs,(Fig 1). They then show that midbodies accumulate at the apical membranes prior
to lumen formation and that this placement occurs during cytokinesis (Figs 2 and 3).
They subsequently report that ablating the cytokinetic bridge impairs lumen formation
(Fig. 4) and that optogenetic clustering of Rab11-vesicles results in abscission failure,
abnormal lumen formation and reduced delivery of the cystic fibrosis transmembrane
conductance regulator (CFTR) at the apical surface during KV formation (Fig. 5 and 6).
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Most of the results presented in this paper are confirmatory. The Prekeris lab has
published that midbodies are involved in lumen formation in an ex-vivo 3D culture
system (Mangan et al, 2016, Nat Commun., PMID: 27484926) and it has been known
for a while that Rab11 and its effector FIP3 are important for membrane trafficking
during cytokinesis (reviewed in PMID: 19704869). As the authors mentioned in the
paper, previous studies have shown a requirement for Rab11 in KV morphology and
lumen formation (page 6) as well as in CFTR exocytosis (page 7). Therefore, the only
novelty of this study seems to be that it is the first in vivo study showing a requirement
for midbody/cytokinetic bridge in lumen formation in zebrafish embryos. Although I
appreciate the importance of confirming ex-vivo studies in animal models, in my opinion
this study does not represent a significant advance in the field to warrant publication
in NatureCommunications. Moreover, the ablation experiments, that
probably are the most important part of the paper, do not seem well controlled (see
comments below).”

Specific comments:
1. “The introduction is very succinct and does not provide sufficient information to the
readers about the current knowledge of KV formation in zebrafish and of midbodies and
their role in lumen formation.”
We thank the reviewer for this feedback. We have added more citations and a
more comprehensive introduction of abscission and cytokinetic bridge cleavage. Please
refer to page 4, lines 74-87, which are highlighted with blue font for your convenience.
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2. “In Fig 1d, the mitotic index after treatment with BI or nocodazole should be properly
quantified and plotted; how many replicates?”
As per Reviewer 2’s comments, we have carefully quantified both the cell
number and mitotic index within KV for each of the drug treatments (new
Supplementary Figure 1e-g). With this new data, we have correlated an increase in
mitotic index and decrease in KV cell number with a decrease in KV lumen area
(correlation plot shown in new Supplementary Figure 1g for cell number versus lumen
size), suggesting that as cells are either inhibited from entering and/or progressing
through mitosis (PLK1 inhibition with BI2536) or arrested in mitosis (nocodazole
synchronization), lumen defects arise. All n values are included in Supplementary Table
5 and included in figure legends, n>27 embryos were used for each treatment in
Supplementary Figures 1e-g across n>3 experiments.

3. “It is not specified what cell type(s) are shown in Supplementary figure 2a-c.
Moreover, it should be made clear in the text that these figures only confirm a well
established distribution of MKLP1 and Plk1 during mitosis.”
Supplementary Figure 2a-c are images of early embryonic zebrafish cells
expressing markers that have never before been resolved and/or shown in a live
zebrafish embryo. However, we have confirmed that their distribution is similar to that
reported in other contexts (refer to updated text on page 7-9, lines 134-179). Panel A
shows an example of a live mitotic division within Kupffer’s Vesicle with PLK1-mCherry
expression (denoted by Sox17:GFP-CAAX marker). Panel b is an example of another
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live mitotic division in the zebrafish embryo, this time in cells expressing GFP-MKLP1
and PLK1-mCherry. Lastly, panel C is a representative image of mitotic stages within
fixed zebrafish cells, highlighting specificity of GFP-MKLP1 and PLK1-mCherry
expression at the cytokinetic midbody as shown by acetylated tubulin antibody staining.

4. “The term ‘abscission’ indicates a precise and unique time point, when the two
daughter cells are physically separated. However, the authors use this term incorrectly.
For example, there cannot be an ‘early’ and ‘late’ abscission as indicated in
Supplementary figure 2c, and it is unclear what is the difference between ‘abscission’
and ‘cytokinetic bridge cleavage’ (Fig. 3b), as they may actually mean the same thing.
In that figure, the two daughter cells appear still connected at 22 min, but the authors
define this stage as ‘abscission’. Moreover, why the authors used the term ‘cytokinetic
bridge’ instead of ‘intercellular bridge’, which is more appropriate?”
While the final severing of the cytokinetic/intercellular bridge is often termed
“abscission”, in this manuscript we are referring to the resolution of the cytokinetic
bridge in preparation for abscission, the final cleavage step. We have edited the
manuscript to clarify on the confusion of abscission terminology (see page 4, lines 7487). This is now outlined carefully in our expanded introduction based on your specific
comment #1.
In short, we are using the term abscission to describe the end of cytokinesis
when the cytokinetic/intercellular bridge is resolving to a diameter of approximately 1-2
microns and the bridge is subsequently cleaved2. Furthermore, studies have shown that
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membrane trafficking pathways are required for abscission to bring new membrane to
the sever site 3,4, which is required to allow for ESCRT complexes to complete the final
severing step5. This process is now carefully laid out in the introduction and we have
edited the language to achieve the consistency you requested.

5. “I can’t really see any specific accumulation of RacGAP1 in Fig. 2c-d, there are dots
everywhere.”
In order to clarify the positioning of RacGAP-positive midbodies throughout this
paper, we have carefully quantified their positioning in relation to the inner or outer 50%
of KV both for endogenous midbodies (immunostained for RacGAP in new Figure 2d-e)
and for midbodies that we follow live (new Supplementary Figure 3c-d). In both Figure
2d-e and Supplementary Figure 3c-d, the percentage of midbodies localized to the inner
50% of KV volume (“apical midbodies”) significantly increases as KV progresses from
pre-rosette to lumen. We have also provided additional representative images depicting
midbody localization (shown by RacGAP or MKLP1) at regions of apical polarity
establishment, shown by CFTR-GFP expression (new Figure 2d-e and new
Supplementary Figure 3c-d).

6. “The distribution of MKLP1 in Fig. 3 does not reflect the normal localization of this
kinesin (compare with Supplementary figure 2b-c). It is clearly much more diffuse along
microtubules instead of accumulating at the plus ends. This might indicate that the
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construct is highly overexpressed, which would affect cytokinesis. Have the authors
measured the level of expression of their constructs?”
A plasmid construct was utilized to visualize GFP- or mKate-MKLP1 in the case
of Figure 3, as its localization on the microtubule cytoskeleton was useful in following
the formation and severing of the cytokinetic bridge over time. We also utilize mRNA
injections to visualize GFP- or mKate-MKLP1. While this plasmid construct is
overexpressed compared to the mRNA injections, the timing of mitosis including
cytokinesis and abscission was consistent with other experiments in this paper. Since
the mitotic timing was not different between cells that ectopically expressed mKateMKLP1 or PLK1-mCherry when compared to two transgenic lines where we can monitor
division timing ( actin:H2B-Dendra or actin:EMTB-3xGFP), we are confident that this
overexpression is not detrimental to mitotic progression in this case.

7. “There are major issues with the ablation experiments (Fig. 4). First, the author claim
that they ablated cytokinetic bridges while it is evident from the images (Fig. 4a-b) that
they ablated midbody remnants (marked by MKLP1) instead. In order to correctly sever
the cytokinetic bridge, the authors should visualise the central spindle microtubules. The
most important control in these experiments is to show that ablation of cell-cell junctions
adjacent to midbodies during apical clustering does not affect lumen formation. These
are indicated by the authors as KV cell-cell interface controls, but only 3 of these
experiments were carried out (Figure 4d-g) and it is impossible to identify the location of

163

these ablation sites from the kymograph (why a kymograph?) shown in Supplementary
Figure 4.”
While we appreciate the concern for distinguishing midbodies within cytokinetic
bridges versus midbodies post-abscission, we are confident that the midbodies ablated
were still housed within a cytokinetic bridge at the time of laser ablation. When
identifying a midbody/cytokinetic bridge we first had to image pre-ablation. This process
takes time and a midbody remnant would not remain in frame. Specifically, we began
by identifying a midbody for ablation and taking a two-color z-stack image to capture the
midbody and its position within Kupffer’s vesicle. Then we proceeded to snap a preablation image of the midbody plane, ablate the midbody with multiple pulses of laser,
and snap a post-ablation image to ensure complete ablation (refer to new Supplemental
Figure 4a-b). Therefore, midbodies that remain in the same position for this lengthy
process are deemed to be housed within a cytokinetic bridge pre-severing.
To directly address your concern about midbody remnants, we’ve used improved
imaging parameters to visualize the cytokinetic bridge on either side of the midbody
during ablation (refer to new Supplemental Figure 4c). We identified the same defects
under these conditions as in our previous experiments reported in the manuscript.
Here, we noted that the midbody was ablated, leaving the severed cytokinetic bridge
floating in the embryo, and KV lumen formation defects were identified when cytokinetic
bridges within KV were ablated in this manner.
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Rebuttal Figure 1. Live markers for microtubules during
zebrafish development. Top panels: Examples of EMTB3xmCherry mRNA expression (grayscale) during early (left) and
later (right) zebrafish development. Bottom panels: Expression
of EMTB-3xGFP (cyan) and Sox17:RFP (magenta) resulting
from the crossing of two stable transgenic zebrafish lines. Early
(left) and later (right) developmental stages shown. Note the
loss of clear microtubule signal during late developmental
stages (~8-10hpf) in both cases.
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Unfortunately, it is not feasible for us to visualize microtubules in a live embryo
during KV development. We have a stable zebrafish line that expresses a fluorescentlylabelled microtubule binding protein (EMTB-3xGFP) that is commonly used for this
purpose, however fluorescence is dim at best by the time the fish reaches KV
developmental stages and we are unable to use it for careful microtubule identification
(examples in rebuttal Figure 1). Additionally, we have attempted to use injectable
mRNA expressing EMTB-3xmCherry to obtain live microtubule fluorescent labelling,
however we experience the same difficulties as the transgenic line and are unable to
visualize microtubules at this developmental stage in this locale. We have attached
representative images of these tools during early (~2-4hpf) and later (~8-10hpf)
zebrafish development for clarity (Rebuttal Figure 1). This has been a recurring problem
in KV development and there are no publications that have demonstrated live
microtubules in KV to date.
Additionally, we have included added controls and representative images as
requested for cell-cell interface ablations (updated Figure 4c-f). We doubled the
number of cell-cell interface ablation controls and added cell cytosol control ablations to
make this section more rigorous (See updated Figure 4c-f, refer to updated
Supplementary Table 5, n>6 embryos used for each ablation condition). We have also
included added representative images of each type of ablation treatment (midbodies
within and outside of KV, KV cell-cell interface control, KV cell cytosol control) for clarity
and transparency (see updated Figure 4a-c). An inset is included for an ablation of cellcell interface (updated Figure 4c) to replace kymograph.
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8. “The authors did not indicate the number of cells and experiments for the graph in
Fig. 5c and the number of cells for the graph in Fig. 5e.”
For the cell culture experiments in Figure 5c, n=100 cells were counted per
experiment over three independent experiments for normal light conditions and 488nm
blue light conditions. For the zebrafish experiments in Figure 5f, n>161 cells were
counted for each experimental condition over n>5 embryos. This information is now in
the revised figure legend and detailed in Supplementary Table 5.

9. “Multinucleation is a general readout for cytokinesis failure and not specifically for
abscission failure as wrongly stated several times by the authors. Depletion or
inactivation of factors specifically required for abscission, like some ESCRT-III
components for example, often does not cause a large increase in multinucleation.”
We have added experiments to this manuscript that demonstrate that a Rab11
CRISPR line has a significantly higher percentage of binucleate cells compared to
controls. Additionally, we have provided time-lapse images of these binucleate cells
forming following the formation of a cytokinetic bridge (new Supplementary Figure 5c-f).
This quantification is very similar to the results of the optogenetic clustering of Rab11
(Figure 5c). From these images, we hope you can appreciate that the process of
cytokinesis occurs as normal, however abscission fails and the dividing cell transforms
into a binucleate cell well after the formation of the cytokinetic bridge.
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Reviewer #3 (Remarks to the Author):
“The revised manuscript from Rathbun and colleagues provides significant
improvements. The study now comes with more quantifications of the authors
observations, some control experiments and with a new functional assay to support the
authors’ hypothesis. I have some questions regarding these additions, which I am
convinced the authors should be able to address, and I remain very skeptical about the
benefit of including the theoretical model in this study.

Major concerns:
1 – The authors include a modified theoretical model of the function that cytokinetic
bridges (CB) could have in cell packing. This is mentioned in the main text in a brief
paragraph and more detailed in supplementary. The model is not mentioned in the rest
of the text, which questions its relevance to the study.
The authors claim the model is “testable” but I fail to see where they describe how they
test it. In addition, I fail to see what predictions come out of the model that would be
relevant to the rest of the study.
The model hypothesis would be that CB could provide a line tension that would help
packing cells. I see how a leash connecting sister cells could prevent them from going
too far apart and essentially tether cells to one another. I find it more difficult to conceive
how this would pack cells into a compact structure in the same way as actomyosin
contractility and/or adhesion could do, as described in tens (if not hundreds) of studies.
The authors then plug in values found in the literature to compare the line tension
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applied by contractility onto the CB to speculate that CB could withstand this tension
thanks to a line tension that would be between twice and 20 times the one of
contractility. This is based on values found in the literature in different cells and
experimental settings. In addition to their relevance to the KV, the uncertainty on these
values makes the conclusion of the model weak in my opinion. Besides, this would
explain how sister cells stay together but not how the entire KV packs itself.
Finally, the laser ablation experiment disproves the authors speculations. After ablating
the midbodies (MBs), the KV doesn’t form a lumen and nevertheless stays nicely
packed, arguing that CBs are dispensable for KV packing.
In conclusion, I think the model lacks relevance and consistency with the study. As
such, it is detrimental to the study and should be removed.”
We thank Dr. Maître for his careful analysis of the model included in this
manuscript. We agree with quite a bit of what is said above.
Very briefly, we intended the model to provide a null hypothesis about the
magnitude of the mechanical work involved in forming a rosette structure, under a
strong assumption that the cortical actomyosin is not significantly remodeled during
rosette formation. This was to help us understand whether there could be a mechanical
role for the cytokinetic bridges. As Dr. Maître correctly highlights, in the end the
experimental data contradicted our null hypothesis: our data suggest cytokinetic bridges
are not mechanically necessary for the packing, just the lumen formation. We should
have been more clear about this in the original version of this manuscript. As teasing
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apart these details is neither necessary or important for this manuscript, and we have
now removed the modeling description entirely from the new revision.
We hope to revisit the question in future work.

2 – “The authors have added quantifications to some of their experiments but some
experiments remain unquantified and some quantifications are unclear.
For example, the data shown in figures 2 and 3 are not quantified and it is therefore
difficult to appreciate how frequent the phenomena are. The authors could count the
MBs or CBs positioned apically over the total number of MBs and CBs in the KV.”
To address this comment and to further demonstrate the frequency of cytokinetic
bridge placement towards the center of developing KV, we have quantified midbody
localization within KV as requested. We determined the percentage of midbodies
located within the inner 50% of the KV volume, termed “apical midbodies”, during prerosette, rosette, and lumen stages of KV development (diagram describing
quantification found in Supplementary Fig. 2h). We found that in both fixed (new Fig.
2d-e) and live samples (new Supplementary Fig. 3c-d), there was a significant increase
in the percentage of midbodies located in the center of KV.

“When assessing the size of the lumen, the authors measure the projected area.
Because the KV is not spherical (it is more of a flat asymmetric capsule), the projected
area is going to depend on the orientation of the imaging (and this orientation will
change with the migration of the KV over the spherical embryo). I think this readout is
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not ideal. From the methods, it is unclear to me if the authors correct for the orientation
of the imaging (dynamically that is) to measure the KV projected area facing its
equatorial plane. Based on their images, I think the authors may be better off measuring
the volume of the KV. There are quick and efficient software nowadays that can do the
job fairly easily. I could recommend Limeseg, which is a FIJI plugin that is very easy to
use and will give a more accurate measurement than what the authors currently show.”
When mounting zebrafish embryos in agarose, every effort is made to ensure
Kupffer’s vesicle is close to the coverglass and as flat as possible to ensure the area
measurement is representative of the true KV lumen structure. All KVs were processed
and lumen area quantified in Imaris software to ensure lumen was facing its equatorial
plane when measured. Imaris is ideal for 3D imaging as it allows the 3D rendering to be
turned (see Rebuttal Figure 2). We’ve carefully detailed this into our revised methods
section (page 24, lines 516-525).
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Rebuttal Figure 2. Representative image of KV lumen before (left) and
after (right) reorientation in Imaris. KV images were turned in Imaris to
orient the KV along its equatorial axis for proper lumen area measurement.
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“In Figure 6b, the authors normalize the projected lumen area to the mean control area.
It is unclear to me why the authors decided to normalize the area for this experiment
specifically. It may be linked to my previous point about the inaccuracy of the area
measurement. Nevertheless, the absolute values should be given to unambiguously
report the authors’ findings.”
Our optogenetic experiments were completed through the use of a NightSea
fluorescent lamp to blanket the embryos in blue light. Therefore, many of these
experiments were completed at “room temperature”, which fluctuated slightly based on
season and building parameters. This slight temperature variability may affect
developmental timing, as slight changes in temperature have been shown to either
speed up or slow down zebrafish development6. In order to control for this possibility,
we normalized the lumen area data from each independent experiment to the mean of
the uninjected control group for that experiment. This would ensure that differences we
noted between the experimental group and controls of the amalgamated data set were
in fact due to the variables being tested, instead of differences in ambient room
temperature and subsequent zebrafish developmental speeds between independent
experiments.
Because embryos were ablated at a specific developmental timepoint and
followed through live microscopy, data normalization wasn’t necessary for ablation
experiments. However, a large population was used for the optogenetic experiments
where developmental stages varied slightly from embryo to embryo within the
population. Since these embryos were exposed to blue light in bulk and differences in

173

room temperature and clutch developmental speed would alter their exact
developmental stage, data normalization was necessary to be able to compare results
between separate independent experiments. We have included a raw data set to
demonstrate that while the trend remains the same as in the normalized data set, this
normalization accounts for differences in lumen area due to slight variations in clutch
developmental timing to focus on the effects from the optogenetic experiment
specifically (see new Supplemental Figure 6b where clutches are individually color
coded).

“When reporting the effects of the ablation and optogenetic experiments on KV
formation, the authors give the area under the curve (AUC) of the lumen projected area
over time, the final projected area and the growth rate. The first two parameters are very
sensitive to the timing of lumen opening time relative to the time of imaging (that’s what
I gathered this time indicates, it is unclear from the description and, by the way, a time
indicated as hour post-fertilization would be much more useful and appropriate to be
able to reproduce these experiments). Any delayed embryos (and this seems to be
frequent in the reported experiments) will see these parameters affected in an
unspecific manner. Indeed, the growth of the KV does not seem to reach a plateau
during the time of imaging shown by the authors. When is the final area value taken
then? What is the time period taken for the AUC measurement? The growth rate on the
other hand seems more robust to these experimental biases.”
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These are valid points and we agree that perhaps AUC is not the simplest way to
quantify the differences we’re seeing. Therefore, we are simplifying our analyses to only
include graphs depicting lumen area over time and lumen growth rate.
For these experiments, laser ablations were performed at midbodies within or
outside KV, at KV cell-cell interfaces or cytosol (experimentally modeled in new
Supplemental Figure 4a). From here, embryos were imaged for approximately two
hours post-ablation to track lumen growth. Since timepoint duration differed in a few of
the experimental setups due to the number of embryos being imaged, lumen areas
were binned and plotted every thirty minutes to depict the averaged lumen growth over
time for each of the control and experimental groups (see updated Figure 4d-e). Lumen
growth rate was determined by dividing the final lumen area by the timepoint of the last
image to calculate the growth in m2/ min. These values were then plotted in the bar
graph shown in updated Figure 4f. n-values were increased for all treatments.

3 – “The authors have added some controls to their previous experiments but some
controls for the newly added experiments are missing or would need clarifications.
Regarding the ablation experiments, the Figure 4a shows a control where no ablation is
performed. This is not the appropriate control to show. The authors would need to show
a case in which a contact or a cell has been ablated.”
We have included example images of ablation controls in our revised manuscript.
The unablated control, MB outside lumen ablation, cell-cell interface ablation, cell
cytosol ablation, and MB within KV ablation are represented in updated Figure 4a-c.
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“Along this line, how are contacts and cells chosen for the control ablation experiments?
These control cells should be chosen for having an apical MB or CB. I could not find this
information and this needs to be described clearly whether it is the case or not. “
We have included a diagram to describe the relative locations of ablations in the
developing KV (new Supplementary Figure 4a), where we have designed our controls to
test how KV development as an organ is effected by the premature severing of a bridge
compared to other locations in the tissue. When choosing cell-cell interface and cell
cytosol ablation locations, we chose regions that we could clearly focus on and ablate.
Control conditions did not have a cytokinetic bridge attached, only a clearly identifiable
region that was either a cell-cell interface or cytosol (cell-cell interface inset shown in
updated Figure 4c). MBs outside KV were ablated within the same microscope field as
KV. MBs inside KV (experimental group) were located at the center of KV, colocalizing
with the central rosette structure just prior to lumen formation. When we do laser
ablations we work in a single z-plane for the ablation (limitations of our ablation set up),
this makes it very difficult to resolve the edges of the cells that are associated with the
bridge. Cell edges are only clearly identified when we do 3D image analysis post
acquisition (Figure 3). Following the short 2D ablation time-course, we then do 3D
imaging over time to assess defects in lumen formation. Therefore, due to our
experimental limitations, we picked structures/locales that were not cytokinetic bridges
to ablate and compare to bridge ablation. This allowed us to control for the effects of
laser ablation upon the KV organ as a whole compared to the targeted ablation of a
cytokinetic midbody at the site of future lumen formation. Under these conditions, we
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saw significant defects in lumen formation when ablating cytokinetic bridges and not
with cell-cell interfaces or cytosolic regions. This is now clearly described on page 11,
lines 234-238.

“Also, the authors indicate that the ablation of MBs is ensured by the lack of fluorescent
recovery. I think such example would be good to show as a control of when ablation is
incomplete, if the KV can form.”
We added a new figure panel to distinguish a successful laser ablation from an
unsuccessful laser ablation. In new Supplemental Figure 4b, we depict the lack of
fluorescence recovery noted during a successful laser ablation (top panel) compared to
the subsequent fluorescence recovery noted after an unsuccessful laser ablation.
Typically, the fluorescence recovery of an unsuccessful laser ablation is noted less than
a second or two later as shown in Supplemental Figure 4c.
Furthermore, we included an example of a successful laser ablation where the
cleavage of the cytokinetic bridge can be observed with improved microscopy
parameters (see new Supplementary Figure 4c). The retraction of the cytokinetic bridge
can be observed post-ablation in the time lapse included, demonstrating the result of a
successful ablation.

“Regarding the optogenetic experiments, the failed division described in figure 5 are
quite difficult to see. Are the images of Hela cells shown in 5a,b the images used for
counting binucleated cells? Are the movies more convincing than the still images? As
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far as KV cells are concerned, I am not convinced that the image shown in 5d is of a
binucleated cell but could rather be of a cell with lobed nucleus. Can the authors film a
failed division instead or can they obtain more convincing images of multiple nuclei in a
cell? Since the authors express their constructs in the entire embryo, this could maybe
be observed in a different tissue where imaging is easier.”
We have included additional images in updated Figure 5d-e to represent the
binucleate and multinucleate cells we observe in Rab11-disrupted embryos. We have
also outlined the boundaries between the multiple nuclei for clarity. In addition, we
included examples of cells failing abscission and forming binucleates when Rab11
expression is removed from HeLa cells in new Supplementary Figure 5c-f, which also
contains examples of binucleates (new Supplementary Figure 5d) that are very similar
to the results noted when Rab11 function is disrupted with optogenetics (Figure 5d).

“Following up on this, the effect of the inhibition of Rab11 in the surrounding tissue
should be assessed to know whether what the authors report is autonomous to the KV
(as they explicitly assume) or not. This should be at least discussed explicitly or tested
by doing late yolk injections, which would lead the mRNAs to be up-taken by the YSL
and the forerunner cells, which will become the KV cells.”
The advantage to optogenetics is that we can acutely expose embryos to 488nm light
specifically during the development of KV. While this is still ~4-6 hours, we find that
embryo death rates were similar and that the loss of embryos noted was consistent
across injection control and experimental groups, suggesting that embryo death was
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due to injection trauma (updated Supplemental Figure 5h). Additionally, we quantified
heart looping defects in the embryos at the end of the trials and found that while defects
were present in heart looping in the experimental groups, the fish appeared to have
developed normally otherwise. This indicates that the Rab11 clustering during that 4-6
hour window was mainly specific to KV development (producing left-right asymmetry
defects and little else in terms of morphological defects). One reason for this is that
defects that occur in non-KV cells could recover after light was removed. This 4-6 hour
window of 488nm light exposure occurs when the KV sets up a left-right body axis, and
is likely unable to recover. We would like to follow up on these studies in a later
manuscript.
We attempted the late injection experiment that Dr. Maître mentioned in his
comment, however we were unable to obtain mRNA expression specifically in KV using
this tactic (see Rebuttal Figure 3). While we were unable to directly test this as
requested, we would like to add that the mosaic expression of optogenetic constructs in
regions surrounding KV but excluding KV resulted in lumen areas similar to those in
uninjected or single injected embryos (see updated Figure 6b), suggesting that Rab11
disruption in the tissue surrounding KV has no discernable effect on KV development.
This result is in stark contrast to our experimental group that includes embryos with KV
expression of the optogenetic constructs under 488nm light conditions, where severe
lumen defects were noted. We have expanded upon this section in the manuscript text
(see page 15, lines 314-323).
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Rebuttal Figure 3. Representative images from a late-injection optogenetic
experiment. KV marker (CFTR-GFP, grayscale/magenta) and CIB1-mCherryRab11 (grayscale/cyan) expression shown. Uninjected (top), CIB1-mCherryRab11-only injection, and CRY2 + CIB1-mCherry-Rab11 double injection
groups displayed. Embryos were injected between the 500-1000-cell stages
of development.
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“Following up on this, the time window of illumination used by the authors is very
broad and will affect the precursors of the KV, namely the forerunner cells. How can the
authors ascertain that the effects they observe on lumen opening comes specifically
from the inhibition of Rab11 function in CB related trafficking? Rab11 related defects
could arise, not only from the surrounding tissue, as mentioned previously, but also from
defects inherited from the precursors of the KV cells. This is not discussed explicitly by
the authors and could be tested by narrowing down the time window of light exposure
to, as the authors claim, “acutely” inhibit CBs polarizing functions.”
In order to test this, we narrowed the time frame of light exposure by two hours,
beginning blue light exposure at the 75-90% epiboly stages versus the 50-60% epiboly.
We carefully quantified the lumen area of these embryos and found a similar trend,
where lumen area is significantly decreased in embryos injected with both optogenetic
mRNA constructs and blue light treatment. We have added this late light exposure
experiment into updated Figure 6b of the manuscript.

“The functions of Rab11 in cell trafficking are broader than just the ones associated to
the CB (this should be explicitly mentioned). It is nice to see the effect on CFTR
trafficking upon Rab11 inhibition. The same readout would be important to see after
laser ablation, which is more specifically targeting the MB and more acute. It would
therefore nicely complement these observations.”
To address this, we ablated embryos expressing CFTR-GFP and followed the
fate of CFTR localization. We were unable to resolve the trafficking of CFTR to the
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cytokinetic bridge within the single ablated cell due to photobleaching of the ablated
area. We have added this experiment to new Supplementary Figure 4b-c.

“Minor concerns:
1 – I wonder how the authors explain that inhibiting cell division in Figure 1 results in a
graded effect on lumen size when they propose that cell division would have more of an
on/off or permissive function.”
PLK1 inhibition can halt cells in G2, prometaphase, metaphase, or cytokinesis.
This inhibition is leaky and can therefore results in this wide variety of mitotic delays, as
well as allowing for cells to exit mitosis on occasion. Additionally, mitotic delay from
nocodazole inhibition is also leaky, allowing cells to either sync in prometaphase or
progress through mitosis on occasion. We attribute these phenomena to the dosage
dependent inhibition with both chemicals. We have changed the language in the revised
manuscript accordingly (refer to page 6, lines 111-131).

2 – “The nocodazole experiment is quite brutal as all intracellular trafficking will be
affected, not only the spindle formation. This should be stated explicitly.”
This has been updated in our revised manuscript. Please refer to page 6, lines
116-119.

3 – “The observation of MB apical localization in MDCK cysts is already known and not
particularly relevant to the study. I think it is sufficient to show the KV data.”
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We have moved this panel from the main figure to Supplementary Figure 2g to
support previous relevant studies.

4 – “Figure S5 shows 75% survival of the control embryos. This seems low.”
We have added data from three independent experiments with our wildtype
zebrafish line to the graph in Supplementary Figure 5h. We attribute the low control
survival rate to the transgenic line, Sox17:GFP-CAAX, when compared to a wild-type
TAB line.

5 – “The time stamps are missing in Figure S2c-f.”
These panels were fixed zebrafish embryos with mRNA expression and/or
immunostaining. Still images from live embryo movies are in Supplemental Figure 2a-b
and now are clearly labeled with time stamps.

Best wishes,
Jean-Léon Maître
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A.3. The following Response to Reviewers is from the 07/22/2019 resubmission:
Reviewers' comments:

Reviewer #1 (Remarks to the Author):
“In the manuscript by Rathbun et al the authors examine the role of cytokinetic bridges
(CKBs) in lumen formation in the zebrafish organ of laterality (KV). They first use
modeling to explore the potential role of CKBs in the organization of rosettes in the KV
primordium and take published tension values to estimate the relative strength of CKBs.
They argue CKBs withstand much greater tensions (up to one order of magnitude) than
that of acto-myosin along cell boundaries. They then examine the formation of CKBs
and the localization of midbodies
during KV development and monitor the cell division angles between KV cells. They
observed that CKBs are unusually long-lived, that midbodies localize to the apical
domains before lumen opening and that, unlike in vitro results, cell divisions are not
oriented perpendicular to the prospective lumen. Importantly, they observe that the
position of the CKBs correlates with the site of lumen formation, which occurs following
CKB cleavage. Finally, they test the importance of timing of CKB cleavage in lumen
formation using laser ablation and conclude premature cleavage impairs lumen
formation.
Overall, this manuscript addresses an interesting question from a novel angle. While
much of the data is descriptive, it does provide new insights. However, further
experimental evidence is needed to support their conclusions. The major points are:
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1-It is unclear whether midbody localization to the prospective apical membrane
precedes apical polarization and results mainly from the site of CKB cleavage or
whether this simply reflects centrosome localization and microtubule organization. That
is, midbody localization would be downstream of cell polarization and depend on
centrosome localization rather than how it is proposed.”
Whether midbody formation precedes or follows apical polarity is an interesting
point, specifically whether the centrosome localizes at the apical membrane before
cleavage. To address this point we monitored the placement of the cytokinetic midbody
in relation to the mitotic centrosomes in live embryos by assembling a video montage,
along with visualizing fixed embryos where we focused on dividing cells. To do this we
had to find and then utilize several mitotic markers that would work in zebrafish embryos
(New Supplementary Fig. 2). One of these markers, the mitotic kinase Polo-Like
Kinase-1 (PLK1) labels both the midbody and mitotic centrosomes. Here we find that
when a midbody forms, the mitotic centrosomes are still on the side of the nucleus
furthest away from the cytokinetic bridge, yet to orient towards the cytokinetic bridge
where an apical membrane forms (Supplementary Fig. 2a-c, late abscission, green
arrows). With this, we argue that formation of the cytokinetic bridge and associated
midbody precedes cell polarity formation and centrosome positioning to the apical
membrane.
However, we do not intend to propose that the midbody drives apical polarity
formation, but that the process of abscission is required for establishment of a de novo
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lumen and robust apical polarity. The midbody serves as a landmark for our studies to
follow the cytokinetic bridge. A long-term goal of my lab is to examine whether the
centrosome directs Rab11-endosome transport into the cytokinetic bridge to initiate
polarity formation. However, we argue that this is beyond the scope of this paper. This
study is important in that it first demonstrates that KV morphogenesis requires division
(updated Fig. 1), and that the process of abscission is involved in the initiation of the KV
lumen formation (new Fig. 5-6).

“2-The ablation experiment lacks controls and it is impossible to determine whether
lumen formation is impaired due to premature CKB cleavage, due cell damage or any
number of side effects. 2A-What happens if the ablation is performed at a different
time? 2B-Can the role of CKB cleavage be explore using genetic tools? An alternative
method is clearly needed.”
We were able to address your concerns and perform additional ablation
experiments and additional controls (updated Fig. 4, and Supplementary Fig. 4). In
addition, we utilized alternative approaches to examine the general role of the cell cycle
in lumen formation (new Fig. 1d-e, Supplementary Fig. 1d) and a genetic tool to
examine the role of cytokinetic bridge abscission in de novo lumen formation (new Fig.
5 and 6).
For our ablation experiments, we observe little to no cell death over a two-hour
period following the ablation. This is either when we ablate a midbody inside the KV
(experimental), a midbody outside the KV (control), a site of cell-cell contacts within KV
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(control), and within the cell body of a cell within KV (control) (updated Fig. 4). With the
three control groups, we hope to control for the additional side effects that can no doubt
occur with ablation techniques. We analyzed our control and experimental conditions by
live cell imaging where cell membranes and cell bodies could be monitored. We
observed no obvious signs of cell death such as severe loss in overall cell number
during this two-hour period. Under control ablation conditions, normal lumen formation
suggests that the process of applying an ablation laser is not causing severe effects to
the embryo that would inhibit lumen formation. It is only when we apply the ablation
laser to the cytokinetic bridge-associated midbody that we prevent lumen formation
(updated Fig. 4).
We have strategically focused on ablating midbodies during apical clustering
because during this time, KV is towards the outside of the embryo and can be placed
closer to the cover glass to optimize ablation conditions. Also, this developmental stage
precedes the de novo formation of the lumen. Once the lumen starts to form, the KV
dives into the cell mass of the embryo (>200 nm away from the coverglass). Once this
occurs, it is difficult to accurately ablate a midbody.
We have now utilized two alternative methods to test the role of cell division in
KV lumen formation. First, we took a pharmacological approach and treated cells with
two different concentrations of nocodazole, a microtubule destabilizing drug that can
synchronize cells in prometaphase (100 nM and 1µM), and BI2536, a PLK1 inhibitor
(100 nM and 1µM). Both of these drugs resulted in cells that were unable to exit
metaphase, leading to an increased mitotic index within the KV (Fig. 1d-e,
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Supplementary Fig. 1d). Strikingly, our findings demonstrate that if cells are not allowed
to progress through mitosis, a KV lumen cannot fully form (new Fig. 1d-e) suggesting
that the process of cell division is required for KV lumen formation.
A second new alternative approach to our ablation studies that prematurely
severed the cytokinetic bridge (Fig. 4) was to test a scenario where we could prevent
abscission while also inhibiting the delivery of apical polarity proteins to the cytokinetic
bridge (new Figs 5 and 6). Previous work in an in vitro model has identified that apicaltargeted endosomes containing the Par3/aPKC polarity complex assemble adjacent to
the cytokinetic midbody 7. These endosomes contain a small monomeric GTPase,
Rab11, required for late cytokinesis and to initiate abscission 8. To determine the role of
these Rab11-associated vesicles in lumen formation, we acutely inhibited Rab11associated membrane vesicles through an optogenetic oligomerization approach
(modeled from 9, new Supplementary Fig. 5a). We first tested the efficacy of this system
in HeLa cells (new Fig. 5a) where we can promote a blue-light-inducible heterointeraction between CRY2 and CIB1. To examine whether the cellular aggregation of
Rab11-associated membranes disrupts function, HeLa cells in the early stages of
abscission were treated with and without blue light. These cells co-expressed CRY2mCherry and CIB1-Cerulean-Rab11 (new Fig. 5a-b). Under control conditions, cells
can progress through the final stages of cytokinesis/abscission within approximately 90
min. (new Fig. 5a). When cells are exposed to 488nm light throughout the 90 min. time
course, Rab11-associated vesicles are unable to move into the cytokinetic bridge and
remain clustered within the cell body, inhibiting the ability of this cell to abscise (new
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Fig. 5b) resulting in an increased number of binucleated cells (new Fig. 5c). Based on
these studies, we next utilized this system in vivo to inactivate Rab11-associated
vesicles during KV formation and found that blue light-induced clustering of Rab11associated endosomes also resulted in a significant increase in binucleated KV cells
(new Fig. 5d-e). These studies strongly suggest that the optogenetic clustering of
Rab11 causes abscission inhibition.
By utilizing the CIB1-mCerulean-Rab11 and CRY2-mCherry optical clustering
system outlined in Supplementary Fig. 5a, we examined whether disrupting Rab11
caused defects in KV formation (experimentally modeled in Supplementary Fig. 5c). In
control embryos (uninjected, injected with CRY2-mCherry only, or injected with CIB1mCerulean-Rab11 only), a robust lumen was able to form by the 4-somite stage (new
Fig. 6a-b). Lumen area was calculated across multiple embryos. No significant
difference in lumen area was noted between uninjected and injected control embryos
exposed to blue light (new Fig. 6b). In double injected embryos exposed to blue light
where KV cells have clustered Rab11-associated membranes, significant defects in KV
lumen formation occurred such as decreased lumen area or an inability to form a lumen
at all (new Fig. 6b). These findings suggest that acute inhibition of Rab11-associated
vesicles within KV-destined cells during early KV development disrupts KV formation.

“3-The simulations are used to argue about tissue tension and the potential role of
CKBs. 3A-Do membranes recoil upon CKB ablation? 3B-if so, is the speed greater than
that of cell-cell adhesions? 3C-Is rosette organization affected by CKB ablation?”
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We don’t observe significant or measurable recoil (Refer to updated Fig. 4b,
Supplementary Fig. 4a). We believe this to be the case because we are ablating a very
small cytokinetic bridge instead of an area that is composed of multiple cell-cell
interfaces. This makes it difficult to resolve the recoiling of the bridge in the mass of
membranes projecting towards the center of the apical cluster.
Since we ablate when KV is in a rosette structure, we see some moderate
changes in cell geometry but the rosette itself remains intact. We want to examine this
in future studies.

Additional points:
“4-The findings on cell division angles presented in Fig.2 are surprising given the
published literature, which includes other refs not cited (e.g. PMID 19001128, PMID
24421325, PMID 22965908). 5A-Are the results comparable? i.e. in the published
literature the angle of cell division affects single lumen maintenance rather than
establishment.”
PMID19001128 is a study from Alan Hall’s lab that examines the role of CDC42
in spindle orientation in 3D MDCK cells, PMID 24421325 and 22965908 are similar
studies from the Martin-Belmonte group that uses the same model system to show the
role of spindle orientation in epithelial morphogenesis. While these studies are
compelling in creating a testable model for the role of spindle orientation in epithelial
morphogenesis, this is an in vitro model system (MDCK cells). While there are striking
similarities between 3D MDCK cells and KV lumenogenesis, such as the organization of
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cytokinetic midbodies at sites of apical polarity (refer to new Fig. 2a that uses MDCK
cells and compare to Fig. 2b-d that demonstrates midbodies at the sites of apical
clustering in the zebrafish KV), during the formation of KV, spindle orientation is
randomized and doesn’t seem to be essential for placing daughter cells in the correct
position preceding lumen formation (Fig. 3, Supplementary Fig. 3).

“5-Do the signals from antibody staining and tagged construct for MKLP co-localize?”
We now have included Supplementary Figure 2 with corresponding
Supplementary Movies 2-4, where we utilize multiple mitotic markers to monitor
cytokinesis and demonstrate that MKLP1, RacGAP, and PLK1 all localize to the
midbody. This localization was also confirmed by immunostaining. These studies are
the first to examine these markers in the developing zebrafish embryo.

“6-The mitotic index for non-KV cells is reported at ~2%, isn’t this too low for an early
embryo?”
We have added an additional study where we have carefully calculated the
mitotic index of a developing zebrafish embryo during the cleavage period, blastula
period, gastrula period, and segmentation period (new Supplementary Fig. 1a-c).
During the cleavage period the mitotic index is 100% and steadily decreases to ~3%
during the subsequent periods (new Supplementary Fig. 1a-c, refer to new
Supplementary Movie 1).
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“7-The writing is confusing at times, making the logic hard to follow.”
Due to reviewer 1’s comments we have extensively reworked the paper to focus
on specific conclusions per figure, which we hope will bring added clarity. Due to this
expansion of figures we have rewritten the text in hopes of clarifying the studies being
presented.

Reviewer #2 (Remarks to the Author):
“The midbody is an organelle that forms at the center if the intercellular bridge during
cytokinesis. Recent studies have indicated that the midbody is not only required for the
final abscission of the two daughter cells, but it is also involved in establishing cell fate,
apical-basal polarity, lumen and cilium formation. In this manuscript, Rathbun et al.
investigates the correlation between midbody positioning and lumen formation in the
Kupffer’s vesicle (KV) of zebrafish embryos. The authors show that KV cells assemble
their intercellular bridges at the apical site and that spindle orientation is not required for
KV organization. They then report that intercellular bridges are positioned at the site of
apical clustering and that abscission seems associated with lumen formation. Finally,
they show that prematurely severing the intercellular bridge by laser-mediated midbody
ablation prevented lumen formation.
This a very descriptive paper that does not provide any novel insights into the
role of the midbody in lumen formation, which was already described in a different
system by the Prekeris lab (Magan et al, 2016, Nat Commun., PMID: 27484926).
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Moreover, the only evidence that the midbody is required for lumen formation is based
on a single ablation experiment (Fig. 4). For these reasons, in my opinion this paper
does not meet the standards for publication in Nature Communications.”
The study mentioned above (Mangan et al, 2016)1 did not examine this process
in vivo, but instead used a 3D in vitro tissue culture system. There are some key
findings that our study highlights that are unique from an in vitro 3D culture system: (1)
unlike MDCK 3-D acini, zebrafish KV do not utilize spindle orientation in expanding a
lumen. (2) Uniquely, zebrafish KV utilizes a prerequisite temporary rosette structure
before evolving into a sphere. Our study, for the first time, has identified that rosette
formation incorporates cell division. Unlike zebrafish, in vitro MDCK 3D acini do not
utilize a rosette scenario. Instead one cell divides, forms two daughter cells, and then a
lumen forms between the two cells where the cytokinetic bridge was once placed,
bypassing the formation of a multicellular rosette. While this system can identify many
molecular players that are involved in lumen formation, it does not define the steps of
forming a de novo lumen in vivo, which we have done in our study in regard to KV. This
suggests that there are differences between these two systems, and the importance of
identifying what is occurring in vivo. These two points make our study broadly
applicable to both developmental and cellular biologists.

“I have no major technical comments, as I am not very familiar with the system used by
authors, but I can say that the images are not very clear and the number of markers
used in this study is very limited. It is also unclear to me why the authors did not use the
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zebrafish KIF23/MKLP1 gene instead of the human homolog in their live-imaging
experiments in Fig. 3.”
We have increased the number of mitotic markers used in this study to denote
the cytokinetic bridge and/or mitotic stages (please refer to new Supplementary Fig. 2).
We think that this comment has increased the significance of our manuscript in that
none of the sub-cellular localization patterns of these markers have been previously
described during zebrafish development. The new data and markers we have used for
this resubmission include acetylated tubulin, RacGAP, PLK1, and MKLP1 (highlighted in
our new Supplementary Fig. 2, Fig. 2 and 3). These studies were completed through
immunostaining or fluorescently tagged constructs. We also have confirmed that the
localization of the expressed human MKLP1 localizes in the same locale as two
zebrafish midbody proteins, MKLP1 and RacGAP, by immunohistochemistry
(Supplementary Fig. 2). All of this is included in new Fig. 2, and new Supplementary
Figure 2.

Reviewer #3 (Remarks to the Author):
“In “Cytokinetic bridge triggers de novo lumen formation in vivo”, Rathbun, Colicino and
colleagues describe the cellular events following cytokinesis of Kupffer’s Vesicle cells as
they initiate lumen formation during zebrafish gastrulation. They propose that cytokinetic
bridges are essential for bringing cell apices together into a rosette so that lumen
formation can be initiated where midbodies are being released. Although, they become
more frequent, this is one of the few in vivo studies of lumen formation, which moreover
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takes advantage of live imaging possibilities of the zebrafish embryo. This study
remains largely descriptive, sometimes relying on anecdotal observations. The single
functional experiment of the study is based on laser ablation, which should be taken
with more caution than the authors did. Finally, there is a theoretical model included in
the study. It is unclear to me what this model brings to the study and what the study
brings to the model.”
We thank the reviewer for acknowledging that this is one of the few in vivo
studies that examines lumen formation. To address the reviewers concerns on our
laser ablation studies we have added additional parameters, and discussed more
thoroughly controls that were used, new controls performed, and additional results
obtained (updated Figure 4). We have also developed a genetic tool to analyze the role
of Rab11-vesicle trafficking, an essential process for abscission, in forming a lumen
(new Fig. 5 and 6). In regard to the theoretical model, we used this model to present a
testable hypothesis that an intercellular connection is likely present to explain for the
discrepancy in force. We have now presented the model to frame a question for
examining whether cells were remaining interconnected by a cytokinetic bridge during
KV formation (Supplementary Equations and Model). Specific concerns are addressed
below.

Major concerns:
“1 - The manuscript begins with a theoretical model which concludes that cell-cell
adhesion and cell contractility, two major morphogenetic force generators, are too weak
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to bring cells together during KV cells gathering before lumen opening. This claim is
based on values of abscission, adhesion and contractile forces that have been taken is
vastly different contexts, none of them being in the system that is studied here. Also,
there is no attempt from the authors to actually test any of the assumptions of the
model. Finally, it is unclear what this conclusion brings to the study. Altogether, this is
far from convincing if the authors want to make their point that adhesion would not be
sufficient to keep sister cells together while they regroup with other KV cells.”
We apologize for the confusion, but we did not want to state that adhesion was
not sufficient. Instead, we hoped to propose a scenario where adhesion is likely not the
only force driving this process and that cytokinetic bridges may provide additional
support for packing geometries seen in KV. Due to your concern, we have rewritten this
section where we present this theoretical model as a model for why cytokinetic bridges
may be important, which sets precedence for our ablation studies. Our future directions
are to examine aspects of this model, such as differences in forces at cell-cell interfaces
compared to the bridge. We argue that our study highlights the novelty that cytokinetic
bridges are present during this developmental process and are likely contributing to
tissue morphogenesis that requires further consideration.

“2 - The authors use live imaging to follow the movements of the cells, cytokinetic
bridges and midbodies during KV formation. They quantify division rates, angles of
divisions, velocities and fluorescent intensities. However, several experiments are not
backed up with quantifications, making some observations rather anecdotal. For
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example, the laser ablation experiment is not quantified. Another example is the
description of the cell movements in Fig 3a,b which is not quantified either. How
common are these phenomena?”
We have significantly expanded our ablation studies to address your concerns.
We ablated a midbody inside the KV (experimental), a midbody outside the KV (control),
a site of cell-cell contact within KV (control), and within the cell body of a cell within KV
(control) (updated Fig. 4). With our three control groups, we hope to control for the
additional side effects that can occur with ablation techniques. We measured lumen
area over time following the apical clustering stage. In non-ablated embryos, lumens
form in ~20 min (new Fig. 4c). When midbodies are ablated outside KV a delay in lumen
formation occurs, but the lumen can still reach maximum area (Fig. 4c). Here we predict
application of the ablation laser outside KV causes trauma to the embryo resulting in a
slight but significant delay in KV lumen formation. We found a severe inhibition or delay
in lumen formation when midbodies are ablated in KV during apical clustering (Fig. 4dg). In KVs that do form a lumen, we find that lumen area is decreased at least by half
(Fig. 4g).
We monitored the movements of 17 pairs of daughter cells across 7 embryos in
updated Supplementary Fig. 3b. Here we monitored daughter cell distances (nucleus to
nucleus) from cytokinesis into abscission and found that this distance decreases as
cells pack together. Thus, we suggest that this is a common occurrence where daughter
cells remain interconnected to pack next to each other into the forming KV.
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“3 - The laser ablation experiment is key to the claim of the authors that cytokinetic
bridges and midbodies would be essential for lumen formation. Laser ablation is
generally a crude experiment which, if badly done, can have many unwanted
consequences, like the death of the sample for example or wound response. The fact
that the authors see no more development of the tissue (no lumen formation) after
ablation is not reassuring. After ablation, are the cells still dividing? Is the embryo still
developing? Are their left/right asymmetry affected (which is a standard readout for KV
related phenotypes)? Do KV cells still polarize apico-basally? What is it that goes wrong
so that they do not form the lumen? This clearly needs to be better described.
Also, the control experiment is only shown (without quantification either) in
supplementary material and is not mention in the main text, as far as I could read.
Controls are essential, this should be displayed in the main figure, quantified and
mentioned in the main text.”
Similar to Reviewer 1 comment 2, we believe Reviewer 3’s main concerns were
what controls we were using, and what are the downstream consequences of disrupting
the timing of abscission. To address these concerns, we have added additional controls
for our ablation experiments, and utilized alternative models to examine the general role
of the cell cycle in lumen formation (Fig. 1d) and a genetic tool to examine the role of
the cytokinetic bridge abscission in de novo lumen formation (new Fig. 5 and 6).
For our ablation experiments, we observe little to no cell death over a two-hour
period following the ablation. This is either when we ablate a midbody inside the KV
(experimental), a midbody outside the KV (control), a site of cell-cell contact within KV
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(control), and within the cell body of a cell within KV (control) (updated Fig. 4). However,
we did not notice any additional divisions during this time. We only note about 1-2
metaphase cells within this time frame and think the majority are in
cytokinesis/abscission. This point has been difficult to quantify due to our mosaic
labeling of MKLP1 to resolve the cytokinetic bridge. When we do ablation studies,
embryos are dechorinated and mounted in low-melting point agarose on MatTek coverglass bottom dishes. Imaging occurs on an inverted Leica DMI8 microscope. Following
ablation, the embryos are very difficult to extract from the agarose and both unablated
and ablated embryos end up falling apart. Thus, it’s very difficult with our ablation
experiments to examine whether there are left/right asymmetry defects. What we can
conclude from our ablation studies, especially now with our additional controls, is that
the cytokinetic bridge with its associated midbody is a structure involved during apical
clustering to initiate lumen formation in vivo.
Based on Reviewer 3’s concerns, we developed an alternative genetic
approach to test a scenario where we could prevent abscission while also inhibiting the
delivery of apical polarity proteins to the cytokinetic bridge (as described in Reviewer 1
comment 2). In brief, we acutely inhibited Rab11-associated membrane vesicles
through an optogenetic oligomerization approach (modeled from 9, Supplementary Fig.
5a). We first tested the efficacy of this system in HeLa cells (new Fig. 5a-b) where we
can promote a blue-light-inducible hetero-interaction between CRY2 and CIB1. HeLa
cells co-expressing CRY2-mCherry and CIB1-Cerulean-Rab11 (Fig. 5a-c) were treated
with and without blue light in the early stages of abscission. Under control conditions,
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cells progress through abscission within approximately 90 min. (Fig. 5a), but when cells
are exposed to blue light, Rab11-associated vesicles are unable to move into the
cytokinetic bridge and remain clustered within the cell body. Under these conditions
abscission is inhibited (Fig. 5b) and results in an increased number of binucleated cells
(Fig. 5c). Based on these studies, we next utilized this system in vivo to inactivate
Rab11-associated vesicles during KV formation.
By utilizing the CIB1-mCerulean-Rab11 and CRY2-mCherry optogenetic
clustering system, we examined whether Rab11-associated membranes were required
for KV formation. In control embryos (uninjected, injected with CRY2-mCherry only, or
injected with CIB1-mCerulean-Rab11 only), a robust lumen was able to form by the 4somite stage (Fig. 6b). No significant difference in lumen area was noted between
uninjected and injected control embryos exposed to blue light (Fig. 6b). In double
injected embryos exposed to blue light (experimental group) where KV cells have
clustered Rab11-associated membranes, significant defects in KV lumen formation
occurred such as decreased lumen area or an inability to form a lumen at all (Fig. 6b),
along with similar defects in assembling an apical membrane (Fig. 6c). These findings
suggest that acutely inhibiting Rab11-associated vesicles within KV-destined cells
starting at the migratory stage disrupts KV formation.
Under these conditions, we do not calculate a significant difference in embryo
death between control and experimental groups over a 42 hour period (Supplementary
Fig. 5d). However, we note an increase in rightward heart looping under conditions
where embryos co-expressed CRY2-mCherry and CIB1-Cerulean-Rab11 and were

200

exposed to blue light, but not under controls conditions (data not shown). This finding
suggests that disrupting Rab11 vesicle transport, which leads to defects in abscission
(Fig. 5, 8) and apical polarity (Fig. 6c-e) specifically during KV development results in
left/right asymmetry defects. We chose not to include this data in this study because we
wanted to focus on the cellular mechanisms in KV morphogenesis.

“Finally, I have difficulties following the rational of the authors in the interpretation of this
experiment. Their working model is that midbodies help lumen formation and they
observe multiple midbodies in each KV before they form their lumen. However, they
claim to be precisely ablating only one midbody. Why aren’t the remaining midbodies
able to trigger lumen formation? How many midbodies are left after ablation?”
We are sorry for the confusion. First, we would like to clarify that we utilize
midbodies as a marker for the cytokinetic bridge locale. We argue that the cytokinetic
bridge is a locale where directed membrane transport can occur towards the cytokinetic
midbody where vesicles can deliver apical polarity proteins to the newly forming apical
membrane. Rab11-associated vesicles have been identified to carry apical proteins
that include CFTR, which is essential in lumen expansion10. CFTR is a master regulator
of fluid secretion by controlling the transport of chloride to generate osmotic gradients
that drive the movement of water through a tissue11. If the cytokinetic bridge is
prematurely removed or if its abscission is inhibited through blocking Rab11-membrane
transport and thus blocking CFTR delivery, then lumens are unable to form properly
(Fig. 6). From this we present a model where premature abscission or clustering of
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Rab11-associated vesicles carrying CFTR results in a decrease of CFTR at the apical
membrane (new Fig. 6c-e), causing a loss of fluid flow and defects in lumen formation
and/or expansion.
We have clarified the text to state that we are attempting to ablate one midbody.
A particular experiment where we attempt to ablate one midbody is in updated Fig. 4b.
A time series demonstrates that one midbody (marking a cytokinetic bridge) is lost after
application of an ablation laser and the subsequent result was an inability to form a
lumen. We also have shown the membrane (GFP-CAAX) during this series (updated
Fig. 4b). It’s difficult to determine whether an additional cytokinetic bridge could be in
the vicinity of the ablation laser. Thus, we performed this experiment over a number of
embryos when we ablate a midbody during apical clustering. We find that some lumens
are unable to form, and some are able to form but are significantly smaller (refer to Fig.
4e-g). This could be due to a number of possibilities that include: 1) some cytokinetic
bridges are more important in providing a landmark for initial lumen formation, 2) more
than one cytokinetic bridge could have been accidentally ablated, or 3) adjacent cell-cell
interfaces where adhesions could be important may have become disrupted. This last
point we do not believe to be the case, because one of our controls is ablating cell-cell
interfaces where no defects in lumen formation are calculated (Fig. 4d-g).
The question “How many midbodies are left after ablation?” is technically
challenging to answer. In our experiments we try to only ablate one midbody (Fig. 4b)
and if you refer to Supplementary Movie 6, the midbody is released into the expanding
lumen following abscission and is very difficult to follow after that point. Thus, with our

202

current approaches it is difficult to monitor midbody number throughout the development
of KV.

“Altogether, this is the only functional experiment of the study that is backing up the
working model of the authors. It needs to be done carefully and ideally an alternative
strategy should complement it.”
Based on your concern we added additional controls for the ablation studies (Fig.
4), an additional optogenetic system (Fig. 5 and 6), and small molecule inhibitors to
block the cell cycle in general (Fig. 1d-e). We argue that these studies for the first time
highlight the importance of cell division during KV development and de novo formation
of its lumen.
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Personal Statement:
My graduate research in Dr. Heidi Hehnly’s lab (Syracuse University) focuses on
how cell division is used to create more complex, three-dimensional structures during
development. To test this, I use the vertebrate developmental model Danio rerio
(zebrafish) to uniquely address aspects of cell biology such as cell division and
membrane trafficking. My studies have examined the mechanisms involved in spindle
formation and subsequent placement in both in vitro cell culture (Colicino et al 2019
Molecular Biology of the Cell, Bucko et al 2019 eLife, Rathbun et al Nature
Communications, in press, Taneja et al 2016 Scientific Reports, Taneja et al 2019
Current Opinions in Cell Biology), and in an in vivo developmental model (Colicino et al
2019 Molecular Biology of the Cell, Bucko et al 2019 eLife, Rathbun et al Nature
Communications, in press). Additionally, my first author publication from Dr. Hehnly’s
lab identified for the first time in vivo that the cleavage of the cytokinetic bridge is
associated with lumen formation of the zebrafish organ of asymmetry, Kupffers Vesicle
(KV, Rathbun et al Nature Communications, in press).
• Taneja N, Rathbun L, Hehnly H, Burnette DT. The balance between adhesion
and contraction during cell division. Current opinion in cell biology. 2019 Feb
1;56:45-52. PMID: 30268802
• Taneja N, Fenix AM, Rathbun L, Millis BA, Tyska MJ, Hehnly H, Burnette DT.
Focal adhesions control cleavage furrow shape and spindle tilt during mitosis.
Scientific reports. 2016 Jul 19;6:29846. PMID: 27432211
• Colicino E, Curtis E, Bates M, Stevens K, Rathbun L, Manikas J, Amack J,
Freshour J, Hehnly H. Chromosome misalignment is associated with PLK1
activity at cenexin-positive mitotic centrosomes. Mol. Biol. Cell 30, 1598–1609
(2019). Awarded cover. PMID: 31042116
• Rathbun, LI, Colicino, EG, Manikas, J. et al. Cytokinetic bridge triggers de novo
lumen formation in vivo. Nat Commun 11, 1269 (2020).
https://doi.org/10.1038/s41467-020-15002-8
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Professional Memberships and Experiences
2016-present
American Society for Cell Biology (ASCB)
2017-present
Central New York Zebrafish Group
2018
Search Committee for SUNY Upstate Reference and Research
Services Librarian
2018
Selection Committee for SUNY Upstate President’s Award for
Research
2018-present
International Zebrafish Society (IZFS)
2018-present
Women in Science and Engineering (WiSE) Future Professionals
Program at Syracuse University

Awards and Honors
- Travel Award to attend ASCB/EMBO 2019 conference (December 2019)
- Inaugural Summer Dissertation Fellowship (Summer 2019)
- 3rd Place Poster Award at International Zebrafish Society (IZFS) Meeting (June
2018)
- Multiple Travel Awards from SUNY Upstate to attend IZFS International Meeting
(June 2018)
- Multiple Travel Awards from SUNY Upstate to attend the American Society for
Cell Biology (ASCB) international conference (December 2016, 2017, 2018)
- Research Presentation Award for Best Poster (SUNY Upstate, Spring 2017)

Invited Seminars
November 2019 Developmental Biology New York (DBNY), Ithaca College, NY
Title: “The role of cell division during lumen formation”
July 2019
Donut Talk Seminar, Biology Department, University of Rochester,
Rochester, NY
Title: “Shaping tissues through cell division”
April 2019
Central New York Zebrafish Meeting, Syracuse, NY
Title: “Optogenetic clustering of Rab11 vesicles during
Kupffer’s Vesicle development”
June 2018
International Zebrafish Society Meeting, Madison, WI
Title: “Cytokinetic bridge triggers de novo lumen formation in
vivo”
May 2017
Developmental Biology Interest Group of Syracuse, NY
Title: “Mechanisms regulating tissue expansion”
April 2017
Central New York Zebrafish Meeting, Syracuse, NY
Title: “The role of spindle orientation in embryonic patterning”
December 2016 American Society for Cell Biology (ASCB) International Meeting,
San Francisco, CA
Title: “The role of division orientation in tissue patterning”
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Contributions to Science
In collaboration with Dr. Dylan Burnette’s laboratory (Vanderbilt University, Nashville, TN),
we found that focal adhesions asymmetrically assemble following anaphase underneath
the oldest spindle pole to direct the placement of the mitotic spindle. These studies
resulted in a publication in Scientific Reports (Taneja et al. 2016), and a review article in
Current Opinions in Cell Biology (Taneja et al 2019).
• Taneja N, Rathbun L, Hehnly H, Burnette DT. The balance between adhesion and
contraction during cell division. Current opinion in cell biology. 2019 Feb 1;56:4552. PMID: 30268802
• Taneja N, Fenix AM, Rathbun L, Millis BA, Tyska MJ, Hehnly H, Burnette DT.
Focal adhesions control cleavage furrow shape and spindle tilt during mitosis.
Scientific reports. 2016 Jul 19;6:29846. PMID: 27432211
To further explore the mechanisms driving spindle placement in vivo, the zebrafish
embryo was used. These studies were done either immediately post-fertilization or during
the development of the zebrafish organ of asymmetry, Kupffer’s vesicle (KV). Our studies
identified that during the first five rounds of cell division, the spindle synchronously orients
with the spindles in the neighboring cells to set up the first monolayer of cells on top of
the yolk (Rathbun et al., in preparation). Later in development, we found that spindle
orientation is dispensable during KV development, but in this case placement of the
cytokinetic bridge plays an important role in organizing cell placement post-mitosis in this
developing tissue (Rathbun et al., 2020 Nat. Comm.).
• Rathbun, LI, Colicino, EG, Manikas, J. et al. Cytokinetic bridge triggers de novo
lumen formation in vivo. Nat Commun 11, 1269 (2020).
https://doi.org/10.1038/s41467-020-15002-8
• Rathbun L, Aljiboury A, Bai X, Bembenek J, Amack J, Hehnly H. A novel
embryonic centrosome strcture coordinates zebrafish spindle directionality in a
PLK1- and PLK4-dependent manner. In preparation.
Through work with Erica Colicino (graduate student in Dr. Hehnly’s laboratory), I utilized
zebrafish embryos that expressed fluorescently labelled PLK1 to document its localization
and asymmetry across the two mitotic centrosomes, and correlated this with the presence
of missegregated or lagging chromosomes during mitosis. This project resulted in a
publication at Molecular Biology of the Cell (Colicino et al 2019). Additionally, in a
collaborative project with John Scott’s lab at University of Washington at Seattle, I utilized
a centrosome-targeted version of the PLK1 inhibitor BI2536 to investigate the function of
PLK1 specifically at zebrafish centrosomes.
• Colicino E, Curtis E, Bates M, Stevens K, Rathbun L, Manikas J, Amack J,
Freshour J, Hehnly H. Chromosome misalignment is associated with PLK1 activity
at cenexin-positive mitotic centrosomes. Mol. Biol. Cell 30, 1598–1609 (2019).
Awarded cover. PMID: 31042116
• Bucko P, Lombard C, Rathbun L (co-second author), Bhat A, Garcia I,
Wordeman L, Smith D, Maly D, Hehnly H, Scott J. Subcellular drug targeting
illuminates local kinase action. eLife. 23 December 2019; 8: 1-29. PMID: 31872801
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Student Outreach
I am an active participant in the Skype a Scientist program, where I have
been matched with classrooms around the country to video conference with K-12
students to discuss scientific topics and STEM as a potential career choice.
Additionally, I have helped to organize a microsymposium with the high school
biology class at Naples High School (Naples, NY) where we discussed the dayto-day activities in a graduate-level research lab, our paths to college/graduate
school and the possible career options afterwards.
Community Outreach
I participate as a student organizer for the BioArt Mixer seminar series that
serves as a bridge and conversation starter between the science and art
communities of Syracuse University, SUNY Upstate, and the greater Syracuse
area. Additionally, I volunteer with other graduate students at the Westcott
Community Center in Syracuse, NY, where we lead students in scientific
activities afterschool.
Mentor to Graduate/Undergraduate Students
Nicole Hall
Syracuse University undergraduate, September 2019-present
Abrar Aljiboury
Syracuse University graduate student, Spring 2019-present
Julie Manikas
Syracuse University undergraduate, Fall 2018-Spring 2019
Post-baccalaureate technician, Fall 2019 - present
Erin Curtis
Syracuse University post-baccalaureate technician, Nov. 2018-May 2019,
Current graduate student at Duke University
Shannon Coyne
SUNY Geneseo summer student, June 2017 - August 2017
Current medical student at Tuoro School of Osteopathic Medicine
Shelby Helwig
Lock Haven University summer student, June 2016 - August 2016
Current graduate student at University of Maine
Alice Garrastegui
Syracuse University undergraduate, August 2016 - May 2018
Current medical student at State University of New York University at
Buffalo, Jacobs School of Medicine
Paul Lovell
Syracuse University undergraduate, August 2015 – May 2017
Current graduate student at University of Nebraska

231

